{"fcce653525bba82ca40e8934a2e37ee4de6e2c23": [["INTRODUCTIONMilitary recruits are at high risk of respiratory infections.", [["respiratory", "ANATOMY", 50, 61], ["respiratory infections", "DISEASE", 50, 72], ["respiratory infections", "PROBLEM", 50, 72], ["respiratory", "ANATOMY", 50, 61], ["infections", "OBSERVATION", 62, 72]]], ["1 The congregation of individuals from diverse geographic locations in semi-closed settings, together with high levels of close contact, provide conditions that favor the introduction and transmission of respiratory pathogens.", [["respiratory", "ANATOMY", 204, 215], ["respiratory pathogens", "DISEASE", 204, 225], ["respiratory pathogens", "PROBLEM", 204, 225], ["diverse", "OBSERVATION_MODIFIER", 39, 46], ["geographic", "OBSERVATION_MODIFIER", 47, 57], ["respiratory", "ANATOMY", 204, 215], ["pathogens", "OBSERVATION", 216, 225]]], ["2 Studies among military recruits have found high rates of illness and infection with respiratory viruses.", [["illness", "DISEASE", 59, 66], ["infection", "DISEASE", 71, 80], ["respiratory viruses", "DISEASE", 86, 105], ["illness", "PROBLEM", 59, 66], ["infection", "PROBLEM", 71, 80], ["respiratory viruses", "PROBLEM", 86, 105], ["infection", "OBSERVATION", 71, 80], ["respiratory viruses", "OBSERVATION", 86, 105]]], ["A longitudinal study in Singapore found that 39.4% of military personnel had evidence of seroconversion against influenza A/H1N1 during the 2009 pandemic, compared with 13.5% of individuals in the community and 6.5% of hospital staff.", [["influenza A/H1N1", "DISEASE", 112, 128], ["influenza A/H1N1", "ORGANISM", 112, 128], ["influenza A/H1N1", "SPECIES", 112, 128], ["A longitudinal study", "TEST", 0, 20], ["seroconversion", "PROBLEM", 89, 103], ["influenza", "PROBLEM", 112, 121], ["H1N1", "PROBLEM", 124, 128], ["seroconversion", "OBSERVATION", 89, 103]]], ["3 Numerous outbreaks of respiratory infections among military recruits have been reported in the literature, including outbreaks of influenza, adenovirus, 4-6 and pertussis.", [["respiratory", "ANATOMY", 24, 35], ["respiratory infections", "DISEASE", 24, 46], ["influenza", "DISEASE", 132, 141], ["adenovirus, 4-6 and pertussis", "CHEMICAL", 143, 172], ["adenovirus", "ORGANISM", 143, 153], ["4-6", "ORGANISM", 155, 158], ["pertussis", "ORGANISM", 163, 172], ["respiratory infections", "PROBLEM", 24, 46], ["influenza", "PROBLEM", 132, 141], ["adenovirus", "PROBLEM", 143, 153], ["pertussis", "PROBLEM", 163, 172], ["Numerous", "OBSERVATION_MODIFIER", 2, 10], ["outbreaks", "OBSERVATION_MODIFIER", 11, 20], ["respiratory infections", "OBSERVATION", 24, 46], ["influenza", "OBSERVATION", 132, 141]]], ["7 Resumption of vaccination against adenovirus types 4 and 7 in the U.S. military is estimated to have resulted in a 7-fold decrease in acute respiratory disease 8 and a shift in the predominant adenovirus types from types 4, 3, and 7 to types 1 and 2.INTRODUCTIONThe increasing availability of multiplex molecular diagnostic assays can yield data on multiple pathogens that would not routinely be detected.", [["respiratory", "ANATOMY", 142, 153], ["acute respiratory disease", "DISEASE", 136, 161], ["adenovirus", "ORGANISM", 36, 46], ["adenovirus", "ORGANISM", 195, 205], ["vaccination", "TREATMENT", 16, 27], ["a 7-fold decrease", "PROBLEM", 115, 132], ["acute respiratory disease", "PROBLEM", 136, 161], ["multiplex molecular diagnostic assays", "TEST", 295, 332], ["multiple pathogens", "PROBLEM", 351, 369], ["7-fold", "OBSERVATION_MODIFIER", 117, 123], ["decrease", "OBSERVATION_MODIFIER", 124, 132], ["acute", "OBSERVATION_MODIFIER", 136, 141], ["respiratory disease", "OBSERVATION", 142, 161], ["predominant", "OBSERVATION_MODIFIER", 183, 194], ["adenovirus", "OBSERVATION", 195, 205], ["increasing", "OBSERVATION_MODIFIER", 268, 278]]], ["9, 10 Studies in military populations can provide valuable information regarding the epidemiology and transmission of respiratory infections in adults because of the availability of well-defined populations that can be followed up over time.", [["respiratory", "ANATOMY", 118, 129], ["respiratory infections", "DISEASE", 118, 140], ["respiratory infections", "PROBLEM", 118, 140], ["well-defined populations", "PROBLEM", 182, 206], ["respiratory", "ANATOMY", 118, 129], ["infections", "OBSERVATION", 130, 140]]], ["Despite this, data from tropical settings, in which the epidemiology of influenza and other respiratory infections differs substantially from temperate settings, are limited.", [["respiratory", "ANATOMY", 92, 103], ["influenza", "DISEASE", 72, 81], ["respiratory infections", "DISEASE", 92, 114], ["tropical settings", "TREATMENT", 24, 41], ["influenza", "PROBLEM", 72, 81], ["other respiratory infections", "PROBLEM", 86, 114], ["influenza", "OBSERVATION", 72, 81], ["respiratory infections", "OBSERVATION", 92, 114]]], ["Increased understanding of the etiology of respiratory infections in these settings is important to identify opportunities for disease control in high-risk military populations and to identify risks of pathogen emergence with potential for spread into the wider community.INTRODUCTIONWe present the results of a longitudinal study of the burden and etiology of respiratory infections in Thai military recruits.MATERIALS AND METHODSThe study setting and procedures have been previously described.", [["respiratory", "ANATOMY", 43, 54], ["respiratory", "ANATOMY", 361, 372], ["respiratory infections", "DISEASE", 43, 65], ["respiratory infections", "DISEASE", 361, 383], ["respiratory infections", "PROBLEM", 43, 65], ["disease control", "TREATMENT", 127, 142], ["a longitudinal study", "TEST", 310, 330], ["respiratory infections", "PROBLEM", 361, 383], ["METHODSThe study", "TEST", 424, 440], ["procedures", "TREATMENT", 453, 463], ["respiratory", "ANATOMY", 43, 54], ["infections", "OBSERVATION", 55, 65], ["respiratory", "ANATOMY", 361, 372], ["infections", "OBSERVATION", 373, 383]]], ["11 Between May 2014 and May 2015, we enrolled participants from consecutive cohorts of recruits undertaking basic military training at two Royal Thai Army (RTA) barracks in Bangkok.", [["participants", "SPECIES", 46, 58]]], ["The camps consist of large, common sleeping quarters with beds arranged foot-to-foot in long rows.", [["foot", "ANATOMY", 72, 76], ["foot", "ORGANISM_SUBDIVISION", 72, 76], ["foot", "ORGANISM_SUBDIVISION", 80, 84], ["large", "OBSERVATION_MODIFIER", 21, 26], ["foot", "ANATOMY", 72, 76], ["foot", "ANATOMY", 80, 84]]], ["Trainees share meals in a common canteen and train in a large field in the center of the barracks and a number of ancillary buildings.", [["large", "OBSERVATION_MODIFIER", 56, 61]]], ["Each camp has its own medical unit.MATERIALS AND METHODSIndividuals were eligible for enrollment if they were aged \u00b3 18 years and were entering one of the two army barracks involved in the study.", [["the study", "TEST", 185, 194]]], ["Suspected tuberculosis cases or individuals with immune deficiencies, such as acquired immune deficiency syndrome, leukemia, or lymphoma, were excluded.", [["leukemia", "ANATOMY", 115, 123], ["lymphoma", "ANATOMY", 128, 136], ["tuberculosis", "DISEASE", 10, 22], ["immune deficiencies", "DISEASE", 49, 68], ["acquired immune deficiency syndrome", "DISEASE", 78, 113], ["leukemia", "DISEASE", 115, 123], ["lymphoma", "DISEASE", 128, 136], ["leukemia", "CANCER", 115, 123], ["lymphoma", "CANCER", 128, 136], ["tuberculosis cases", "PROBLEM", 10, 28], ["immune deficiencies", "PROBLEM", 49, 68], ["acquired immune deficiency syndrome", "PROBLEM", 78, 113], ["leukemia", "PROBLEM", 115, 123], ["lymphoma", "PROBLEM", 128, 136], ["tuberculosis", "OBSERVATION", 10, 22], ["immune deficiencies", "OBSERVATION", 49, 68], ["immune deficiency", "OBSERVATION", 87, 104], ["leukemia", "OBSERVATION", 115, 123], ["lymphoma", "OBSERVATION", 128, 136]]], ["Individuals providing informed consent were enrolled in the study and a demographic and clinical questionnaire was administered.", [["the study", "TEST", 56, 65]]], ["Participants were then followed up for symptoms of respiratory illness until the end of the 10-week training period.", [["respiratory", "ANATOMY", 51, 62], ["respiratory illness", "DISEASE", 51, 70], ["Participants", "SPECIES", 0, 12], ["symptoms", "PROBLEM", 39, 47], ["respiratory illness", "PROBLEM", 51, 70], ["respiratory", "ANATOMY", 51, 62], ["illness", "OBSERVATION", 63, 70]]], ["At one camp, nasal and throat swabs were obtained at the time of enrolment and at the end of the follow-up period (10 weeks later) from consenting participants.", [["nasal", "ANATOMY", 13, 18], ["throat swabs", "ANATOMY", 23, 35], ["nasal", "ORGANISM_SUBDIVISION", 13, 18], ["throat swabs", "ORGANISM_SUBSTANCE", 23, 35], ["participants", "SPECIES", 147, 159], ["nasal and throat swabs", "TEST", 13, 35], ["enrolment", "TREATMENT", 65, 74], ["nasal", "ANATOMY", 13, 18], ["throat", "ANATOMY", 23, 29]]], ["Participants experiencing respiratory symptoms were asked to consult the medical unit, where medical staff took a history, conducted a medical examination, and recorded symptoms of upper respiratory illness (URI) or influenza-like illness (ILI).", [["respiratory", "ANATOMY", 26, 37], ["respiratory", "ANATOMY", 187, 198], ["respiratory symptoms", "DISEASE", 26, 46], ["upper respiratory illness", "DISEASE", 181, 206], ["URI", "DISEASE", 208, 211], ["influenza-like illness", "DISEASE", 216, 238], ["ILI", "DISEASE", 240, 243], ["Participants", "SPECIES", 0, 12], ["respiratory symptoms", "PROBLEM", 26, 46], ["a medical examination", "TEST", 133, 154], ["recorded symptoms", "PROBLEM", 160, 177], ["upper respiratory illness", "PROBLEM", 181, 206], ["URI", "PROBLEM", 208, 211], ["influenza", "PROBLEM", 216, 225], ["upper", "ANATOMY_MODIFIER", 181, 186], ["respiratory", "ANATOMY", 187, 198], ["illness", "OBSERVATION", 199, 206]]], ["Upper respiratory illness was defined as an illness with at least two of the following: 1) runny nose or sneezing; 2) nasal congestion; 3) sore throat, hoarseness, or difficulty swallowing; 4) cough; 5) swollen or tender glands in the neck; and 6) fever (oral temperature > 38\u00b0C) at the time of presentation.", [["respiratory", "ANATOMY", 6, 17], ["nose", "ANATOMY", 97, 101], ["nasal", "ANATOMY", 118, 123], ["swollen", "ANATOMY", 203, 210], ["tender glands", "ANATOMY", 214, 227], ["neck", "ANATOMY", 235, 239], ["oral", "ANATOMY", 255, 259], ["respiratory illness", "DISEASE", 6, 25], ["sneezing", "DISEASE", 105, 113], ["nasal congestion", "DISEASE", 118, 134], ["sore throat", "DISEASE", 139, 150], ["hoarseness", "DISEASE", 152, 162], ["cough", "DISEASE", 193, 198], ["fever", "DISEASE", 248, 253], ["nose", "ORGANISM_SUBDIVISION", 97, 101], ["nasal", "ORGANISM_SUBDIVISION", 118, 123], ["swollen", "ORGANISM_SUBDIVISION", 203, 210], ["tender glands", "ORGAN", 214, 227], ["neck", "ORGANISM_SUBDIVISION", 235, 239], ["oral", "ORGANISM_SUBDIVISION", 255, 259], ["Upper respiratory illness", "PROBLEM", 0, 25], ["runny nose", "PROBLEM", 91, 101], ["sneezing", "PROBLEM", 105, 113], ["nasal congestion", "PROBLEM", 118, 134], ["sore throat", "PROBLEM", 139, 150], ["hoarseness", "PROBLEM", 152, 162], ["difficulty swallowing", "PROBLEM", 167, 188], ["cough", "PROBLEM", 193, 198], ["swollen or tender glands in the neck", "PROBLEM", 203, 239], ["fever", "PROBLEM", 248, 253], ["oral temperature", "TEST", 255, 271], ["respiratory", "ANATOMY", 6, 17], ["illness", "OBSERVATION", 18, 25], ["sneezing", "OBSERVATION", 105, 113], ["nasal", "ANATOMY", 118, 123], ["congestion", "OBSERVATION", 124, 134], ["sore throat", "ANATOMY", 139, 150], ["tender glands", "ANATOMY", 214, 227], ["neck", "ANATOMY", 235, 239]]], ["Influenza-like illness was defined as a respiratory illness with acute onset presenting with fever and cough or sore throat.", [["respiratory", "ANATOMY", 40, 51], ["Influenza-like illness", "DISEASE", 0, 22], ["respiratory illness", "DISEASE", 40, 59], ["fever", "DISEASE", 93, 98], ["cough", "DISEASE", 103, 108], ["sore throat", "DISEASE", 112, 123], ["Influenza", "PROBLEM", 0, 9], ["a respiratory illness", "PROBLEM", 38, 59], ["fever", "PROBLEM", 93, 98], ["cough", "PROBLEM", 103, 108], ["sore throat", "PROBLEM", 112, 123], ["acute", "OBSERVATION_MODIFIER", 65, 70]]], ["All ILI cases also met the case definition for URI.", [["URI", "PROBLEM", 47, 50]]], ["Non-ILI cases were defined as URI cases not meeting the case definition for ILI.", [["ILI", "DISEASE", 76, 79], ["Non-ILI cases", "PROBLEM", 0, 13], ["URI cases", "TEST", 30, 39], ["ILI", "PROBLEM", 76, 79]]], ["Additional nasal and throat swabs were requested from participants presenting with acute ILI or URI.MATERIALS AND METHODSLaboratory investigations.", [["nasal", "ANATOMY", 11, 16], ["throat swabs", "ANATOMY", 21, 33], ["ILI", "DISEASE", 89, 92], ["URI", "DISEASE", 96, 99], ["nasal", "MULTI-TISSUE_STRUCTURE", 11, 16], ["throat", "ORGANISM", 21, 27], ["swabs", "ORGANISM_SUBSTANCE", 28, 33], ["participants", "SPECIES", 54, 66], ["Additional nasal and throat swabs", "PROBLEM", 0, 33], ["acute ILI", "PROBLEM", 83, 92], ["URI", "PROBLEM", 96, 99], ["METHODSLaboratory investigations", "TEST", 114, 146], ["nasal", "ANATOMY", 11, 16], ["throat", "ANATOMY", 21, 27], ["URI", "OBSERVATION", 96, 99]]], ["Nasal and throat swabs were placed in viral transport media and stored at \u221220\u00b0C until transfer to the Armed Forces Research Institute of Medical Sciences for further testing.", [["Nasal", "ANATOMY", 0, 5], ["throat swabs", "ANATOMY", 10, 22], ["Nasal", "MULTI-TISSUE_STRUCTURE", 0, 5], ["throat swabs", "ORGANISM_SUBSTANCE", 10, 22], ["Nasal and throat swabs", "TREATMENT", 0, 22], ["viral transport media", "TREATMENT", 38, 59], ["further testing", "TEST", 158, 173], ["throat", "ANATOMY", 10, 16]]], ["We tested acute swabs for influenza virus using reverse transcription polymerase chain reaction (RT-PCR) following the U.S. Centers for Disease Control protocol.", [["influenza virus", "SPECIES", 26, 41], ["influenza virus", "SPECIES", 26, 41], ["acute swabs", "TEST", 10, 21], ["influenza virus", "PROBLEM", 26, 41], ["reverse transcription polymerase chain reaction", "PROBLEM", 48, 95], ["Disease Control protocol", "TREATMENT", 136, 160]]], ["12, 13 We also tested acute samples (from both camps) and the routine enrolment and follow-up specimens (from one camp) using a multiplex real-time PCR assay comprising 33 bacterial, viral, and fungal targets (FTD33 kit; Fast Track Diagnostics, Esch-sur-Alzette, Luxembourg).", [["samples", "ANATOMY", 28, 35], ["specimens", "ANATOMY", 94, 103], ["acute samples", "PROBLEM", 22, 35], ["follow-up specimens", "TEST", 84, 103], ["a multiplex real-time PCR assay", "TEST", 126, 157], ["bacterial", "TEST", 172, 181], ["viral", "TEST", 183, 188], ["fungal targets", "TEST", 194, 208], ["Esch", "TEST", 245, 249], ["acute", "OBSERVATION_MODIFIER", 22, 27], ["fungal targets", "OBSERVATION", 194, 208]]], ["A cycle threshold value of < 33 was considered a positive result.", [["A cycle threshold value", "TEST", 0, 23]]], ["Previous studies have shown high agreement between FTD33 and other commercial multiplex assays with specificities > 95% for most viral targets.", [["Previous studies", "TEST", 0, 16], ["other commercial multiplex assays", "TEST", 61, 94], ["specificities", "TEST", 100, 113]]], ["14,15 Sensitivity for influenza A and B, and human coronaviruses is high (> 90%), but is lower and more variable for other viral targets, including human bocavirus (80-92%), rhinovirus (61-75%), respiratory syncytial virus (50-72%), and human metapneumovirus (74-100%).", [["influenza A and B", "DISEASE", 22, 39], ["respiratory syncytial virus", "DISEASE", 195, 222], ["human metapneumovirus", "DISEASE", 237, 258], ["B", "CANCER", 38, 39], ["human", "ORGANISM", 45, 50], ["coronaviruses", "ORGANISM", 51, 64], ["human", "ORGANISM", 148, 153], ["bocavirus", "GENE_OR_GENE_PRODUCT", 154, 163], ["rhinovirus", "ORGANISM", 174, 184], ["respiratory syncytial virus", "ORGANISM", 195, 222], ["human", "ORGANISM", 237, 242], ["metapneumovirus", "ORGANISM", 243, 258], ["human", "SPECIES", 45, 50], ["human", "SPECIES", 148, 153], ["respiratory syncytial virus", "SPECIES", 195, 222], ["human", "SPECIES", 237, 242], ["metapneumovirus", "SPECIES", 243, 258], ["influenza A", "SPECIES", 22, 33], ["human coronaviruses", "SPECIES", 45, 64], ["human", "SPECIES", 148, 153], ["respiratory syncytial virus", "SPECIES", 195, 222], ["human metapneumovirus", "SPECIES", 237, 258], ["Sensitivity", "TEST", 6, 17], ["influenza", "PROBLEM", 22, 31], ["human coronaviruses", "TEST", 45, 64], ["other viral targets", "PROBLEM", 117, 136], ["human bocavirus", "TEST", 148, 163], ["rhinovirus", "TEST", 174, 184], ["respiratory syncytial virus", "PROBLEM", 195, 222], ["human metapneumovirus", "TEST", 237, 258], ["high", "OBSERVATION_MODIFIER", 68, 72], ["respiratory syncytial", "ANATOMY", 195, 216]]], ["14, 15 In a subset of recruits, we measured influenza antibody titers in paired sera taken at enrollment and at the end of followup using a hemagglutinin inhibition assay.", [["sera", "ANATOMY", 80, 84], ["sera", "ORGANISM_SUBSTANCE", 80, 84], ["influenza antibody titers", "TEST", 44, 69], ["paired sera", "TEST", 73, 84], ["a hemagglutinin inhibition assay", "TREATMENT", 138, 170]]], ["Seroconversion was defined as a 4-fold rise in influenza subtype-specific antibody titers.MATERIALS AND METHODSStatistical analysis.", [["Seroconversion", "TREATMENT", 0, 14], ["a 4-fold rise", "PROBLEM", 30, 43], ["influenza subtype-specific antibody titers", "PROBLEM", 47, 89], ["METHODSStatistical analysis", "TEST", 104, 131], ["influenza subtype-specific", "OBSERVATION", 47, 73], ["antibody titers", "OBSERVATION", 74, 89]]], ["Rates of illness.", [["illness", "DISEASE", 9, 16], ["illness", "PROBLEM", 9, 16], ["illness", "OBSERVATION", 9, 16]]], ["We computed the rates of URI and ILI as the number of cases of each outcome divided by the total person-time at risk, using robust standard errors in the calculation of 95% confidence intervals (CIs) to allow for clustering of illness episodes by camp and cohort.MATERIALS AND METHODSDisease etiology.", [["illness", "DISEASE", 227, 234], ["person", "SPECIES", 97, 103], ["URI", "PROBLEM", 25, 28], ["ILI", "PROBLEM", 33, 36], ["illness episodes", "PROBLEM", 227, 243]]], ["We determined the percentage of URI and ILI cases positive for each target pathogen, the percentage positive for more than one pathogen, and the percentage with no pathogen identified.MATERIALS AND METHODSInfluenza seroconversion.", [["URI", "PROBLEM", 32, 35], ["ILI cases", "TEST", 40, 49], ["each target pathogen", "PROBLEM", 63, 83], ["the percentage", "TEST", 85, 99], ["pathogen", "PROBLEM", 164, 172], ["METHODSInfluenza seroconversion", "PROBLEM", 198, 229], ["URI", "OBSERVATION", 32, 35], ["no", "UNCERTAINTY", 161, 163], ["pathogen", "OBSERVATION", 164, 172], ["METHODSInfluenza seroconversion", "OBSERVATION", 198, 229]]], ["We calculated the percentage of recruits who seroconverted, overall and by influenza subtype, based on a 4-fold rise in antibody titer between baseline and end of follow-up samples.MATERIALS AND METHODSBacterial colonization.", [["influenza subtype", "PROBLEM", 75, 92], ["a 4-fold rise in antibody titer", "PROBLEM", 103, 134], ["follow-up samples", "TEST", 163, 180], ["METHODSBacterial colonization", "PROBLEM", 195, 224], ["percentage", "OBSERVATION_MODIFIER", 18, 28], ["METHODSBacterial colonization", "OBSERVATION", 195, 224]]], ["We determined the percentage of recruits with a positive identification of a bacterial pathogen at recruitment, the overall change in colonization prevalence between baseline and end of follow-up for each bacterial species, and the risk of acquisition of bacterial pathogens over the follow-up period among those initially negative.MATERIALS AND METHODSAntibiotic use.", [["a bacterial pathogen", "PROBLEM", 75, 95], ["each bacterial species", "PROBLEM", 200, 222], ["bacterial pathogens", "PROBLEM", 255, 274], ["bacterial", "OBSERVATION_MODIFIER", 77, 86], ["pathogen", "OBSERVATION", 87, 95], ["overall", "OBSERVATION_MODIFIER", 116, 123], ["change", "OBSERVATION_MODIFIER", 124, 130], ["colonization", "OBSERVATION_MODIFIER", 134, 146], ["bacterial", "OBSERVATION_MODIFIER", 255, 264], ["pathogens", "OBSERVATION", 265, 274]]], ["We calculated the percentage of URI and ILI cases that were prescribed antibiotics and investigated clinical signs and symptoms associated with antibiotic prescription using logistic regression.", [["URI", "PROBLEM", 32, 35], ["ILI cases", "TREATMENT", 40, 49], ["antibiotics", "TREATMENT", 71, 82], ["clinical signs", "PROBLEM", 100, 114], ["symptoms", "PROBLEM", 119, 127], ["antibiotic prescription", "TREATMENT", 144, 167], ["logistic regression", "TREATMENT", 174, 193]]], ["Among those prescribed antibiotics, we determined the fraction of cases with a likely viral etiology based on the available Fast Track multiplex PCR results.MATERIALS AND METHODSAnalyses were conducted using Stata 11 (StataCorp, College Station, TX) and R 3.2.2.MATERIALS AND METHODSEthical approval.", [["those prescribed antibiotics", "TREATMENT", 6, 34], ["Fast Track multiplex PCR", "TEST", 124, 148], ["METHODSEthical approval", "TREATMENT", 276, 299]]], ["The study was approved by the Institutional Review Boards of the RTA in Bangkok, Thailand, the Walter Reed Army Institute of Research, and the London School of Hygiene & Tropical Medicine.", [["The study", "TEST", 0, 9], ["Tropical Medicine", "TREATMENT", 170, 187]]], ["All participants provided written informed consent.RESULTSThree cohorts of army recruits undertook basic military training at the two camps during the study period, in May 2014-July 2014, November 2014-January 2015, and May 2015-July 2015.", [["participants", "SPECIES", 4, 16]]], ["Of these, 867 (93%) were enrolled in the study.", [["the study", "TEST", 37, 46]]], ["Of the 867 participants, five participants withdrew from the study and 44 participants recruited in November 2014 were transferred out of the camp to complete their training elsewhere.", [["participants", "SPECIES", 11, 23], ["participants", "SPECIES", 30, 42], ["participants", "SPECIES", 74, 86], ["the study", "TEST", 57, 66]]], ["The remaining 818 (94%) completed the 10-week follow-up and were included in the analysis.", [["the analysis", "TEST", 77, 89]]], ["All participants were male and the median age was 21 years (range: 20-29 years).", [["participants", "ORGANISM", 4, 16], ["participants", "SPECIES", 4, 16]]], ["Details of recruitment and follow-up completion for each cohort are given in Supplemental Figure 1 .RESULTSRates of illness.", [["illness", "DISEASE", 116, 123], ["illness", "PROBLEM", 116, 123], ["illness", "OBSERVATION", 116, 123]]], ["There were a total of 248 episodes of URI and 8,063 person-weeks of follow-up, yielding an overall URI rate of 3.1 per 100 person-weeks.", [["person", "SPECIES", 52, 58], ["URI", "PROBLEM", 38, 41], ["an overall URI rate", "TEST", 88, 107]]], ["Upper respiratory illness rates ranged from 2.6 to 4.6 per 100 person-weeks across cohorts, with the exception of the camp A May 2014 cohort, in which no URI episodes were reported ( Figure 1 ).", [["respiratory", "ANATOMY", 6, 17], ["respiratory illness", "DISEASE", 6, 25], ["Upper respiratory illness rates", "PROBLEM", 0, 31], ["URI episodes", "PROBLEM", 154, 166], ["respiratory", "ANATOMY", 6, 17], ["illness", "OBSERVATION", 18, 25]]], ["There were 160 ILI episodes, giving an overall ILI rate of 2.0 per 100 person-weeks, ranging from 0 to 4.1 per 100 person-weeks across cohorts.RESULTSSymptoms and time off work.", [["160 ILI episodes", "PROBLEM", 11, 27], ["an overall ILI rate", "TEST", 36, 55]]], ["Fever was present in nearly two-thirds of URI episodes.", [["Fever", "DISEASE", 0, 5], ["Fever", "PROBLEM", 0, 5], ["URI episodes", "PROBLEM", 42, 54], ["URI", "OBSERVATION", 42, 45]]], ["Cough and sore throat occurred in > 90% of URI episodes, nasal congestion and headache in > 80% of episodes, and malaise and breathing difficulty in > 60% of episodes.", [["sore throat", "ANATOMY", 10, 21], ["nasal", "ANATOMY", 57, 62], ["Cough", "DISEASE", 0, 5], ["sore throat", "DISEASE", 10, 21], ["nasal congestion", "DISEASE", 57, 73], ["headache", "DISEASE", 78, 86], ["breathing difficulty", "DISEASE", 125, 145], ["nasal", "ORGANISM_SUBDIVISION", 57, 62], ["Cough", "PROBLEM", 0, 5], ["sore throat", "PROBLEM", 10, 21], ["URI episodes", "PROBLEM", 43, 55], ["nasal congestion", "PROBLEM", 57, 73], ["headache", "PROBLEM", 78, 86], ["episodes", "PROBLEM", 99, 107], ["malaise", "PROBLEM", 113, 120], ["breathing difficulty", "PROBLEM", 125, 145], ["episodes", "PROBLEM", 158, 166], ["sore throat", "ANATOMY", 10, 21], ["nasal", "ANATOMY", 57, 62], ["congestion", "OBSERVATION", 63, 73], ["headache", "OBSERVATION", 78, 86]]], ["All these symptoms were significantly more common in ILI compared with non-ILI episodes ( Table 1) .", [["ILI", "DISEASE", 53, 56], ["non-ILI", "DISEASE", 71, 78], ["All these symptoms", "PROBLEM", 0, 18], ["non-ILI episodes", "PROBLEM", 71, 87]]], ["Influenza-like illness cases were also more likely to take time off work than non-ILI cases (57.5% versus 13.6%, P < 0.001), although the length of time taken off work was short (median 1 day).", [["Influenza-like illness", "DISEASE", 0, 22], ["Influenza", "SPECIES", 0, 9], ["Influenza", "PROBLEM", 0, 9], ["non-ILI cases", "TEST", 78, 91], ["P", "TEST", 113, 114]]], ["There was one hospitalization in an individual diagnosed with pneumonia who was off work for 7 days.RESULTSDisease etiology.", [["pneumonia", "DISEASE", 62, 71], ["pneumonia", "PROBLEM", 62, 71], ["pneumonia", "OBSERVATION", 62, 71]]], ["Among the 134 URI and ILI samples tested by multiplex PCR, a pathogen was detected in 128.", [["samples", "ANATOMY", 26, 33], ["ILI samples", "TEST", 22, 33], ["multiplex PCR", "TEST", 44, 57], ["a pathogen", "TEST", 59, 69]]], ["A single pathogen was detected in 26% of samples, two pathogens in 31%, three pathogens in 26%, and four pathogens in 12%.", [["samples", "ANATOMY", 41, 48], ["samples", "CANCER", 41, 48], ["A single pathogen", "PROBLEM", 0, 17], ["samples", "TEST", 41, 48], ["two pathogens", "TEST", 50, 63], ["three pathogens", "TEST", 72, 87]]], ["Among URI pathogens, the most common viruses detected were rhinoviruses (22.4%), influenza B (11.9%), coronavirus 229 (5.2%), adenovirus (3.0%), and influenza A/H3 (3.0%).", [["rhinoviruses", "DISEASE", 59, 71], ["influenza B", "DISEASE", 81, 92], ["coronavirus 229", "DISEASE", 102, 117], ["rhinoviruses", "ORGANISM", 59, 71], ["influenza B", "ORGANISM", 81, 92], ["coronavirus 229", "ORGANISM", 102, 117], ["adenovirus", "ORGANISM", 126, 136], ["influenza A/H3", "ORGANISM", 149, 163], ["influenza B", "SPECIES", 81, 92], ["influenza B", "SPECIES", 81, 92], ["coronavirus 229", "SPECIES", 102, 117], ["adenovirus", "SPECIES", 126, 136], ["influenza A/H3", "SPECIES", 149, 163], ["Among URI pathogens", "PROBLEM", 0, 19], ["the most common viruses", "PROBLEM", 21, 44], ["rhinoviruses", "TEST", 59, 71], ["influenza B", "TEST", 81, 92], ["coronavirus", "TEST", 102, 113], ["adenovirus", "TEST", 126, 136], ["influenza A/H3", "PROBLEM", 149, 163]]], ["Other viruses accounted for < 3% of URI cases each.", [["Other viruses", "PROBLEM", 0, 13], ["URI cases each", "PROBLEM", 36, 50], ["viruses", "OBSERVATION", 6, 13]]], ["Of 133 samples tested for influenza by both RT-PCR and the Fast Track multiplex assay, 20 (15%) tested positive by at least one assay, and all of these were also positive by RT-PCR.", [["samples", "ANATOMY", 7, 14], ["influenza", "DISEASE", 26, 35], ["samples", "CANCER", 7, 14], ["133 samples", "TEST", 3, 14], ["influenza", "PROBLEM", 26, 35], ["PCR", "TEST", 47, 50], ["the Fast Track multiplex assay", "TEST", 55, 85], ["RT", "TEST", 174, 176], ["PCR", "TEST", 177, 180]]], ["Of the 20 RT-PCR positives, four were positive for influenza A/H3, of which one was also positive by the multiplex assay.", [["influenza A/H3", "ORGANISM", 51, 65], ["influenza A/H3", "SPECIES", 51, 65], ["the 20 RT-PCR positives", "TEST", 3, 26], ["influenza A/H3", "PROBLEM", 51, 65], ["the multiplex assay", "TEST", 101, 120]]], ["Of the remaining 16 positive for influenza B by RT-PCR, 14 were also positive by the multiplex assay.", [["influenza B", "DISEASE", 33, 44], ["influenza B", "ORGANISM", 33, 44], ["influenza", "PROBLEM", 33, 42], ["RT-PCR", "TEST", 48, 54], ["the multiplex assay", "TEST", 81, 100]]], ["There were no samples that tested positive by the multiplex assay and negative by RT-PCR.RESULTSAmong the bacteria, the most commonly detected species were Haemophilus influenzae type B (62.7%), H. influenzae non-type B (58.2%), Streptococcus pneumoniae (16.4%), and Klebsiella pneumoniae (16.4%).", [["samples", "ANATOMY", 14, 21], ["Haemophilus influenzae type B", "DISEASE", 156, 185], ["H. influenzae non-type B", "DISEASE", 195, 219], ["Streptococcus pneumoniae", "DISEASE", 229, 253], ["Klebsiella pneumoniae", "DISEASE", 267, 288], ["Haemophilus influenzae type B", "ORGANISM", 156, 185], ["H. influenzae non-type B", "ORGANISM", 195, 219], ["Streptococcus pneumoniae", "ORGANISM", 229, 253], ["Klebsiella pneumoniae", "ORGANISM", 267, 288], ["Haemophilus influenzae", "SPECIES", 156, 178], ["H. influenzae", "SPECIES", 195, 208], ["Streptococcus pneumoniae", "SPECIES", 229, 253], ["Klebsiella pneumoniae", "SPECIES", 267, 288], ["Haemophilus influenzae type B", "SPECIES", 156, 185], ["H. influenzae non-type B", "SPECIES", 195, 219], ["Streptococcus pneumoniae", "SPECIES", 229, 253], ["Klebsiella pneumoniae", "SPECIES", 267, 288], ["samples", "TEST", 14, 21], ["the multiplex assay", "TEST", 46, 65], ["RT", "TEST", 82, 84], ["PCR", "TEST", 85, 88], ["the bacteria", "TEST", 102, 114], ["Haemophilus influenzae type B", "TEST", 156, 185], ["H. influenzae non-type B", "TEST", 195, 219], ["Streptococcus pneumoniae", "TEST", 229, 253], ["Klebsiella pneumoniae", "PROBLEM", 267, 288], ["no", "UNCERTAINTY", 11, 13], ["bacteria", "OBSERVATION", 106, 114], ["Klebsiella pneumoniae", "OBSERVATION", 267, 288]]], ["However, these were commonly found in combination with other pathogens.", [["other pathogens", "PROBLEM", 55, 70], ["pathogens", "OBSERVATION", 61, 70]]], ["When considering only samples in which a single organism was found, H. influenzae type B was found in 13.4% of samples, H. influenzae non-type B in 9.0%, and S. pneumoniae, K. pneumoniae, and Legionella pneumophila in 0.7% each.", [["samples", "ANATOMY", 22, 29], ["samples", "ANATOMY", 111, 118], ["Legionella pneumophila", "DISEASE", 192, 214], ["H. influenzae type B", "ORGANISM", 68, 88], ["samples", "CANCER", 111, 118], ["H. influenzae non-type B", "ORGANISM", 120, 144], ["S. pneumoniae", "ORGANISM", 158, 171], ["K. pneumoniae", "ORGANISM", 173, 186], ["Legionella pneumophila", "ORGANISM", 192, 214], ["H. influenzae", "SPECIES", 68, 81], ["H. influenzae", "SPECIES", 120, 133], ["S. pneumoniae", "SPECIES", 158, 171], ["K. pneumoniae", "SPECIES", 173, 186], ["Legionella pneumophila", "SPECIES", 192, 214], ["H. influenzae type B", "SPECIES", 68, 88], ["H. influenzae non-type B", "SPECIES", 120, 144], ["S. pneumoniae", "SPECIES", 158, 171], ["K. pneumoniae", "SPECIES", 173, 186], ["Legionella pneumophila", "SPECIES", 192, 214], ["a single organism", "PROBLEM", 39, 56], ["H. influenzae type B", "TEST", 68, 88], ["H. influenzae non-type B", "TEST", 120, 144], ["S. pneumoniae", "PROBLEM", 158, 171], ["pneumoniae", "PROBLEM", 176, 186], ["Legionella pneumophila", "PROBLEM", 192, 214], ["pneumoniae", "OBSERVATION", 161, 171], ["pneumophila", "OBSERVATION_MODIFIER", 203, 214]]], ["There was little evidence to suggest that etiological agents differed between ILI and non-ILI cases, with the exception of H. influenzae non-type B and coronavirus 229, which occurred more frequently in non-ILI cases, and influenza A/H3 and coronavirus HKU1, which occurred more frequently in ILI cases ( Table 2) .RESULTSAnalysis of URI cases by time since the start of follow-up indicated strong temporal clustering of cases, with each cluster involving several respiratory pathogens (Figure 2 ).", [["ILI", "DISEASE", 78, 81], ["non-ILI", "DISEASE", 86, 93], ["ILI", "DISEASE", 293, 296], ["respiratory pathogens", "DISEASE", 464, 485], ["H. influenzae non-type B", "ORGANISM", 123, 147], ["coronavirus 229", "ORGANISM", 152, 167], ["non-ILI", "CANCER", 203, 210], ["influenza A/H3", "ORGANISM", 222, 236], ["coronavirus HKU1", "ORGANISM", 241, 257], ["H. influenzae", "SPECIES", 123, 136], ["coronavirus", "SPECIES", 241, 252], ["H. influenzae", "SPECIES", 123, 136], ["influenza A/H3", "SPECIES", 222, 236], ["ILI and non-ILI cases", "PROBLEM", 78, 99], ["H. influenzae non-type B", "PROBLEM", 123, 147], ["coronavirus", "PROBLEM", 152, 163], ["influenza", "PROBLEM", 222, 231], ["H3", "PROBLEM", 234, 236], ["coronavirus HKU1", "PROBLEM", 241, 257], ["URI cases", "PROBLEM", 334, 343], ["strong temporal clustering of cases", "PROBLEM", 391, 426], ["several respiratory pathogens", "PROBLEM", 456, 485], ["little evidence to suggest", "UNCERTAINTY", 10, 36], ["several", "OBSERVATION_MODIFIER", 456, 463], ["respiratory pathogens", "OBSERVATION", 464, 485]]], ["For example, the single cluster in Camp A during the November 2014 cohort resulted in identification of both rhinovirus and coronavirus 63, as well as numerous colonizing bacteria.", [["rhinovirus", "ORGANISM", 109, 119], ["coronavirus 63", "ORGANISM", 124, 138], ["coronavirus", "SPECIES", 124, 135], ["both rhinovirus", "PROBLEM", 104, 119], ["coronavirus", "PROBLEM", 124, 135], ["numerous colonizing bacteria", "PROBLEM", 151, 179], ["both rhinovirus", "ANATOMY", 104, 119], ["colonizing bacteria", "OBSERVATION", 160, 179]]], ["In other clusters, rhinovirus was also identified in combination with parainfluenza viruses, adenovirus, and influenza B virus ( Figure 2) .RESULTSInfluenza vaccination and seroconversion.", [["parainfluenza viruses", "DISEASE", 70, 91], ["influenza B", "DISEASE", 109, 120], ["RESULTSInfluenza", "CHEMICAL", 140, 156], ["rhinovirus", "ORGANISM", 19, 29], ["parainfluenza viruses", "ORGANISM", 70, 91], ["adenovirus", "ORGANISM", 93, 103], ["influenza B virus", "ORGANISM", 109, 126], ["parainfluenza", "SPECIES", 70, 83], ["influenza B virus", "SPECIES", 109, 126], ["parainfluenza viruses", "SPECIES", 70, 91], ["influenza B virus", "SPECIES", 109, 126], ["rhinovirus", "PROBLEM", 19, 29], ["parainfluenza viruses", "PROBLEM", 70, 91], ["adenovirus", "PROBLEM", 93, 103], ["influenza B virus", "PROBLEM", 109, 126], ["RESULTSInfluenza vaccination", "TREATMENT", 140, 168], ["seroconversion", "PROBLEM", 173, 187], ["rhinovirus", "OBSERVATION", 19, 29], ["parainfluenza viruses", "OBSERVATION", 70, 91]]], ["At enrollment, 2.4% of recruits reported having received influenza vaccination in the previous 12 months.", [["influenza vaccination", "TREATMENT", 57, 78]]], ["Seroconversion was most common against influenza B/Massachusetts (N = 7) and influenza A/H3 (N = 3) (Table 3) Colonization.", [["influenza B", "DISEASE", 39, 50], ["influenza B", "ORGANISM", 39, 50], ["Seroconversion", "TREATMENT", 0, 14], ["influenza", "PROBLEM", 39, 48], ["influenza A/H3 (N", "PROBLEM", 77, 94], ["Colonization", "PROBLEM", 110, 122]]], ["At baseline, 82.3% of recruits were colonized with H. influenzae type B and 31.5% with H. influenzae non-type B. Other common colonizing bacteria were K. pneumoniae (14.6%), Staphylococcus aureus (8.5%), and S. pneumoniae (8.5%).", [["H. influenzae type B", "DISEASE", 51, 71], ["K. pneumoniae", "DISEASE", 151, 164], ["Staphylococcus aureus", "DISEASE", 174, 195], ["S. pneumoniae", "DISEASE", 208, 221], ["H. influenzae type B", "ORGANISM", 51, 71], ["H. influenzae non-type B.", "ORGANISM", 87, 112], ["K. pneumoniae", "ORGANISM", 151, 164], ["Staphylococcus aureus", "ORGANISM", 174, 195], ["S. pneumoniae", "ORGANISM", 208, 221], ["H. influenzae", "SPECIES", 51, 64], ["H. influenzae", "SPECIES", 87, 100], ["K. pneumoniae", "SPECIES", 151, 164], ["Staphylococcus aureus", "SPECIES", 174, 195], ["S. pneumoniae", "SPECIES", 208, 221], ["H. influenzae type B", "SPECIES", 51, 71], ["H. influenzae", "SPECIES", 87, 100], ["K. pneumoniae", "SPECIES", 151, 164], ["Staphylococcus aureus", "SPECIES", 174, 195], ["S. pneumoniae", "SPECIES", 208, 221], ["H. influenzae type B", "PROBLEM", 51, 71], ["H. influenzae non-type B.", "PROBLEM", 87, 112], ["Other common colonizing bacteria", "PROBLEM", 113, 145], ["K. pneumoniae", "TEST", 151, 164], ["Staphylococcus aureus", "PROBLEM", 174, 195], ["S. pneumoniae", "PROBLEM", 208, 221], ["pneumoniae", "OBSERVATION", 211, 221]]], ["At the end of follow-up, colonization with H. influenzae non-type B had increased to 74.1%, and S. pneumoniae to 33.6%, whereas colonization with H. influenzae type B and K. pneumoniae had decreased to 67.2% and 8.4%, respectively.", [["H. influenzae non-type B", "ORGANISM", 43, 67], ["S. pneumoniae", "ORGANISM", 96, 109], ["H. influenzae type B", "ORGANISM", 146, 166], ["K. pneumoniae", "ORGANISM", 171, 184], ["H. influenzae", "SPECIES", 43, 56], ["S. pneumoniae", "SPECIES", 96, 109], ["H. influenzae", "SPECIES", 146, 159], ["K. pneumoniae", "SPECIES", 171, 184], ["H. influenzae", "SPECIES", 43, 56], ["S. pneumoniae", "SPECIES", 96, 109], ["H. influenzae type B", "SPECIES", 146, 166], ["K. pneumoniae", "SPECIES", 171, 184], ["colonization", "PROBLEM", 25, 37], ["H. influenzae non-type B", "TEST", 43, 67], ["S. pneumoniae", "PROBLEM", 96, 109], ["H. influenzae type B", "TEST", 146, 166], ["K. pneumoniae", "PROBLEM", 171, 184]]], ["In addition, Moraxella catarrhalis was found in four (3.1%) and L. pneumophila in two (1.5%) end of follow-up samples.", [["samples", "ANATOMY", 110, 117], ["Moraxella catarrhalis", "ORGANISM", 13, 34], ["L. pneumophila", "ORGANISM", 64, 78], ["Moraxella catarrhalis", "SPECIES", 13, 34], ["L. pneumophila", "SPECIES", 64, 78], ["Moraxella catarrhalis", "SPECIES", 13, 34], ["L. pneumophila", "SPECIES", 64, 78], ["Moraxella catarrhalis", "PROBLEM", 13, 34], ["L. pneumophila", "PROBLEM", 64, 78], ["follow-up samples", "TEST", 100, 117], ["Moraxella catarrhalis", "OBSERVATION", 13, 34], ["L.", "OBSERVATION_MODIFIER", 64, 66], ["pneumophila", "OBSERVATION", 67, 78]]], ["No change in S. aureus colonization was found.", [["S. aureus", "ORGANISM", 13, 22], ["S. aureus", "SPECIES", 13, 22], ["S. aureus", "SPECIES", 13, 22], ["S. aureus colonization", "PROBLEM", 13, 35], ["change", "OBSERVATION_MODIFIER", 3, 9], ["aureus", "OBSERVATION_MODIFIER", 16, 22], ["colonization", "OBSERVATION", 23, 35]]], ["In a subset of paired baseline and end of follow-up samples initially negative for H. influenzae non-type B (N = 89), the risk of H. influenzae non-type B acquisition was 70.1% (95% CI: 54.4-90.6%).", [["samples", "ANATOMY", 52, 59], ["H. influenzae", "ORGANISM", 83, 96], ["H. influenzae", "ORGANISM", 130, 143], ["H. influenzae", "SPECIES", 83, 96], ["H. influenzae", "SPECIES", 130, 143], ["H. influenzae non-type B", "SPECIES", 83, 107], ["H. influenzae", "SPECIES", 130, 143], ["follow-up samples", "TEST", 42, 59], ["H. influenzae", "TEST", 83, 96], ["H. influenzae non-type B acquisition", "TEST", 130, 166], ["CI", "TEST", 182, 184]]], ["Among those negative for S. pneumoniae at baseline (N = 119), the risk of acquiring S. pneumoniae during the follow-up period was 31.9% (95% CI: 22.6-43.8%).RESULTSUse of medications.", [["S. pneumoniae", "DISEASE", 84, 97], ["S. pneumoniae", "ORGANISM", 25, 38], ["S. pneumoniae", "ORGANISM", 84, 97], ["S. pneumoniae", "SPECIES", 25, 38], ["S. pneumoniae", "SPECIES", 84, 97], ["S. pneumoniae", "SPECIES", 25, 38], ["S. pneumoniae", "SPECIES", 84, 97], ["S. pneumoniae", "PROBLEM", 25, 38], ["acquiring S. pneumoniae", "PROBLEM", 74, 97], ["CI", "TEST", 141, 143], ["medications", "TREATMENT", 171, 182], ["pneumoniae", "OBSERVATION", 28, 38], ["pneumoniae", "OBSERVATION", 87, 97]]], ["Of 248 URI episodes, 39.1% were prescribed antibiotics.", [["URI episodes", "PROBLEM", 7, 19], ["antibiotics", "TREATMENT", 43, 54]]], ["Of these, all but one were prescribed amoxicillin or azithromycin.", [["amoxicillin", "CHEMICAL", 38, 49], ["azithromycin", "CHEMICAL", 53, 65], ["amoxicillin", "CHEMICAL", 38, 49], ["azithromycin", "CHEMICAL", 53, 65], ["amoxicillin", "SIMPLE_CHEMICAL", 38, 49], ["azithromycin", "SIMPLE_CHEMICAL", 53, 65], ["amoxicillin", "TREATMENT", 38, 49], ["azithromycin", "TREATMENT", 53, 65]]], ["In multivariable logistic regression, cases were more likely to be prescribed antibiotics if they presented with tonsillitis (OR = 5.10, 95% CI: 2.35-11.10), chills (OR = 3.91, 95% CI: 1.44-10.62), and swollen lymph nodes (OR = 2.54, 95% CI: 1.07-6.04).", [["lymph nodes", "ANATOMY", 210, 221], ["tonsillitis", "DISEASE", 113, 124], ["chills", "DISEASE", 158, 164], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 210, 221], ["antibiotics", "TREATMENT", 78, 89], ["tonsillitis", "PROBLEM", 113, 124], ["CI", "TEST", 141, 143], ["chills", "PROBLEM", 158, 164], ["CI", "TEST", 181, 183], ["swollen lymph nodes", "PROBLEM", 202, 221], ["CI", "TEST", 238, 240], ["tonsillitis", "OBSERVATION", 113, 124], ["chills", "OBSERVATION", 158, 164], ["swollen", "OBSERVATION_MODIFIER", 202, 209], ["lymph nodes", "OBSERVATION", 210, 221]]], ["Antibiotic prescription was less likely if patients presented with nasal congestion (OR = 0.26, 95% CI: 0.12-0.54).", [["nasal", "ANATOMY", 67, 72], ["nasal congestion", "DISEASE", 67, 83], ["patients", "ORGANISM", 43, 51], ["nasal", "ORGAN", 67, 72], ["patients", "SPECIES", 43, 51], ["Antibiotic prescription", "TREATMENT", 0, 23], ["nasal congestion", "PROBLEM", 67, 83], ["CI", "TEST", 100, 102], ["nasal", "ANATOMY", 67, 72], ["congestion", "OBSERVATION", 73, 83]]], ["There was no difference in prescribing between ILI and non-ILI patients.", [["ILI", "DISEASE", 47, 50], ["patients", "ORGANISM", 63, 71], ["patients", "SPECIES", 63, 71], ["no", "UNCERTAINTY", 10, 12], ["difference", "OBSERVATION_MODIFIER", 13, 23]]], ["Of 35 URI cases prescribed antibiotics and with available multiplex PCR results, 16 (45.6%) had viral pathogens detected and eight (22.9%) had a bacterial target detected in the absence of other pathogens.DISCUSSIONWe found a high incidence of URI in Thai army recruits, indicating that approximately 30% of recruits experienced a URI episode over the 10-week training period.", [["antibiotics", "TREATMENT", 27, 38], ["available multiplex PCR", "TEST", 48, 71], ["viral pathogens", "PROBLEM", 96, 111], ["a bacterial target", "PROBLEM", 143, 161], ["other pathogens", "PROBLEM", 189, 204], ["URI", "PROBLEM", 244, 247], ["a URI episode", "PROBLEM", 329, 342], ["bacterial target", "OBSERVATION", 145, 161], ["pathogens", "OBSERVATION", 195, 204], ["URI", "OBSERVATION", 244, 247]]], ["Comparison with other military cohorts is not straightforward because of differences between settings in terms of vaccination policies and seasonality of key pathogens such as influenza.", [["influenza", "DISEASE", 176, 185], ["vaccination policies", "TREATMENT", 114, 134], ["key pathogens", "PROBLEM", 154, 167], ["influenza", "PROBLEM", 176, 185]]], ["The URI and ILI rates in our study are nonetheless comparable with those reported by other studies in the United States.", [["The URI", "PROBLEM", 0, 7], ["ILI rates", "TEST", 12, 21], ["our study", "TEST", 25, 34], ["URI", "OBSERVATION", 4, 7]]], ["[16] [17] [18] Despite this, we found low rates of clinical influenza A in this minimally vaccinated population.", [["low rates", "PROBLEM", 38, 47], ["clinical influenza A", "PROBLEM", 51, 71], ["this minimally vaccinated population", "TREATMENT", 75, 111]]], ["Possible reasons for this could be exposure to circulating influenza strains before recruits entering the training camps.", [["circulating influenza strains", "PROBLEM", 47, 76], ["the training camps", "TREATMENT", 102, 120]]], ["Thai national influenza surveillance data indicate high influenza activity in the first half of 2014, with influenza A/H1N1 and influenza B predominating.", [["influenza A/H1N1", "DISEASE", 107, 123], ["influenza B", "DISEASE", 128, 139], ["influenza A/H1N1", "ORGANISM", 107, 123], ["influenza B", "ORGANISM", 128, 139], ["A/H1N1", "SPECIES", 117, 123], ["A/H1N1", "SPECIES", 117, 123], ["Thai national influenza surveillance data", "TEST", 0, 41], ["high influenza activity", "PROBLEM", 51, 74], ["influenza", "PROBLEM", 107, 116], ["H1N1", "PROBLEM", 119, 123], ["influenza B", "PROBLEM", 128, 139], ["high", "OBSERVATION_MODIFIER", 51, 55], ["influenza activity", "OBSERVATION", 56, 74]]], ["Titers greater than this value have been shown to be associated with a 50% reduction in risk of clinical influenza from homologous strains, for both influenza A and B viruses.", [["influenza", "DISEASE", 105, 114], ["influenza A and B viruses", "DISEASE", 149, 174], ["influenza A", "ORGANISM", 149, 160], ["B viruses", "ORGANISM", 165, 174], ["influenza A", "SPECIES", 149, 160], ["B viruses", "SPECIES", 165, 174], ["Titers", "TEST", 0, 6], ["clinical influenza", "PROBLEM", 96, 114], ["homologous strains", "PROBLEM", 120, 138], ["both influenza A and B viruses", "PROBLEM", 144, 174]]], ["[20] [21] [22] [23] Of interest, 86% of recruits also had baseline titers against influenza B/Massachusetts greater than this level.", [["[20] [21] [22] [23]", "SIMPLE_CHEMICAL", 0, 19], ["influenza B", "ORGANISM", 82, 93], ["baseline titers", "TEST", 58, 73], ["influenza B/Massachusetts", "PROBLEM", 82, 107]]], ["The higher baseline titers against influenza B/Massachusetts are consistent with the frequent detection of influenza B isolates from the Yamagata lineage in clinical specimens from Thailand in the first half of 2014.", [["specimens", "ANATOMY", 166, 175], ["influenza B", "DISEASE", 107, 118], ["influenza B", "ORGANISM", 35, 46], ["influenza B isolates", "ORGANISM", 107, 127], ["Yamagata lineage", "CELL", 137, 153], ["influenza B/Massachusetts", "PROBLEM", 35, 60], ["influenza B isolates", "PROBLEM", 107, 127], ["clinical specimens", "TEST", 157, 175], ["consistent with", "UNCERTAINTY", 65, 80], ["influenza", "OBSERVATION", 107, 116]]], ["19 In our study, the Fast Track multiplex assay appeared to have lower sensitivity for influenza compared with the CDC RT-PCR assay.", [["influenza", "DISEASE", 87, 96], ["our study", "TEST", 6, 15], ["the Fast Track multiplex assay", "TEST", 17, 47], ["lower sensitivity", "PROBLEM", 65, 82], ["influenza", "PROBLEM", 87, 96], ["the CDC RT-PCR assay", "TEST", 111, 131]]], ["We did not specifically investigate reasons for these discrepancies, although it should be noted that the two assays were not performed at the same time, as the multiplex assays were all performed at the end of data collection.", [["these discrepancies", "PROBLEM", 48, 67], ["the two assays", "TEST", 102, 116], ["the multiplex assays", "TEST", 157, 177]]], ["We therefore cannot discount the possibility that sample degradation might have influenced the relative performance of the Fast Track assay.", [["sample", "ANATOMY", 50, 56], ["sample degradation", "PROBLEM", 50, 68], ["the Fast Track assay", "TEST", 119, 139]]], ["Although influenza incidence was low, pathogen detection with sensitive multiplex diagnostics indicated high frequencies of respiratory pathogens, with co-circulation of multiple viruses including rhinovirus, adenovirus, and coronaviruses as well as influenza.", [["influenza", "DISEASE", 9, 18], ["respiratory pathogens", "DISEASE", 124, 145], ["rhinovirus, adenovirus, and coronaviruses", "DISEASE", 197, 238], ["influenza", "DISEASE", 250, 259], ["rhinovirus", "ORGANISM", 197, 207], ["adenovirus", "ORGANISM", 209, 219], ["adenovirus", "SPECIES", 209, 219], ["influenza incidence", "PROBLEM", 9, 28], ["pathogen detection", "TEST", 38, 56], ["multiplex diagnostics", "TEST", 72, 93], ["respiratory pathogens", "PROBLEM", 124, 145], ["multiple viruses", "PROBLEM", 170, 186], ["rhinovirus", "PROBLEM", 197, 207], ["adenovirus", "PROBLEM", 209, 219], ["coronaviruses", "PROBLEM", 225, 238], ["influenza", "PROBLEM", 250, 259], ["respiratory pathogens", "OBSERVATION", 124, 145], ["multiple", "OBSERVATION_MODIFIER", 170, 178], ["viruses", "OBSERVATION", 179, 186], ["rhinovirus", "OBSERVATION", 197, 207]]], ["In addition, we found high levels of colonization with numerous bacterial species, including both type B and non-type B H. influenzae, K. pneumoniae, and S. pneumoniae.", [["non-type B H. influenzae", "ORGANISM", 109, 133], ["K. pneumoniae", "ORGANISM", 135, 148], ["S. pneumoniae", "ORGANISM", 154, 167], ["B", "SPECIES", 118, 119], ["H. influenzae", "SPECIES", 120, 133], ["K. pneumoniae", "SPECIES", 135, 148], ["S. pneumoniae", "SPECIES", 154, 167], ["H. influenzae", "SPECIES", 120, 133], ["K. pneumoniae", "SPECIES", 135, 148], ["S. pneumoniae", "SPECIES", 154, 167], ["high levels of colonization", "PROBLEM", 22, 49], ["numerous bacterial species", "PROBLEM", 55, 81], ["type B and non-type B H. influenzae", "PROBLEM", 98, 133], ["K. pneumoniae", "PROBLEM", 135, 148], ["S. pneumoniae", "PROBLEM", 154, 167], ["high levels", "OBSERVATION_MODIFIER", 22, 33], ["colonization", "OBSERVATION", 37, 49], ["numerous", "OBSERVATION_MODIFIER", 55, 63], ["bacterial species", "OBSERVATION", 64, 81], ["pneumoniae", "OBSERVATION", 157, 167]]], ["Although we did not specifically study transmission chains or epidemiologic links between cases of illness, in the context of our study, recruits did not leave the camps during the 10-week training periods, such that the occurrence of respiratory pathogens is most likely to have resulted from transmission within the camps rather than from external sources.", [["illness", "DISEASE", 99, 106], ["respiratory pathogens", "DISEASE", 235, 256], ["illness", "PROBLEM", 99, 106], ["our study", "TEST", 126, 135], ["respiratory pathogens", "PROBLEM", 235, 256], ["respiratory", "ANATOMY", 235, 246], ["pathogens", "OBSERVATION", 247, 256], ["most likely", "UNCERTAINTY", 260, 271]]], ["Intense transmission of bacterial species was apparent, as the risks of acquiring H. influenzae non-type B and S. pneumoniae among initially non-colonized individuals were 70% and 31%, respectively.", [["H. influenzae non-type B", "ORGANISM", 82, 106], ["S. pneumoniae", "ORGANISM", 111, 124], ["H. influenzae", "SPECIES", 82, 95], ["S. pneumoniae", "SPECIES", 111, 124], ["H. influenzae", "SPECIES", 82, 95], ["S. pneumoniae", "SPECIES", 111, 124], ["bacterial species", "PROBLEM", 24, 41], ["acquiring H. influenzae non-type B", "PROBLEM", 72, 106], ["S. pneumoniae", "PROBLEM", 111, 124], ["bacterial species", "OBSERVATION", 24, 41], ["pneumoniae", "OBSERVATION", 114, 124]]], ["Bacterial species were also commonly found in samples from URI cases.", [["samples", "ANATOMY", 46, 53], ["Bacterial species", "PROBLEM", 0, 17], ["URI cases", "PROBLEM", 59, 68], ["species", "OBSERVATION", 10, 17]]], ["The colonizing nature of these bacterial species makes it difficult to determine the clinical relevance of these detections.", [["these bacterial species", "PROBLEM", 25, 48], ["these detections", "TEST", 107, 123], ["colonizing", "OBSERVATION_MODIFIER", 4, 14], ["bacterial species", "OBSERVATION", 31, 48]]], ["However, H. influenzae type B and non-type B were identified in 13% and 9% of clinical samples in the absence of any other pathogens, suggesting that these pathogens could be responsible for illness in a fraction of adult URI cases.", [["samples", "ANATOMY", 87, 94], ["illness", "DISEASE", 191, 198], ["H. influenzae type B", "ORGANISM", 9, 29], ["non-type B", "GENE_OR_GENE_PRODUCT", 34, 44], ["samples", "CANCER", 87, 94], ["H. influenzae", "SPECIES", 9, 22], ["H. influenzae", "SPECIES", 9, 22], ["H. influenzae type B", "TEST", 9, 29], ["non-type B", "PROBLEM", 34, 44], ["clinical samples", "TEST", 78, 94], ["any other pathogens", "PROBLEM", 113, 132], ["these pathogens", "PROBLEM", 150, 165], ["illness", "PROBLEM", 191, 198], ["adult URI cases", "PROBLEM", 216, 231]]], ["Interestingly, H. influenzae type B has not been previously associated with a significant burden of URI in adults.", [["H. influenzae type B", "DISEASE", 15, 35], ["URI", "DISEASE", 100, 103], ["H. influenzae type B", "ORGANISM", 15, 35], ["H. influenzae", "SPECIES", 15, 28], ["H. influenzae type B", "SPECIES", 15, 35], ["H. influenzae type B", "PROBLEM", 15, 35], ["URI", "PROBLEM", 100, 103], ["URI", "OBSERVATION", 100, 103]]], ["24 It is possible, however, that these cases were caused by other pathogens not included in the multiplex assay.DISCUSSIONHigh levels of colonization with bacterial species also point to the need for judicious use of antibiotics to treat URI in military populations.", [["URI", "DISEASE", 238, 241], ["other pathogens", "PROBLEM", 60, 75], ["the multiplex assay", "TEST", 92, 111], ["colonization", "PROBLEM", 137, 149], ["bacterial species", "PROBLEM", 155, 172], ["antibiotics", "TREATMENT", 217, 228], ["URI", "PROBLEM", 238, 241], ["colonization", "OBSERVATION", 137, 149]]], ["A quarter of URI cases in our study were prescribed broad-spectrum antibiotics, of whom 50% were more likely to have infections caused by viral pathogens based on multiplex PCR results.", [["infections", "DISEASE", 117, 127], ["URI cases", "PROBLEM", 13, 22], ["our study", "TEST", 26, 35], ["broad-spectrum antibiotics", "TREATMENT", 52, 78], ["infections", "PROBLEM", 117, 127], ["viral pathogens", "PROBLEM", 138, 153], ["multiplex PCR", "TEST", 163, 176], ["infections", "OBSERVATION", 117, 127]]], ["Although we lacked additional information to determine whether this resulted in adverse antibiotic resistance patterns, high levels of antibiotic use in a population with a high background of bacterial colonization presents a risk for development of antibiotic resistance, and highlights the importance of improved rapid diagnostics to rule out viral etiologies to aid clinical management.", [["adverse antibiotic resistance patterns", "PROBLEM", 80, 118], ["antibiotic use", "TREATMENT", 135, 149], ["bacterial colonization", "PROBLEM", 192, 214], ["antibiotic resistance", "PROBLEM", 250, 271], ["viral etiologies", "PROBLEM", 345, 361], ["clinical management", "TREATMENT", 369, 388], ["bacterial colonization", "OBSERVATION", 192, 214], ["antibiotic resistance", "OBSERVATION", 250, 271]]], ["In addition, it points to the need for increased antibiotic stewardship and health-care provider education to reduce unnecessary use of antibiotics in military settings.DISCUSSIONOur study also emphasizes the importance of systematic microbiological surveillance of URI in military populations, to allow prompt detection and control of outbreaks and early identification of emerging pathogens that may be circulating or could be introduced in the wider population.", [["increased antibiotic stewardship", "TREATMENT", 39, 71], ["antibiotics", "TREATMENT", 136, 147], ["DISCUSSIONOur study", "TEST", 169, 188], ["URI", "PROBLEM", 266, 269], ["prompt detection", "TEST", 304, 320], ["outbreaks", "PROBLEM", 336, 345], ["emerging pathogens", "PROBLEM", 374, 392]]], ["This is particularly important as infection control options in such closed settings are limited and vaccination coverage for key pathogens is low.DISCUSSIONLimited resources meant it was not possible to conduct multiplex diagnostics for all baseline, acute, and end of followup samples, as well as influenza serology.", [["samples", "ANATOMY", 278, 285], ["infection", "DISEASE", 34, 43], ["infection control options", "TREATMENT", 34, 59], ["such closed settings", "TREATMENT", 63, 83], ["vaccination coverage", "TREATMENT", 100, 120], ["key pathogens", "PROBLEM", 125, 138], ["multiplex diagnostics", "TEST", 211, 232], ["followup samples", "TEST", 269, 285], ["influenza serology", "TEST", 298, 316], ["particularly important", "UNCERTAINTY", 8, 30], ["infection", "OBSERVATION", 34, 43], ["acute", "OBSERVATION_MODIFIER", 251, 256]]], ["As a result, there was limited power to investigate whether colonization influenced risk of illness, or factors associated with colonization and acquisition of bacteria.", [["illness", "DISEASE", 92, 99], ["illness", "PROBLEM", 92, 99], ["colonization", "PROBLEM", 128, 140], ["bacteria", "PROBLEM", 160, 168]]], ["In addition, co-circulation of multiple pathogens makes it difficult to establish chains of transmission, which would require more detailed microbial sequencing information.", [["multiple pathogens", "PROBLEM", 31, 49], ["co-circulation", "OBSERVATION_MODIFIER", 13, 27], ["multiple", "OBSERVATION_MODIFIER", 31, 39], ["pathogens", "OBSERVATION", 40, 49]]], ["Clinical signs and symptoms were available at presentation only, and we did not have information regarding the duration of individual symptoms or additional clinical investigations conducted longitudinally during the course of illness, as these were not routinely performed.DISCUSSIONThe specific barracks setting and population characteristics limit the generalizability of our findings to other military settings with similar conditions.", [["Clinical signs", "TEST", 0, 14], ["symptoms", "PROBLEM", 19, 27], ["individual symptoms", "PROBLEM", 123, 142], ["additional clinical investigations", "TEST", 146, 180], ["illness", "PROBLEM", 227, 234]]], ["Nevertheless, our study provides key data regarding the epidemiology and transmission of respiratory pathogens in military populations in tropical settings.", [["respiratory", "ANATOMY", 89, 100], ["respiratory pathogens", "DISEASE", 89, 110], ["our study", "TEST", 14, 23], ["respiratory pathogens", "PROBLEM", 89, 110], ["respiratory pathogens", "OBSERVATION", 89, 110]]], ["Our results emphasize the need for improved infection prevention and control strategies in military settings, given the potential for intense transmission of a wide range of respiratory pathogens.DISCUSSIONFinancial support: This work was supported by the United States Department of Defense-Global Emerging Infectious Disease Surveillance (DoD-GEIS), Protocol 989A.DISCUSSIONDisclosures: The authors declare that they have no competing interests.", [["respiratory", "ANATOMY", 174, 185], ["infection", "DISEASE", 44, 53], ["respiratory pathogens", "DISEASE", 174, 195], ["Infectious Disease", "DISEASE", 308, 326], ["improved infection prevention", "TREATMENT", 35, 64], ["respiratory pathogens", "PROBLEM", 174, 195], ["infection", "OBSERVATION", 44, 53], ["respiratory pathogens", "OBSERVATION", 174, 195]]], ["There is no objection to its presentation and/or publication.", [["objection", "PROBLEM", 12, 21], ["no", "UNCERTAINTY", 9, 11], ["objection", "OBSERVATION", 12, 21]]], ["The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25.", [["human", "ORGANISM", 65, 70], ["human", "SPECIES", 65, 70], ["human", "SPECIES", 65, 70], ["protection of human subjects", "TREATMENT", 51, 79]]]], "49940b534cbf0d27bcaf250284c3b76e34410e5a": [["catastrophic risk for the future (Global Priorities Project 2016).", [["catastrophic risk", "PROBLEM", 0, 17]]], ["In 2003, it was estimated that since 1980 more than thirty-five new infectious diseases have emerged in humans; one every eight months (Smolinski et al. 2003) .", [["infectious diseases", "DISEASE", 68, 87], ["humans", "ORGANISM", 104, 110], ["humans", "SPECIES", 104, 110], ["humans", "SPECIES", 104, 110], ["new infectious diseases", "PROBLEM", 64, 87], ["new", "OBSERVATION_MODIFIER", 64, 67], ["infectious", "OBSERVATION", 68, 78]]], ["Since then the list has only grown (for example, the severe acute respiratory syndrome (SARS) coronavirus, swine influenza (H1N1 and other sub-types), the Middle East respiratory syndrome (MERS) coronavirus, Ebola virus disease (EVD), and the Zika flavivirus).", [["acute respiratory syndrome (SARS) coronavirus", "DISEASE", 60, 105], ["swine influenza", "DISEASE", 107, 122], ["H1N1", "DISEASE", 124, 128], ["Middle East respiratory syndrome (MERS) coronavirus", "DISEASE", 155, 206], ["Ebola virus disease", "DISEASE", 208, 227], ["EVD", "DISEASE", 229, 232], ["Zika flavivirus", "DISEASE", 243, 258], ["swine influenza", "ORGANISM", 107, 122], ["Middle East respiratory syndrome (MERS) coronavirus", "ORGANISM", 155, 206], ["Ebola virus", "ORGANISM", 208, 219], ["Zika flavivirus", "ORGANISM", 243, 258], ["swine influenza", "SPECIES", 107, 122], ["Ebola virus", "SPECIES", 208, 219], ["SARS) coronavirus", "SPECIES", 88, 105], ["Middle East respiratory syndrome (MERS) coronavirus", "SPECIES", 155, 206], ["Ebola virus", "SPECIES", 208, 219], ["Zika flavivirus", "SPECIES", 243, 258], ["the severe acute respiratory syndrome", "PROBLEM", 49, 86], ["SARS", "PROBLEM", 88, 92], ["coronavirus", "PROBLEM", 94, 105], ["swine influenza", "PROBLEM", 107, 122], ["H1N1", "PROBLEM", 124, 128], ["the Middle East respiratory syndrome", "PROBLEM", 151, 187], ["coronavirus", "PROBLEM", 195, 206], ["Ebola virus disease", "PROBLEM", 208, 227], ["EVD", "TREATMENT", 229, 232], ["the Zika flavivirus", "PROBLEM", 239, 258], ["severe", "OBSERVATION_MODIFIER", 53, 59], ["acute", "OBSERVATION_MODIFIER", 60, 65], ["respiratory syndrome", "OBSERVATION", 66, 86], ["Middle", "ANATOMY_MODIFIER", 155, 161], ["respiratory syndrome", "OBSERVATION", 167, 187], ["Ebola virus", "OBSERVATION", 208, 219]]], ["Most of these outbreaks have been localized but the Human Immunodeficiency Virus (HIV), SARS, and avian influenza (H5N1 and other sub-types) should have been warnings that globalization can easily occur.", [["Human Immunodeficiency Virus (HIV), SARS", "DISEASE", 52, 92], ["avian influenza", "DISEASE", 98, 113], ["H5N1", "DISEASE", 115, 119], ["Human Immunodeficiency Virus", "ORGANISM", 52, 80], ["avian influenza", "ORGANISM", 98, 113], ["Human", "SPECIES", 52, 57], ["Immunodeficiency Virus", "SPECIES", 58, 80], ["HIV", "SPECIES", 82, 85], ["avian influenza", "SPECIES", 98, 113], ["Human Immunodeficiency Virus", "SPECIES", 52, 80], ["HIV", "SPECIES", 82, 85], ["the Human Immunodeficiency Virus (HIV)", "PROBLEM", 48, 86], ["SARS", "PROBLEM", 88, 92], ["avian influenza", "PROBLEM", 98, 113], ["H5N1", "PROBLEM", 115, 119], ["outbreaks", "OBSERVATION", 14, 23]]], ["Already in 2005, the WHO launched its Global Influenza Preparedness Plan, urging countries to make national bio-preparedness plans, and many countries did so (WHO 2005) .", [["Influenza", "DISEASE", 45, 54]]]], "PMC7532338": [["IntroductionAfter first being officially reported in December 2019, the virus SARS-CoV-2 spread within months through the world, infecting millions of people with COVID-19.", [["SARS", "DISEASE", 78, 82], ["people", "ORGANISM", 151, 157], ["people", "SPECIES", 151, 157], ["the virus SARS", "TEST", 68, 82], ["CoV", "TEST", 83, 86], ["COVID", "TEST", 163, 168]]], ["At the time of writing, scientists around the world are researching and testing cures, vaccines, and improved tools for tracking, tracing, and containing the virus.", [["testing cures", "TREATMENT", 72, 85], ["vaccines", "TREATMENT", 87, 95], ["tracing", "TEST", 130, 137], ["the virus", "PROBLEM", 154, 163]]], ["This research statement concerns the analyses of the ethical challenges of digital tracking and tracing systems (DTTSs), by which I broadly mean any digital application or device readily usable for viral exposure (or contact) tracing and/or notification.IntroductionUnlike vaccines and cures, many DTTSs are already fully available\u2014while others are being developed\u2014and the ethical evaluation and guidelines have been prompt (see, e.g., Howell O'Neill et al. 2020; Morley et al. 2020; Raskar et al. 2020).", [["DTTSs", "CANCER", 298, 303], ["digital tracking", "TEST", 75, 91], ["tracing systems", "TEST", 96, 111], ["device", "TREATMENT", 172, 178], ["viral exposure", "PROBLEM", 198, 212], ["IntroductionUnlike vaccines", "TREATMENT", 254, 281], ["cures", "TREATMENT", 286, 291], ["the ethical evaluation", "TEST", 369, 391]]], ["An indispensable quality of ethical guidelines for DTTSs is its usability.", [["ethical guidelines", "TREATMENT", 28, 46], ["DTTSs", "TREATMENT", 51, 56]]], ["In this research statement I will present a sketch of improvements of their individual requirements, but I will also present an embryo of a more serious challenge to ethical guidelines for DTTSs.Preliminary assessmentMorley at el.\u2019s check-list contains two sections.", [["embryo", "ANATOMY", 128, 134], ["sections", "ANATOMY", 257, 265], ["DTTSs", "DISEASE", 189, 194], ["embryo", "DEVELOPING_ANATOMICAL_STRUCTURE", 128, 134], ["Preliminary assessment", "TEST", 195, 217]]], ["The first section concerns basic permissibility of using a DTTS (what they call \u201cgo/no-go\u201d) and contains four main questions: whether the solution is necessary, proportionate, scientifically sound (including whether it will be effective), and temporary (including a sunset clause).Preliminary assessmentThe second section concerns an evaluation of the degree of ethical justification for the system\u2019s properties.", [["Preliminary assessment", "TEST", 281, 303], ["an evaluation", "TEST", 331, 344]]], ["A DTTS cannot be efficient for a small set of users.", [["A DTTS", "TREATMENT", 0, 6], ["small", "OBSERVATION_MODIFIER", 33, 38]]], ["Should the DTTS be turned-off until it reaches a sufficient user-base (risking lower willingness to use the system) or should there be a shut-off function in case it never reaches sufficient wide-spread?", [["DTTS", "CANCER", 11, 15], ["the DTTS", "TREATMENT", 7, 15]]], ["Hopefully, modelling uncertainty related to these questions will decrease over time, but irrespective of the degree of factual uncertainty there is also a normative choice of what should be considered justified minimal efficiency.Preliminary assessmentThe effectiveness requirement might also conflict with the justificatory self-erasefunction criterion since data deletion might affect the efficiency criteria negatively in the same way that a small user base might (e.g., if many users selectively deletes data points, especially if deletion overlaps spatiotemporally).", [["minimal efficiency", "PROBLEM", 211, 229], ["Preliminary assessment", "TEST", 230, 252], ["The effectiveness requirement", "PROBLEM", 252, 281], ["data deletion", "PROBLEM", 360, 373], ["small", "OBSERVATION_MODIFIER", 445, 450]]], ["Related to deletion, there should also be an auto-delete function, beyond the sunset clause.", [["deletion", "PROBLEM", 11, 19], ["an auto-delete function", "PROBLEM", 42, 65], ["deletion", "OBSERVATION", 11, 19]]], ["This is because mitigation likely would not need individual data stored longer than approximately 1 month (this varies relative to incubation period, size of the user base, etcetera).1Preliminary assessmentThere are some issues with the consent requirement.", [["Preliminary assessment", "TEST", 184, 206], ["some issues", "PROBLEM", 216, 227], ["the consent requirement", "TREATMENT", 233, 256], ["size", "OBSERVATION_MODIFIER", 150, 154], ["some", "OBSERVATION_MODIFIER", 216, 220], ["issues", "OBSERVATION", 221, 227]]], ["Information aggregation makes it hard, if not impossible, to foresee what can be aggregated from shared data (see, e.g., Ohm 2010; Lundgren 2020), making it difficult to properly inform an agent about the consequences of how her data will be used, violating the standard moral requirements of an informed consent (see, e.g., Eyal 2019).2 We also know from research on the so-called \u2018privacy paradox\u2019, that people\u2019s reported privacy-preferences often do not correspond to their actual behavior (see, e.g., Gerber et al. 2018 for an overview), making consent somewhat of a red herring (i.e., because the presence of a consent agreement can make an ethically problematic agreement seem less problematic than it actually is).", [["people", "ORGANISM", 406, 412], ["people", "SPECIES", 406, 412], ["red herring", "SPECIES", 571, 582]]], ["In response to this, systems should be developed so that it is likely that a reasonable agent would consent, under normal circumstances (of course, it might be difficult to determine those conditions\u2014yet that is, partly, the aim of the other criteria).Preliminary assessmentA more serious set of problems has to do with privacy and anonymity.", [["Preliminary assessmentA", "TEST", 252, 275]]], ["However, requiring locally stored data arguably implies, at least partly, a problematic shift in the causal responsibility for information security, from the operator of a DTTS solution, with centralized data storage, to the end user.", [["a DTTS solution", "TREATMENT", 170, 185]]], ["Since if the sensitive data is stored locally (i.e., on the end user\u2019s device), then the security of that data could partly depend on how the user manages her device.", [["her device", "TREATMENT", 155, 165]]], ["Thus, given that we should not hold the user morally responsible for securing her data when using a DTTS, local storage might be problematic.Preliminary assessmentFurthermore, Morley et al. promotes differential privacy as a means of privacy-protection.", [["a DTTS", "TREATMENT", 98, 104], ["local storage", "TREATMENT", 106, 119], ["Preliminary assessment", "TEST", 141, 163], ["privacy-protection", "TREATMENT", 234, 252]]], ["Moreover, aggregated data could reveal patterns that could be used, or misused, in ways that is harmful for individuals, groups of individuals, or society at large (ibid).", [["aggregated data", "TEST", 10, 25]]], ["In the context of DTTSs, Rasker et al. gives the example of local business, which may be associate with disease-spreading (p.", [["disease", "PROBLEM", 104, 111], ["may be", "UNCERTAINTY", 82, 88]]], ["8).Preliminary assessmentFinally, another justificatory criterion promotes the idea that individuals should only be informed \u201cwhen they have been in contact with people with confirmed infection\u201d.", [["infection", "DISEASE", 184, 193], ["individuals", "ORGANISM", 89, 100], ["people", "ORGANISM", 162, 168], ["people", "SPECIES", 162, 168], ["Preliminary assessmentFinally", "TEST", 3, 32], ["infection", "PROBLEM", 184, 193], ["infection", "OBSERVATION", 184, 193]]], ["This would require that massive testing capabilities be available (if not, it would conflict with the effectiveness requirement).", [["massive testing capabilities", "TEST", 24, 52]]], ["Yet, in the absence of sufficient testing capabilities, it is not necessarily wrong to inform people that they have been in contact with people with a relevant set of symptoms.", [["people", "ORGANISM", 94, 100], ["people", "ORGANISM", 137, 143], ["people", "SPECIES", 94, 100], ["people", "SPECIES", 137, 143], ["symptoms", "PROBLEM", 167, 175]]], ["The question is how to balance informing people that they might have been exposed to a carrier, against the risk associated with communicating uncertain information (e.g., it may cause unnecessary worry or panic, or it may deteriorate trust in the application or the organizations behind it\u2014which in turn may result in, e.g., less efficiency overall).Preliminary assessmentThese are a few examples that I will build on to improve guidelines or checklists for DTTSs based on Morley et al.\u2019s proposal.", [["panic", "DISEASE", 206, 211], ["people", "ORGANISM", 41, 47], ["people", "SPECIES", 41, 47], ["panic", "PROBLEM", 206, 211], ["Preliminary assessment", "TEST", 351, 373], ["DTTSs", "TREATMENT", 459, 464]]], ["Next, I will turn to some more fundamental problems.Slippery slopesLike the pandemic, usage of DTTSs may have far reaching effects.", [["DTTSs", "CHEMICAL", 95, 100], ["DTTSs", "TREATMENT", 95, 100]]], ["However, even with a sunset clause, there is always a risk that temporary measures become permanent (see, e.g., Donohue 2000; Rentoul 2018 for some illustrative examples), or that temporary measures\u2014which are widely adapted\u2014change societal norms.", [["temporary measures", "TREATMENT", 180, 198]]], ["There is a difference between using DTTSs in a liberal democratic society and an oppressive regime.", [["DTTSs", "TREATMENT", 36, 41], ["a liberal democratic society", "TREATMENT", 45, 73], ["an oppressive regime", "TREATMENT", 78, 98]]], ["Moreover, recent changes in the political landscape reveal the risk that even relatively democratic countries can change rapidly.", [["recent changes in the political landscape", "PROBLEM", 10, 51]]], ["If this happens while DTTSs are in use, that arguably complicates matters.", [["DTTSs", "SIMPLE_CHEMICAL", 22, 27]]], ["That is, which measures that are acceptable\u2014and the risk that such measures be abused\u2014can quickly change after an election.Slippery slopesHowever, this issue is arguably even more complex, since we must not only ask how decisions are affected by changes within one country or what is suitable in different countries, we must also ask what effects increased surveillance in a democratic society have on surveillance in non-democratic societies.", [["Slippery slopes", "PROBLEM", 123, 138], ["slopes", "OBSERVATION_MODIFIER", 132, 138]]], ["For example, we have seen how President Trump\u2019s behavior and rhetoric about \u2018fake news\u2019 have been used by oppressive regimes (Schwartz 2019) and there is, likewise, a risk that usage of DTTSs in liberal democracies can influence the ability to\u2014unchallenged\u2014use and abuse DTTSs in less liberal regimes.", [["DTTSs", "CHEMICAL", 186, 191], ["DTTSs", "DISEASE", 271, 276], ["DTTSs in liberal democracies", "PROBLEM", 186, 214]]], ["Of course, we should recognize that with DTTSs, the current trend seems to be the other way around: that liberal democratic are taking the lead from less liberal democracies.", [["liberal democratic", "TREATMENT", 105, 123]]], ["It is worth to note that, at the time of writing, over 70 organizations, as well a long list of dignitaries, have signed a call for protecting democratic values in the wake of Covid-19, expressing a worry of measures taken by authoritative regimes because of the crises following the global pandemic (IDEA 2020).Slippery slopesThus, there are at least three slippery slopes that I want to turn my attention to in this forthcoming research:The risk that temporary measures become permanent and/or permanently change information distribution norms to create a new normal, a normal which may not be preferable;The risk that contextual factors (such as which political parties are in control) changes in a detrimental way after measures are in place, a change that may make previously unproblematic measures problematic;The risk that measures in one country negatively influences policies in another country.Slippery slopesThe problem with slippery slopes is that they consist of direct and indirect effects, effects which may be difficult to both identify and distinguish.", [["authoritative regimes", "TREATMENT", 226, 247], ["the crises", "PROBLEM", 259, 269], ["temporary measures", "TREATMENT", 453, 471], ["previously unproblematic measures problematic", "PROBLEM", 770, 815], ["slippery slopes", "PROBLEM", 936, 951], ["slopes", "OBSERVATION_MODIFIER", 321, 327], ["slopes", "OBSERVATION_MODIFIER", 913, 919], ["slippery slopes", "OBSERVATION", 936, 951]]], ["It will, therefore, be challenging to draw a distinctive line between a measure that blocks one from slipping down the slope and one that does not.", [["a distinctive line", "TREATMENT", 43, 61], ["distinctive", "OBSERVATION_MODIFIER", 45, 56], ["line", "OBSERVATION", 57, 61]]], ["Hence, granted the risk of slippery slopes, it seems that ethical guidelines for DTTSs does not easily lend itself to check-lists, or other forms of easily determinable guidelines that can be used by a non-expert.", [["slippery slopes", "PROBLEM", 27, 42], ["slippery slopes", "OBSERVATION", 27, 42]]]], "PMC7264513": [["INTRODUCTIONAn outbreak of novel coronavirus pneumonia (NCP) in Wuhan, China has spread quickly.", [["coronavirus pneumonia", "DISEASE", 33, 54], ["NCP", "DISEASE", 56, 59], ["coronavirus", "ORGANISM", 33, 44], ["novel coronavirus pneumonia", "PROBLEM", 27, 54], ["coronavirus", "OBSERVATION_MODIFIER", 33, 44], ["pneumonia", "OBSERVATION", 45, 54]]], ["Illness from NCP has had serious impact on public health and caused huge economic losses.", [["NCP", "CHEMICAL", 13, 16], ["Illness", "PROBLEM", 0, 7], ["huge economic losses", "PROBLEM", 68, 88], ["huge", "OBSERVATION_MODIFIER", 68, 72], ["economic losses", "OBSERVATION", 73, 88]]], ["As of February 17, 2020, 2,121 patients have died.", [["patients", "ORGANISM", 31, 39], ["patients", "SPECIES", 31, 39]]], ["It is noteworthy that among this group there were 3,019 medical staff with confirmed NCP, and five medical staff have died.1 It must be pointed out that NCP is highly contagious, and progression is rapid.", [["NCP", "DISEASE", 85, 88], ["NCP", "PROBLEM", 153, 156], ["highly", "OBSERVATION_MODIFIER", 160, 166], ["contagious", "OBSERVATION", 167, 177], ["progression", "OBSERVATION_MODIFIER", 183, 194], ["rapid", "OBSERVATION_MODIFIER", 198, 203]]], ["Generally speaking, the most common symptoms of NCP are fever, cough, myalgia, and/or fatigue.", [["NCP", "DISEASE", 48, 51], ["fever", "DISEASE", 56, 61], ["cough", "DISEASE", 63, 68], ["myalgia", "DISEASE", 70, 77], ["fatigue", "DISEASE", 86, 93], ["fever", "PROBLEM", 56, 61], ["cough", "PROBLEM", 63, 68], ["myalgia", "PROBLEM", 70, 77], ["fatigue", "PROBLEM", 86, 93], ["myalgia", "OBSERVATION", 70, 77]]], ["Less common symptoms are sputum production, headache, hemoptysis, and diarrhea.2 Nevertheless, here we report a case of a patient who was first seen in an ear, nose, and throat (ENT) clinic with the symptoms of left\u2010sided otalgia without fever, cough, and expectoration.CASE REPORTWe have obtained written informed consent from the study participant.", [["sputum", "ANATOMY", 25, 31], ["ear", "ANATOMY", 155, 158], ["nose", "ANATOMY", 160, 164], ["headache", "DISEASE", 44, 52], ["hemoptysis", "DISEASE", 54, 64], ["diarrhea", "DISEASE", 70, 78], ["otalgia", "DISEASE", 222, 229], ["fever", "DISEASE", 238, 243], ["cough", "DISEASE", 245, 250], ["expectoration", "DISEASE", 256, 269], ["sputum", "ORGANISM_SUBSTANCE", 25, 31], ["patient", "ORGANISM", 122, 129], ["ear", "ORGAN", 155, 158], ["nose", "ORGANISM_SUBDIVISION", 160, 164], ["patient", "SPECIES", 122, 129], ["participant", "SPECIES", 338, 349], ["Less common symptoms", "PROBLEM", 0, 20], ["sputum production", "PROBLEM", 25, 42], ["headache", "PROBLEM", 44, 52], ["hemoptysis", "PROBLEM", 54, 64], ["diarrhea", "PROBLEM", 70, 78], ["the symptoms", "PROBLEM", 195, 207], ["left\u2010sided otalgia", "PROBLEM", 211, 229], ["fever", "PROBLEM", 238, 243], ["cough", "PROBLEM", 245, 250], ["expectoration", "PROBLEM", 256, 269], ["hemoptysis", "OBSERVATION", 54, 64], ["diarrhea", "OBSERVATION", 70, 78], ["ear", "ANATOMY", 155, 158], ["nose", "ANATOMY", 160, 164], ["throat", "ANATOMY", 170, 176], ["otalgia", "OBSERVATION", 222, 229], ["cough", "OBSERVATION", 245, 250]]], ["All of the procedures were performed in accordance with the Declaration of Helsinki and relevant policies in China.CASE REPORTOn the morning of January 22, 2020, a 44\u2010year\u2010old man presented to an ENT clinic with a 1\u2010day history of left sided otalgia.", [["left sided otalgia", "ANATOMY", 231, 249], ["otalgia", "DISEASE", 242, 249], ["man", "ORGANISM", 176, 179], ["man", "SPECIES", 176, 179], ["the procedures", "TREATMENT", 7, 21], ["left sided otalgia", "PROBLEM", 231, 249], ["left", "ANATOMY_MODIFIER", 231, 235], ["sided", "ANATOMY_MODIFIER", 236, 241], ["otalgia", "OBSERVATION", 242, 249]]], ["The physical examination revealed erythema of the left tympanic membrane, a body temperature of 37.1\u00b0C, blood pressure of 160/97 mm Hg, and oxygen saturation of 99%.", [["left tympanic membrane", "ANATOMY", 50, 72], ["body", "ANATOMY", 76, 80], ["blood", "ANATOMY", 104, 109], ["erythema", "DISEASE", 34, 42], ["oxygen", "CHEMICAL", 140, 146], ["Hg", "CHEMICAL", 132, 134], ["oxygen", "CHEMICAL", 140, 146], ["tympanic membrane", "MULTI-TISSUE_STRUCTURE", 55, 72], ["body", "ORGANISM_SUBDIVISION", 76, 80], ["blood", "ORGANISM_SUBSTANCE", 104, 109], ["oxygen", "SIMPLE_CHEMICAL", 140, 146], ["The physical examination", "TEST", 0, 24], ["erythema of the left tympanic membrane", "PROBLEM", 34, 72], ["a body temperature", "TEST", 74, 92], ["blood pressure", "TEST", 104, 118], ["oxygen saturation", "TEST", 140, 157], ["erythema", "OBSERVATION", 34, 42], ["left", "ANATOMY_MODIFIER", 50, 54], ["tympanic membrane", "ANATOMY", 55, 72]]], ["The first impression was that the patient had otitis media caused by infection of the upper respiratory tract.", [["upper respiratory tract", "ANATOMY", 86, 109], ["otitis media", "DISEASE", 46, 58], ["infection of the upper respiratory tract", "DISEASE", 69, 109], ["patient", "ORGANISM", 34, 41], ["upper respiratory", "ORGANISM_SUBDIVISION", 86, 103], ["tract", "ORGANISM_SUBDIVISION", 104, 109], ["patient", "SPECIES", 34, 41], ["otitis media", "PROBLEM", 46, 58], ["infection of the upper respiratory tract", "PROBLEM", 69, 109], ["otitis", "OBSERVATION", 46, 52], ["infection", "OBSERVATION", 69, 78], ["upper", "ANATOMY_MODIFIER", 86, 91], ["respiratory tract", "ANATOMY", 92, 109]]], ["With consideration of the patient's travel history, the patient underwent routine blood tests, a rapid nucleic acid amplification test (NAAT) for influenza A and B, a chest computed tomography (CT) scan, and nasopharyngeal swab by real\u2010time polymerase chain reaction (RT\u2010PCR) with NCP\u2010specific primers and probes, specifically.CASE REPORTThe results recovered for the NAAT for influenza A and B were negative.", [["blood", "ANATOMY", 82, 87], ["nasopharyngeal swab", "ANATOMY", 208, 227], ["nucleic acid", "CHEMICAL", 103, 115], ["patient", "ORGANISM", 26, 33], ["patient", "ORGANISM", 56, 63], ["blood", "ORGANISM_SUBSTANCE", 82, 87], ["B", "CANCER", 393, 394], ["NCP\u2010specific primers", "DNA", 281, 301], ["NAAT", "PROTEIN", 368, 372], ["patient", "SPECIES", 26, 33], ["patient", "SPECIES", 56, 63], ["routine blood tests", "TEST", 74, 93], ["a rapid nucleic acid amplification test", "TEST", 95, 134], ["influenza", "PROBLEM", 146, 155], ["a chest computed tomography", "TEST", 165, 192], ["CT) scan", "TEST", 194, 202], ["nasopharyngeal swab", "TEST", 208, 227], ["real\u2010time polymerase chain reaction", "PROBLEM", 231, 266], ["RT\u2010PCR", "TEST", 268, 274], ["NCP\u2010specific primers", "TREATMENT", 281, 301], ["the NAAT", "TEST", 364, 372], ["influenza", "PROBLEM", 377, 386], ["chest", "ANATOMY", 167, 172], ["nasopharyngeal", "ANATOMY", 208, 222]]], ["The blood counts of the patient on admission were reviewed for white blood cell results.", [["blood", "ANATOMY", 4, 9], ["blood cell", "ANATOMY", 69, 79], ["blood", "ORGANISM_SUBSTANCE", 4, 9], ["patient", "ORGANISM", 24, 31], ["blood cell", "CELL", 69, 79], ["patient", "SPECIES", 24, 31], ["The blood counts", "TEST", 0, 16], ["white blood cell results", "TEST", 63, 87], ["blood", "ANATOMY", 4, 9]]], ["These are often reduced in NCP.", [["reduced", "OBSERVATION_MODIFIER", 16, 23], ["NCP", "OBSERVATION_MODIFIER", 27, 30]]], ["The chest CT scan revealed minor inflammatory striation of the middle lobe of the right lung without typical characteristics of NCP.CASE REPORTSeven days later, on the night of January 29, 2020, the patient presented to an emergency clinic with the syndromes of fever and cough.", [["chest", "ANATOMY", 4, 9], ["middle lobe", "ANATOMY", 63, 74], ["right lung", "ANATOMY", 82, 92], ["NCP", "DISEASE", 128, 131], ["fever", "DISEASE", 262, 267], ["cough", "DISEASE", 272, 277], ["lobe", "ORGAN", 70, 74], ["lung", "ORGAN", 88, 92], ["patient", "ORGANISM", 199, 206], ["patient", "SPECIES", 199, 206], ["The chest CT scan", "TEST", 0, 17], ["minor inflammatory striation of the middle lobe of the right lung", "PROBLEM", 27, 92], ["NCP", "PROBLEM", 128, 131], ["the syndromes", "PROBLEM", 245, 258], ["fever", "PROBLEM", 262, 267], ["cough", "PROBLEM", 272, 277], ["chest", "ANATOMY", 4, 9], ["minor", "OBSERVATION_MODIFIER", 27, 32], ["inflammatory", "OBSERVATION", 33, 45], ["middle lobe", "ANATOMY_MODIFIER", 63, 74], ["right", "ANATOMY_MODIFIER", 82, 87], ["lung", "ANATOMY", 88, 92], ["without", "UNCERTAINTY", 93, 100], ["NCP", "OBSERVATION_MODIFIER", 128, 131], ["fever", "OBSERVATION", 262, 267], ["cough", "OBSERVATION", 272, 277]]], ["A chest CT scan showed typical characteristics of NCP (Fig. 1).3 On February 2, 2020, the patient had a positive result with RT\u2010PCR with COVID\u201019\u2013specific primers and probes.4 On February 17, 2020, the patient was discharged with resolution of fever.", [["chest", "ANATOMY", 2, 7], ["NCP", "DISEASE", 50, 53], ["fever", "DISEASE", 244, 249], ["patient", "ORGANISM", 90, 97], ["patient", "ORGANISM", 202, 209], ["COVID\u201019\u2013specific primers", "DNA", 137, 162], ["patient", "SPECIES", 90, 97], ["patient", "SPECIES", 202, 209], ["A chest CT scan", "TEST", 0, 15], ["RT\u2010PCR", "TEST", 125, 131], ["COVID", "TEST", 137, 142], ["fever", "PROBLEM", 244, 249], ["chest", "ANATOMY", 2, 7], ["fever", "OBSERVATION", 244, 249]]], ["All symptoms had resolved with the exception of his cough.DISCUSSIONWe present a case report of an NCP patient who first presented to an ENT clinic.", [["cough", "DISEASE", 52, 57], ["patient", "ORGANISM", 103, 110], ["patient", "SPECIES", 103, 110], ["All symptoms", "PROBLEM", 0, 12], ["his cough", "PROBLEM", 48, 57], ["cough", "OBSERVATION", 52, 57]]], ["It is known that the most common symptoms of NCP at onset of the illness are fever, cough, myalgia, and/or fatigue.", [["NCP", "DISEASE", 45, 48], ["illness", "DISEASE", 65, 72], ["fever", "DISEASE", 77, 82], ["cough", "DISEASE", 84, 89], ["myalgia", "DISEASE", 91, 98], ["fatigue", "DISEASE", 107, 114], ["NCP", "PROBLEM", 45, 48], ["the illness", "PROBLEM", 61, 72], ["fever", "PROBLEM", 77, 82], ["cough", "PROBLEM", 84, 89], ["myalgia", "PROBLEM", 91, 98], ["fatigue", "PROBLEM", 107, 114]]], ["Less common symptoms are sputum production, headache, hemoptysis, and diarrhea.2 From an imaging standpoint, chest CT usually reveals small patchy opacifications in the early stages, often noted in a peripheral distribution, ground\u2010glass opacity, pulmonary infiltration, and at times, lung consolidation.1, 2 Patients do not tend to present with an otologic symptom.", [["sputum", "ANATOMY", 25, 31], ["chest", "ANATOMY", 109, 114], ["pulmonary", "ANATOMY", 247, 256], ["lung", "ANATOMY", 285, 289], ["headache", "DISEASE", 44, 52], ["hemoptysis", "DISEASE", 54, 64], ["diarrhea", "DISEASE", 70, 78], ["opacity", "DISEASE", 238, 245], ["sputum", "ORGANISM_SUBSTANCE", 25, 31], ["pulmonary", "ORGAN", 247, 256], ["lung", "ORGAN", 285, 289], ["Patients", "ORGANISM", 309, 317], ["Patients", "SPECIES", 309, 317], ["Less common symptoms", "PROBLEM", 0, 20], ["sputum production", "PROBLEM", 25, 42], ["headache", "PROBLEM", 44, 52], ["hemoptysis", "PROBLEM", 54, 64], ["diarrhea", "PROBLEM", 70, 78], ["an imaging standpoint", "TEST", 86, 107], ["chest CT", "TEST", 109, 117], ["small patchy opacifications", "PROBLEM", 134, 161], ["ground\u2010glass opacity", "PROBLEM", 225, 245], ["pulmonary infiltration", "PROBLEM", 247, 269], ["lung consolidation", "PROBLEM", 285, 303], ["an otologic symptom", "PROBLEM", 346, 365], ["hemoptysis", "OBSERVATION", 54, 64], ["diarrhea", "OBSERVATION", 70, 78], ["chest", "ANATOMY", 109, 114], ["small", "OBSERVATION_MODIFIER", 134, 139], ["patchy", "OBSERVATION_MODIFIER", 140, 146], ["opacifications", "OBSERVATION", 147, 161], ["early", "OBSERVATION_MODIFIER", 169, 174], ["stages", "OBSERVATION_MODIFIER", 175, 181], ["peripheral", "ANATOMY_MODIFIER", 200, 210], ["distribution", "OBSERVATION_MODIFIER", 211, 223], ["ground\u2010glass", "OBSERVATION_MODIFIER", 225, 237], ["opacity", "OBSERVATION", 238, 245], ["pulmonary", "ANATOMY", 247, 256], ["infiltration", "OBSERVATION", 257, 269], ["lung", "ANATOMY", 285, 289], ["consolidation", "OBSERVATION", 290, 303]]], ["In this case, the patient did not exhibit the typical characteristics of fever, cough, expectoration, abnormal laboratory testing, and characteristic chest CT scan findings, possibly because the patient was in a latent or early stage of NCP.", [["fever", "DISEASE", 73, 78], ["cough", "DISEASE", 80, 85], ["expectoration", "DISEASE", 87, 100], ["NCP", "DISEASE", 237, 240], ["patient", "ORGANISM", 18, 25], ["patient", "ORGANISM", 195, 202], ["patient", "SPECIES", 18, 25], ["patient", "SPECIES", 195, 202], ["fever", "PROBLEM", 73, 78], ["cough", "PROBLEM", 80, 85], ["expectoration", "PROBLEM", 87, 100], ["abnormal laboratory testing", "PROBLEM", 102, 129], ["characteristic chest CT scan findings", "TEST", 135, 172], ["NCP", "PROBLEM", 237, 240], ["fever", "OBSERVATION", 73, 78], ["chest", "ANATOMY", 150, 155]]], ["Of note, the otitis media might have been caused by the COVID\u201019 infection.CONCLUSIONMost NCP patients present to a respiratory clinic or emergency clinic.", [["otitis", "DISEASE", 13, 19], ["infection", "DISEASE", 65, 74], ["patients", "ORGANISM", 94, 102], ["patients", "SPECIES", 94, 102], ["the otitis media", "PROBLEM", 9, 25], ["the COVID\u201019 infection", "PROBLEM", 52, 74]]], ["Unusual symptoms, such as the presentation of otitis media to an otolaryngology clinic, may lead to delay in diagnosis and increased exposure to COVID\u201019 by medical staff.", [["otitis", "DISEASE", 46, 52], ["Unusual symptoms", "PROBLEM", 0, 16], ["otitis media", "PROBLEM", 46, 58]]]], "PMC7179377": [["Im M\u00e4rz dieses Jahres wurde aus der Lombardei und sp\u00e4ter aus New York berichtet, dass Patienten mit COVID-19 und schwerem akuten respiratorischen Syndrom (SARS) verstarben, weil nicht mehr ausreichend Beatmungsger\u00e4te verf\u00fcgbar waren.", [["SARS", "DISEASE", 155, 159], ["Im M\u00e4rz dieses Jahres wurde aus der Lombardei und sp\u00e4ter aus New York berichtet, dass Patienten mit COVID-19 und schwerem akuten respiratorischen Syndrom (SARS) verstarben", "SPECIES", 0, 171], ["Syndrom", "PROBLEM", 146, 153], ["verstarben", "TREATMENT", 161, 171]]], ["Der Bundesgesundheitsminister Jens Spahn veranlasste daraufhin die Bestellung von 10.000 Beatmungsger\u00e4ten, die gesamte Jahresproduktion des gr\u00f6\u00dften deutschen Herstellers.", [["Der Bundesgesundheitsminister Jens Spahn veranlasste daraufhin die Bestellung von 10.000 Beatmungsger\u00e4ten, die gesamte Jahresproduktion des gr\u00f6\u00dften deutschen Herstellers", "SPECIES", 0, 169]]]], "d426700e3d7e92dbc9d886bcb5241d8738a59c32": [["Surgeons are already under stress but the last few months of bushfires, the White Island eruption and now coronavirus disease 2019 (COVID- 19) have made things only more difficult for surgeons in New Zealand and Australia.", [["coronavirus disease", "DISEASE", 106, 125], ["the White Island eruption", "PROBLEM", 72, 97], ["now coronavirus disease", "PROBLEM", 102, 125], ["COVID", "TEST", 132, 137], ["coronavirus disease", "OBSERVATION", 106, 125]]], ["Thus, there is now need more than ever for surgeons to build greater levels of resilience and systems and support frameworks to enable them.", [["support frameworks", "TREATMENT", 106, 124]]], ["There are a myriad of publications on how professionals should handle these external threats but only a few have synthesized the literature in a way that is relevant to surgeons in Australasia.", [["myriad", "OBSERVATION_MODIFIER", 12, 18]]], ["[1] [2] [3] [4] There is a strong body of research that has identified the core components in building optimal resilience and well-being that have been captured in the following evidence-based STRONG model.Staying STRONG S: strengthen relationshipsStrong and supportive relationships are the number one predictor of well-being.", [["[1] [2] [3] [4]", "SIMPLE_CHEMICAL", 0, 15], ["strong", "OBSERVATION_MODIFIER", 27, 33], ["body", "OBSERVATION_MODIFIER", 34, 38], ["core", "OBSERVATION_MODIFIER", 75, 79], ["components", "OBSERVATION_MODIFIER", 80, 90]]], ["Investing in, reaching out towards and cultivating healthy relationships is a core resilient behaviour.Staying STRONG S: strengthen relationshipsIn the midst of challenges and pressure at work, nothing is more critical to well-being than staying connected to others.", [["pressure at work", "TREATMENT", 176, 192], ["pressure", "OBSERVATION_MODIFIER", 176, 184]]], ["5 Yet, when pressure mounts, a common reaction is to withdraw and end up isolated and overwhelmed.Staying STRONG S: strengthen relationshipsBuilding a supportive network of understanding and empathetic friends and colleagues is probably one of the most important ways that surgeons can stay resilient.", [["a common reaction", "PROBLEM", 29, 46]]], ["Having colleagues who will cover, swap call or scrub in on a difficult case is vital in a high-pressure job especially when balancing this with family and other commitments.Staying STRONG S: strengthen relationshipsHigh levels of social support have been associated with improved psychological and physiological health: benefits include a reduction in stress-related illness, increased self-confidence and improved problemsolving.", [["illness", "DISEASE", 367, 374], ["social support", "TREATMENT", 230, 244], ["stress-related illness", "PROBLEM", 352, 374], ["increased self-confidence", "PROBLEM", 376, 401]]], ["Humans, and that includes surgeons, are wired for connection.", [["Humans", "ORGANISM", 0, 6]]], ["Not only does this contribute to well-being and happiness, but also they are more productive, engaged and have more energy available to them and their patients and colleagues.T: take controlConcentrating attention and resources on the things that matter most and that you can influence and change increase one's sense of control and agency.T: take controlThere will be things that disrupt and go wrong in the surgeon's working life.", [["patients", "ORGANISM", 151, 159], ["patients", "SPECIES", 151, 159], ["productive", "OBSERVATION_MODIFIER", 82, 92]]], ["At the best of times, healthcare organizations, along with the patients that present, are complex, ever-changing and unpredictable.", [["patients", "ORGANISM", 63, 71], ["patients", "SPECIES", 63, 71]]], ["When faced with additional high-pressure situations such as COVID-19, it is easy to succumb to feelings of being overwhelmed and lacking control as it unfolds.T: take controlHow a surgeon experiences the world is shaped by perceptions and interpretations of events and triggers.", [["additional high-pressure situations", "TREATMENT", 16, 51], ["COVID", "TEST", 60, 65]]], ["The most successful people are those who have an internal locus of control and the belief that their actions affect their outcomes.", [["people", "ORGANISM", 20, 26], ["people", "SPECIES", 20, 26]]], ["People with an external locus, on the other hand, are more likely to see circumstances and events as largely steered by external forces, which they perceive they have little or no control over.", [["People", "ORGANISM", 0, 6], ["People", "SPECIES", 0, 6], ["an external locus", "PROBLEM", 12, 29], ["external locus", "OBSERVATION", 15, 29]]], ["Concentrating on the things one can influence and control fuel a positive upward spiral, as the direct impact of actions is seen leading to these successful outcomes.T: take controlA feeling of control, or mastery of one's own destiny, is one of the strongest drivers of well-being and performance and capacity to cope with life's challenges and adversities.", [["a positive upward spiral", "PROBLEM", 63, 87], ["life's challenges", "TREATMENT", 324, 341], ["adversities", "PROBLEM", 346, 357], ["upward spiral", "OBSERVATION_MODIFIER", 74, 87]]], ["Identifying the areas where actions and behaviour will have a real impact will ultimately be of personal benefit and of benefit to colleagues and patients.R: recharge and restoreRestoration practices boost mood, concentration and cognitive abilitymuch needed during times of pressure.R: recharge and restoreAs busy surgeons, the pace and demands of working life can be frenetic.", [["patients", "ORGANISM", 146, 154], ["patients", "SPECIES", 146, 154], ["recharge and restoreRestoration practices", "TREATMENT", 158, 199], ["concentration", "TREATMENT", 212, 225], ["cognitive abilitymuch", "TREATMENT", 230, 251], ["pressure", "TEST", 275, 283]]], ["With systemic and patient demands occupying the reality of the day, surgeons often find themselves operating in an optimum high arousal zone.", [["patient", "ORGANISM", 18, 25], ["patient", "SPECIES", 18, 25], ["systemic", "OBSERVATION_MODIFIER", 5, 13]]], ["However, this conception has been shown to be flawed.", [["flawed", "OBSERVATION", 46, 52]]], ["Moreover, there is a direct correlation between lack of recovery and increased risk of health and safety.", [["increased", "OBSERVATION_MODIFIER", 69, 78]]], ["Internal recovery refers to the shorter periods of relaxation that take place within the workday in the form of short breaks, sometimes known as micro-breaks.", [["relaxation", "TREATMENT", 51, 61], ["short breaks", "PROBLEM", 112, 124], ["short breaks", "OBSERVATION_MODIFIER", 112, 124]]], ["Examples of micro-breaks might be seizing a moment during the day to pause, breathe deeply, engage with a colleague or take a short brisk walk.", [["a short brisk walk", "PROBLEM", 124, 142]]], ["It is about giving the brain a break from high mental arousal states.", [["brain", "ANATOMY", 23, 28], ["brain", "ORGAN", 23, 28], ["high mental arousal states", "PROBLEM", 42, 68]]], ["Adopting an optimistic mindset is a skill that can be learned which enables one to choose helpful ways to examine and interpret life's challenges and setbacks.R: recharge and restoreBelieving that positive outcomes are possible during times of struggle can be difficult.", [["positive outcomes", "PROBLEM", 197, 214], ["positive", "OBSERVATION", 197, 205]]], ["The surgical brain is trained in a way that allows surgeons to spot weaknesses, problems or risks but it generally is not as well equipped when it comes to identifying what is right about a situation.", [["brain", "ANATOMY", 13, 18], ["brain", "ORGAN", 13, 18], ["surgical brain", "ANATOMY", 4, 18]]], ["14, 15 Realistic optimistic thinking is a skill that can be learned and developed by consciously choosing more helpful beliefs and interpretations about adverse events no matter how difficult the circumstances are.R: recharge and restorePeople who have an optimistic explanatory style tend to look first for what is right and tend to hold a belief that in the majority of cases, things will work out for the best.", [["People", "ORGANISM", 237, 243], ["People", "SPECIES", 237, 243], ["adverse events", "PROBLEM", 153, 167]]], ["Becoming more aware of one's thinking and its impact on emotions and subsequent actions is key to cultivating an optimistic mindset.R: recharge and restoreSo when negative thinking occurs, asking the following questions can help to strengthen mindset and create more helpful thinking:R: recharge and restore\u2022 What are the advantages associated with the situation?R: recharge and restore\u2022 What are the opportunities presented to the surgeon, the team and the organization by the present situation? \u2022 What new beliefs or thinking can one have about the situation? \u2022 Which aspects of this are in one's control?R: recharge and restore\u2022 How has the current halt on surgery enabled focus on other things that may have been neglectedthings that really matter such as family/downtime?", [["surgery", "TREATMENT", 660, 667]]], ["Choosing one's focus influences the emotions felt which impacts the actions taken and ultimately the type of results achieved, benefiting not only the surgeon but also surgical teams and patients.N: nurture: nourish, move and restMaking healthy food choices, sleeping well and moving regularly throughout the day contribute to building vital energy and longterm physical well-being for building resilience.N: nurture: nourish, move and restCombining diet, exercise and rest determines and leverages their overall impact on health and well-being.", [["patients", "ORGANISM", 187, 195], ["patients", "SPECIES", 187, 195]]], ["Effective resilience building habits lie in the choices made about the food eaten, and decisions made about the frequency of exercise and amount of restorative sleep, particularly when under pressure.N: nurture: nourish, move and restStress changes appetite, eating patterns shift and craving for certain foods increases including those containing sugar, caffeine or those which are high in carbohydrates, inhibiting sustainable levels of energy throughout the day.", [["caffeine", "CHEMICAL", 355, 363], ["sugar", "CHEMICAL", 348, 353], ["caffeine", "CHEMICAL", 355, 363], ["carbohydrates", "CHEMICAL", 391, 404], ["sugar", "SIMPLE_CHEMICAL", 348, 353], ["caffeine", "SIMPLE_CHEMICAL", 355, 363], ["carbohydrates", "SIMPLE_CHEMICAL", 391, 404], ["restorative sleep", "PROBLEM", 148, 165], ["those containing sugar", "TREATMENT", 331, 353], ["caffeine", "TREATMENT", 355, 363], ["restorative sleep", "OBSERVATION", 148, 165]]], ["A diet high in refined carbohydrates may lead to conditions such as diabetes and obesity which may have a negative effect on neurocognition.", [["diabetes", "DISEASE", 68, 76], ["obesity", "DISEASE", 81, 88], ["carbohydrates", "CHEMICAL", 23, 36], ["diabetes", "PROBLEM", 68, 76], ["obesity", "PROBLEM", 81, 88], ["diet high", "OBSERVATION_MODIFIER", 2, 11], ["obesity", "OBSERVATION", 81, 88]]], ["17 A good diet, including the replacement of sugary, fatty, snacks may yield positive benefits.N: nurture: nourish, move and restExercise is an important tool for managing pressure and building resilience.", [["the replacement of sugary", "TREATMENT", 26, 51], ["managing pressure and building resilience", "TREATMENT", 163, 204], ["good", "OBSERVATION_MODIFIER", 5, 9], ["diet", "OBSERVATION", 10, 14]]], ["13 Exercise benefits the brain by aiding concentration, reducing tension and improving well-being, mood and sleep quality.", [["brain", "ANATOMY", 25, 30], ["brain", "ORGAN", 25, 30], ["reducing tension", "PROBLEM", 56, 72], ["brain", "ANATOMY", 25, 30]]], ["Exercise is also good for almost every part of the body.", [["body", "ANATOMY", 51, 55], ["body", "ORGANISM_SUBDIVISION", 51, 55], ["body", "ANATOMY", 51, 55]]], ["It helps to condition the heart and lungs, helps activate the genes which produce proteins that protect the cells from damage and disease and burns up chemicals produced during the stress response.", [["heart", "ANATOMY", 26, 31], ["lungs", "ANATOMY", 36, 41], ["cells", "ANATOMY", 108, 113], ["heart", "ORGAN", 26, 31], ["lungs", "ORGAN", 36, 41], ["cells", "CELL", 108, 113], ["damage", "PROBLEM", 119, 125], ["disease", "PROBLEM", 130, 137], ["burns up chemicals", "PROBLEM", 142, 160], ["the stress response", "PROBLEM", 177, 196], ["heart", "ANATOMY", 26, 31], ["lungs", "ANATOMY", 36, 41]]], ["18 The effects of fatigue and sleep deprivation on performance are well known.", [["fatigue", "DISEASE", 18, 25], ["fatigue", "PROBLEM", 18, 25], ["sleep deprivation", "PROBLEM", 30, 47], ["fatigue", "OBSERVATION", 18, 25]]], ["Lowered judgement and decision-making, diminished situational awareness and lowered emotional control have been linked to preventable errors.", [["diminished situational awareness", "PROBLEM", 39, 71], ["lowered emotional control", "TREATMENT", 76, 101]]], ["19 If lifestyle makes sleep restriction a common occurrence, the ability of the surgical team to function well is likely to suffer.", [["sleep restriction", "PROBLEM", 22, 39]]], ["Moreover, this may be exacerbated by a culture at work that undermines the critical role that sleep has to maintain optimal well-being.", [["a culture", "TEST", 37, 46], ["may be", "UNCERTAINTY", 15, 21]]], ["Making sleep a priority and aiming for the recommended 7-9 h will contribute to enhanced cognitive functioning, sustained energy, stable mood and better immune functioning.", [["enhanced cognitive functioning", "PROBLEM", 80, 110]]], ["20 Making small, daily adjustments across each of these three areas to prioritize healthy food choices, incorporate regular movement and optimizing sleep in combination lead to significant, lasting and measurable gains.", [["small", "OBSERVATION_MODIFIER", 10, 15]]], ["Optimum areas of growth lie in one's areas of strengthnot weakness.", [["strengthnot weakness", "DISEASE", 46, 66], ["growth lie", "PROBLEM", 17, 27], ["strengthnot weakness", "PROBLEM", 46, 66], ["growth lie", "OBSERVATION", 17, 27], ["weakness", "OBSERVATION", 58, 66]]], ["New research about how adversity strengthens can help surgeons view challenging times as opportunities for growth and evolution rather than setbacks that limit.G: grow and developConventional wisdom has it that, in order to grow and develop to one's fullest capabilities, one must actively focus on rectifying weaknesses.", [["rectifying weaknesses", "PROBLEM", 299, 320]]], ["In fact, it has been shown that people's area of greatest potential and growth lies within their areas of unique strength and not in correcting weaknesses.", [["people", "ORGANISM", 32, 38], ["people", "SPECIES", 32, 38], ["greatest", "OBSERVATION_MODIFIER", 49, 57], ["growth", "OBSERVATION_MODIFIER", 72, 78]]], ["Being able to articulate strengths and apply these intelligently on a frequent basis strengthens individuals, boosts self-confidence to overcome life's challenges and leads to higher levels of performance.", [["life's challenges", "TREATMENT", 145, 162]]], ["Recently, psychologists have devoted research to the examination of what is referred to as post-traumatic growth.", [["the examination", "TEST", 49, 64], ["post-traumatic growth", "PROBLEM", 91, 112]]], ["Posttraumatic growth is common in survivors of illness, disasters and accidents, and in many cases survivors report positive life changes as a result of their experience.", [["illness", "DISEASE", 47, 54], ["accidents", "DISEASE", 70, 79], ["Posttraumatic growth", "PROBLEM", 0, 20], ["illness", "PROBLEM", 47, 54]]], ["New techniques and ways of coping are becoming key tools in the surgical armamentarium.", [["New techniques", "TREATMENT", 0, 14], ["surgical armamentarium", "OBSERVATION", 64, 86]]], ["By fusing together the above-mentioned key evidence-based elements that contribute to resilience and well-being, surgeons can apply the science of human flourishing to their own lives to strengthen themselves, the people around them and ultimately benefit their patients.", [["human", "ORGANISM", 147, 152], ["people", "ORGANISM", 214, 220], ["patients", "ORGANISM", 262, 270], ["human", "SPECIES", 147, 152], ["people", "SPECIES", 214, 220], ["patients", "SPECIES", 262, 270], ["human", "SPECIES", 147, 152]]]], "d8827613b667a68d450a3327a0f5f18933f0afe7": [["I've been thinking a great deal about that misperception these last few weeks, not only because of COVID-19 but also because of the powerful protests unfolding across the United States in response to race-related violence and discrimination.", [["COVID", "TEST", 99, 104]]], ["2703) When read at face-value, Dylan's poem-like geriatrics, I suppose-seems a not-so-subtle allusion to death and dying.", [["death", "DISEASE", 105, 110]]]], "PMC7122275": [["IntroductionInfections with fungal and viral pathogens in the surgical intensive critical unit (ICU) are not uncommon.", [["fungal and viral pathogens", "DISEASE", 28, 54], ["fungal and viral pathogens", "PROBLEM", 28, 54], ["fungal", "OBSERVATION", 28, 34], ["viral pathogens", "OBSERVATION", 39, 54]]], ["Often, however, diagnosis tends to be either delayed or superimposed on bacterial infections.", [["bacterial infections", "DISEASE", 72, 92], ["bacterial infections", "PROBLEM", 72, 92], ["bacterial", "OBSERVATION_MODIFIER", 72, 81], ["infections", "OBSERVATION", 82, 92]]], ["In some scenarios, definitive diagnosis can be challenging and a high index of suspicion is warranted to promptly manage critically ill patients.", [["critically ill", "DISEASE", 121, 135], ["patients", "ORGANISM", 136, 144], ["patients", "SPECIES", 136, 144]]], ["This approach is critical especially in immunosuppressed patients given their relative vulnerability to a multitude of infectious processes.", [["patients", "ORGANISM", 57, 65], ["patients", "SPECIES", 57, 65], ["immunosuppressed patients", "TREATMENT", 40, 65], ["infectious processes", "PROBLEM", 119, 139], ["infectious", "OBSERVATION", 119, 129]]], ["Although rare, oddball infections with rare viruses and fungi can significantly affect the clinical course and recovery of patients if timely diagnosis is delayed.", [["oddball infections", "DISEASE", 15, 33], ["patients", "ORGANISM", 123, 131], ["patients", "SPECIES", 123, 131], ["oddball infections", "PROBLEM", 15, 33], ["rare viruses", "PROBLEM", 39, 51], ["fungi", "PROBLEM", 56, 61], ["oddball infections", "OBSERVATION", 15, 33], ["viruses", "OBSERVATION", 44, 51]]], ["This chapter highlights important fungal, viral, and rare infections in the context of critically ill and high-risk patients, including the immunosuppressed patients, in the surgical ICU.Epidemiology: Incidence, Mortality ::: Candidiasis ::: Common Fungal Infections", [["infections", "DISEASE", 58, 68], ["critically ill", "DISEASE", 87, 101], ["Candidiasis", "DISEASE", 226, 237], ["Fungal Infections", "DISEASE", 249, 266], ["patients", "ORGANISM", 116, 124], ["patients", "ORGANISM", 157, 165], ["patients", "SPECIES", 116, 124], ["patients", "SPECIES", 157, 165], ["important fungal, viral", "PROBLEM", 24, 47], ["rare infections", "PROBLEM", 53, 68], ["critically ill", "PROBLEM", 87, 101], ["Candidiasis", "PROBLEM", 226, 237], ["Common Fungal Infections", "PROBLEM", 242, 266], ["fungal", "OBSERVATION", 34, 40], ["rare", "OBSERVATION_MODIFIER", 53, 57], ["infections", "OBSERVATION", 58, 68], ["Fungal", "OBSERVATION_MODIFIER", 249, 255], ["Infections", "OBSERVATION", 256, 266]]]], "ac52363a86f824b23ba126530776cc26c4daf1b7": [["IntroductionThe Coronavirus Disease 2019 , caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is an infectious disease first identified in December 2019 in the Hubei province of China (World Health Organization, 2020b).", [["Coronavirus Disease", "DISEASE", 16, 35], ["Acute Respiratory Syndrome Coronavirus", "DISEASE", 64, 102], ["Severe Acute Respiratory Syndrome Coronavirus 2", "ORGANISM", 57, 104], ["SARS-CoV-2", "ORGANISM", 106, 116], ["Severe Acute Respiratory Syndrome Coronavirus 2", "SPECIES", 57, 104], ["SARS-CoV-2", "SPECIES", 106, 116], ["The Coronavirus Disease", "PROBLEM", 12, 35], ["the Severe Acute Respiratory Syndrome Coronavirus", "PROBLEM", 53, 102], ["SARS-CoV", "TEST", 106, 114], ["an infectious disease", "PROBLEM", 122, 143], ["Coronavirus Disease", "OBSERVATION", 16, 35], ["Severe", "OBSERVATION_MODIFIER", 57, 63], ["Acute", "OBSERVATION_MODIFIER", 64, 69], ["Respiratory Syndrome", "OBSERVATION", 70, 90], ["infectious", "OBSERVATION", 125, 135]]], ["On account of its highly infectious and contagious nature, it has in the past 5 months spread to almost every country of the world (Reynolds and Weiss, 2020) .", [["highly", "OBSERVATION_MODIFIER", 18, 24], ["infectious", "OBSERVATION", 25, 35], ["contagious", "OBSERVATION_MODIFIER", 40, 50]]], ["Ghana registered its first case on 12 March 2020 (Ghana Health Service, 2020a).IntroductionAs the number of cases continued to rise steadily, measures were put in place by the Ghana Government to mitigate the spread of the virus.", [["the virus", "PROBLEM", 219, 228], ["virus", "OBSERVATION", 223, 228]]], ["There was first a presidential ban on all public gatherings including the closure of all schools, which was followed by a closure of all beaches and the Nation's borders (Nyabor, 2020) .", [["closure", "OBSERVATION", 74, 81], ["closure", "OBSERVATION", 122, 129]]], ["Two major cities -Accra and Kumasiwere locked down for three weeks.", [["Accra and Kumasiwere", "TREATMENT", 18, 38]]], ["At present, the Komfo Anokye Teaching Hospital (KATH) continues to run all its services, albeit, with the reduced number of patients at the outpatient clinics.Palliative care services in KATH -Restructuring operationsPalliative care services at the Komfo Anokye Teaching Hospital started in the latter part of 2015.", [["patients", "ORGANISM", 124, 132], ["patients", "SPECIES", 124, 132]]], ["The team now has three nurses trained in palliative care who are dedicated only to performing palliative care-related tasks.", [["palliative care", "TREATMENT", 94, 109]]], ["Each day had a lists of tasks to be accomplished which included patient care, preparing presentations, discussing studies to be undertaken, and reviewing strategies to expand palliative care within the hospital.", [["patient", "ORGANISM", 64, 71], ["patient", "SPECIES", 64, 71], ["palliative care", "TREATMENT", 175, 190]]], ["The team's restructuring included:Palliative care services in KATH -Restructuring operations1.", [["Palliative care services", "TREATMENT", 34, 58]]], ["All patients already with the team will be followed up on teleconsult basis.", [["patients", "ORGANISM", 4, 12], ["patients", "SPECIES", 4, 12]]], ["Those who require refill of drugs will be provided the prescriptions electronically except for controlled drugs such as morphine, in which case a relative must come for the prescription and purchase it from the hospital.", [["morphine", "CHEMICAL", 120, 128], ["morphine", "CHEMICAL", 120, 128], ["morphine", "SIMPLE_CHEMICAL", 120, 128], ["drugs", "TREATMENT", 28, 33], ["controlled drugs", "TREATMENT", 95, 111], ["morphine", "TREATMENT", 120, 128]]], ["One member of the team will remain in charge of all teleconsults with patients and receive referrals made via phone calls.", [["patients", "ORGANISM", 70, 78], ["patients", "SPECIES", 70, 78]]], ["Where referrals are more than one, at least two members will report and see the patients.", [["patients", "ORGANISM", 80, 88], ["patients", "SPECIES", 80, 88]]], ["Research proposal developments will continue as plannedpersons involved will work from home.The emerging challengeAs at 12 May, 2020, 24 out of 5,408 individuals confirmed to be infected with SARS-CoV-2 had died in Ghana, one of the first few deaths occurring at the Komfo Anokye Teaching Hospital (Alamisi, 2020; Ghana Health Service, 2020b) .", [["SARS", "DISEASE", 192, 196], ["deaths", "DISEASE", 243, 249], ["individuals", "ORGANISM", 150, 161], ["SARS-CoV-2", "ORGANISM", 192, 202], ["SARS-CoV", "SPECIES", 192, 200], ["SARS", "PROBLEM", 192, 196], ["infected", "OBSERVATION", 178, 186]]], ["The number of people affected are on the rise, and it is inevitable that the number of deaths may rise too.", [["deaths", "DISEASE", 87, 93], ["people", "ORGANISM", 14, 20], ["people", "SPECIES", 14, 20], ["number", "OBSERVATION_MODIFIER", 4, 10]]], ["It is quite probable that, if public health prevention measures are not properly instituted and adhered to, the death toll may be worse keeping in view the low-resource capacity of Ghana's healthcare sector (Associated Press, 2020) .", [["death", "DISEASE", 112, 117], ["quite probable", "UNCERTAINTY", 6, 20]]], ["In Ghana, death is viewed as the beginning of a new form of existence, for which reason death is celebrated by large funerals by many ethnic and religious groups (Ekore and Lanre-Abass, 2016; Ohene, 2018) .", [["death", "DISEASE", 10, 15], ["death", "DISEASE", 88, 93], ["large", "OBSERVATION_MODIFIER", 111, 116]]], ["Even among Muslims who hold relatively simple funerals for the deceased, a congregation of at least 40, standing shoulder-to-shoulder, is desirable for the funeral prayer, and close relations take pride in bathing the body, applying perfume, wrapping the body in white cloth, and burying their loved one themselves (Ibn al-Hajjaj, 2007) .The emerging challengeWhen these long held customs and beliefs, which bring a sense of closure to the family and aid them deal with the loss of a loved one, are threatened or to a large extent revoked because of the highly infectious disease and public health guidelines, it is inevitable that grief may be prolonged or complicated with its attendant impact on the psychological and physical health of family members (Mayo Clinic, 2017; Weir, 2018) .The emerging challengeIt has been reported that the individual who died of COVID-19 in Kumasi has been buried under the supervision of relevant officials.", [["body", "ANATOMY", 218, 222], ["body", "ANATOMY", 255, 259], ["infectious disease", "DISEASE", 561, 579], ["grief", "DISEASE", 632, 637], ["COVID-19", "CHEMICAL", 863, 871], ["shoulder", "ORGANISM_SUBDIVISION", 113, 121], ["shoulder", "ORGANISM_SUBDIVISION", 125, 133], ["body", "ORGANISM_SUBDIVISION", 218, 222], ["body", "ORGANISM_SUBDIVISION", 255, 259], ["closure", "TREATMENT", 425, 432], ["COVID", "TEST", 863, 868], ["shoulder", "ANATOMY", 113, 121], ["shoulder", "ANATOMY", 125, 133], ["body", "ANATOMY", 218, 222], ["body", "ANATOMY", 255, 259], ["closure", "OBSERVATION", 425, 432], ["infectious", "OBSERVATION", 561, 571]]], ["The report further states that the family rejected any claim that their loved one died of COVID-19 (GhanaWeb, 2020) .", [["COVID-19", "CHEMICAL", 90, 98], ["COVID", "TEST", 90, 95]]], ["Although, in the case of this patient, the timing of burial was consistent with the belief system of the family, they could not perform any ritual with the body they would have wished to apart from the funeral prayer at the cemetery (GhanaWeb, 2020).", [["body", "ANATOMY", 156, 160], ["patient", "ORGANISM", 30, 37], ["body", "ORGANISM_SUBDIVISION", 156, 160], ["patient", "SPECIES", 30, 37]]], ["The potential challenges in the bereavement period for this family could be dealing with the 'stigma' of their loved one dying of COVID-19 and the emotional trauma of not being able to perform death rituals for their loved one (\"End coronavirus stigma now,\" 2020; World Health Organization, 2020a, 2020c).Strategic response to the emerging challengeIn order to meet the palliative care needs of critically ill patients with COVID-19, the following strategy (illustrated in Figure 1 ) was developed after discussions with the COVID teaman interdisciplinary team of doctors and nurses in public health Rasheed Ofosu-Poku et al.Strategic response to the emerging challengeand infectious diseases, a pharmacist, a dietitian, a psychologist, and biomedical scientists.ConclusionIt is hoped that in such uncertain times, the palliative care team remains able to meet the palliative care needs of its patients and their families, either of COVID-19 or any other life-threatening illness.", [["trauma", "DISEASE", 157, 163], ["death", "DISEASE", 193, 198], ["critically ill", "DISEASE", 395, 409], ["infectious diseases", "DISEASE", 673, 692], ["patients", "ORGANISM", 410, 418], ["patients", "ORGANISM", 894, 902], ["patients", "SPECIES", 410, 418], ["patients", "SPECIES", 894, 902], ["End coronavirus stigma", "PROBLEM", 229, 251], ["COVID", "TEST", 424, 429]]]], "4cea69a28a9f0f7ffae57c8e33d870234f466514": [["Keywords:Ambient particulate matter, Toll-like receptor, Lipopolysaccharides, Poly: IC, ORN R-0006, Respiratory infections.Introduction:Exposure to ambient air pollution causes up to 4.2 million annual premature deaths worldwide (Cohen, et al. 2017) .", [["Respiratory infections", "DISEASE", 100, 122], ["deaths", "DISEASE", 212, 218], ["Toll-like receptor", "GENE_OR_GENE_PRODUCT", 37, 55], ["Lipopolysaccharides", "SIMPLE_CHEMICAL", 57, 76], ["ORN R-0006", "SIMPLE_CHEMICAL", 88, 98], ["Toll-like receptor", "PROTEIN", 37, 55], ["Respiratory infections", "PROBLEM", 100, 122], ["ambient air pollution", "TREATMENT", 148, 169], ["Respiratory", "ANATOMY", 100, 111], ["infections", "OBSERVATION", 112, 122]]], ["One major component of air pollution is particulate matter (PM).", [["air pollution", "PROBLEM", 23, 36], ["major", "OBSERVATION_MODIFIER", 4, 9], ["component", "OBSERVATION_MODIFIER", 10, 19], ["air pollution", "OBSERVATION", 23, 36], ["particulate", "OBSERVATION_MODIFIER", 40, 51], ["matter", "OBSERVATION_MODIFIER", 52, 58]]], ["PM is a mixture of solid and liquid particles (organic and inorganic-derived particles) dispersed in ambient air.", [["PM", "SIMPLE_CHEMICAL", 0, 2], ["inorganic", "SIMPLE_CHEMICAL", 59, 68], ["a mixture of solid and liquid particles", "TREATMENT", 6, 45], ["organic and inorganic-derived particles", "TREATMENT", 47, 86], ["ambient air", "OBSERVATION", 101, 112]]], ["Its size, shape, and composition vary depending on the source of origin.", [["size", "OBSERVATION_MODIFIER", 4, 8], ["shape", "OBSERVATION_MODIFIER", 10, 15], ["composition vary", "OBSERVATION_MODIFIER", 21, 37]]], ["Generally, PM originates from natural (e.g. airborne dust, volcanic activity, and pollen) or anthropogenic sources (e.g. industry and traffic primarily by different combustion processes).", [["natural (e.g. airborne dust", "PROBLEM", 30, 57], ["volcanic activity", "PROBLEM", 59, 76], ["volcanic activity", "OBSERVATION", 59, 76], ["anthropogenic sources", "OBSERVATION", 93, 114]]], ["It has been classified according to aerodynamic diameter into coarse (\u226410 \u03bcm), Fine (\u22642.5 \u03bcm), and ultra-fine (\u22640.1 \u03bcm) PM (US EPA 2016).", [["coarse", "TEST", 62, 68], ["ultra", "TEST", 99, 104], ["aerodynamic diameter", "OBSERVATION_MODIFIER", 36, 56], ["coarse", "OBSERVATION_MODIFIER", 62, 68]]], ["The size of the particles directly links with the potential of PM for causing detrimental health outcomes.", [["detrimental health outcomes", "PROBLEM", 78, 105], ["size", "OBSERVATION_MODIFIER", 4, 8], ["particles", "OBSERVATION", 16, 25]]], ["PM with an aerodynamic diameter less than 2.5 \u00b5m (PM 2.5 ) are among the most studied air pollutants of health concern since smaller particles are more likely to penetrate deeper in the lungs and encounter lung surface (Xing. et al. 2016 ).", [["lungs", "ANATOMY", 186, 191], ["lung surface", "ANATOMY", 206, 218], ["lungs", "ORGAN", 186, 191], ["lung surface", "MULTI-TISSUE_STRUCTURE", 206, 218], ["an aerodynamic diameter", "TEST", 8, 31], ["smaller particles", "PROBLEM", 125, 142], ["aerodynamic", "OBSERVATION_MODIFIER", 11, 22], ["diameter", "OBSERVATION_MODIFIER", 23, 31], ["smaller", "OBSERVATION_MODIFIER", 125, 132], ["particles", "OBSERVATION", 133, 142], ["more likely", "UNCERTAINTY", 147, 158], ["lungs", "ANATOMY", 186, 191], ["lung", "ANATOMY", 206, 210], ["surface", "ANATOMY_MODIFIER", 211, 218]]], ["PM 2.5 is not a self-contained pollutant; it contains a heterogeneous combination of solid and liquid particles, which not only includes chemicals but also biological fractions (Kelly and Fussell 2012) .", [["solid", "SIMPLE_CHEMICAL", 85, 90], ["a self-contained pollutant", "PROBLEM", 14, 40], ["solid and liquid particles", "PROBLEM", 85, 111], ["heterogeneous", "OBSERVATION_MODIFIER", 56, 69], ["solid", "OBSERVATION_MODIFIER", 85, 90], ["liquid particles", "OBSERVATION", 95, 111], ["not only includes", "UNCERTAINTY", 119, 136]]], ["Epidemiological evidence suggests that there is an increasing risk of developing bacterial and viral respiratory infection with exposure to ambient air pollution, in particular, fine particulate matter (Ciencewicki and Jaspers 2007; Croft, et al. 2019; Horne, et al. 2018; Zhang, et al. 2019 ).", [["respiratory", "ANATOMY", 101, 112], ["bacterial and viral respiratory infection", "DISEASE", 81, 122], ["developing bacterial and viral respiratory infection", "PROBLEM", 70, 122], ["ambient air pollution", "TREATMENT", 140, 161], ["increasing", "OBSERVATION_MODIFIER", 51, 61], ["bacterial", "OBSERVATION_MODIFIER", 81, 90], ["viral", "OBSERVATION_MODIFIER", 95, 100], ["respiratory infection", "OBSERVATION", 101, 122], ["air pollution", "OBSERVATION", 148, 161]]], ["Furthermore, the recent coronavirus epidemic emphasizes the need for a detailed understanding of the link between air pollution and respiratory infection.", [["respiratory", "ANATOMY", 132, 143], ["coronavirus", "DISEASE", 24, 35], ["air pollution", "DISEASE", 114, 127], ["respiratory infection", "DISEASE", 132, 153], ["the recent coronavirus epidemic", "PROBLEM", 13, 44], ["air pollution", "PROBLEM", 114, 127], ["respiratory infection", "PROBLEM", 132, 153], ["coronavirus", "OBSERVATION", 24, 35], ["air pollution", "OBSERVATION", 114, 127], ["respiratory", "ANATOMY", 132, 143], ["infection", "OBSERVATION", 144, 153]]], ["Nationwide U.S cross-sectional study has highlighted the association between a small increase in long term exposure to PM 2.5 and an increased risk of mortality due to COVID-19 infection (Wu, et al. 2020 ).", [["COVID-19", "CHEMICAL", 168, 176], ["infection", "DISEASE", 177, 186], ["COVID-19", "SPECIES", 168, 176], ["cross-sectional study", "TEST", 15, 36], ["a small increase", "PROBLEM", 77, 93], ["COVID-19 infection", "PROBLEM", 168, 186], ["small", "OBSERVATION_MODIFIER", 79, 84], ["increase", "OBSERVATION_MODIFIER", 85, 93], ["long term exposure", "OBSERVATION_MODIFIER", 97, 115], ["increased", "OBSERVATION_MODIFIER", 133, 142], ["infection", "OBSERVATION", 177, 186]]], ["In experimental models, fine PM exposure has increased the risk of pneumonia due to the deleterious effect on alveolar macrophages and alveolar epithelium (Migliaccio, et al. 2013; Mushtaq, et al. 2011 ).", [["alveolar macrophages", "ANATOMY", 110, 130], ["alveolar epithelium", "ANATOMY", 135, 154], ["PM", "CHEMICAL", 29, 31], ["pneumonia", "DISEASE", 67, 76], ["alveolar macrophages", "CELL", 110, 130], ["alveolar epithelium", "TISSUE", 135, 154], ["alveolar macrophages", "CELL_TYPE", 110, 130], ["pneumonia", "PROBLEM", 67, 76], ["the deleterious effect", "PROBLEM", 84, 106], ["alveolar macrophages", "PROBLEM", 110, 130], ["alveolar epithelium", "PROBLEM", 135, 154], ["pneumonia", "OBSERVATION", 67, 76], ["deleterious", "OBSERVATION", 88, 99], ["alveolar macrophages", "OBSERVATION", 110, 130], ["alveolar", "ANATOMY_MODIFIER", 135, 143], ["epithelium", "ANATOMY_MODIFIER", 144, 154]]], ["As reviewed in Wei and Tang (2018) few studies have focused on the immunemodulatory effect of fine PM and its effects on the immune response to respiratory infections.", [["respiratory", "ANATOMY", 144, 155], ["respiratory infections", "DISEASE", 144, 166], ["PM", "MULTI-TISSUE_STRUCTURE", 99, 101], ["few studies", "TEST", 35, 46], ["respiratory infections", "PROBLEM", 144, 166], ["respiratory", "ANATOMY", 144, 155], ["infections", "OBSERVATION", 156, 166]]], ["Therefore, it is crucial to explore links between fine PM exposure and alteration in the immune response to bacterial and viral respiratory infections since large populations J o u r n a l P r e -p r o o f are exposed to air pollutants and respiratory infections may spread more rapidly in the densely populated areas.Introduction:Alveolar epithelium and alveolar macrophages serve as pillars in the innate immune system of the respiratory tract.", [["respiratory", "ANATOMY", 128, 139], ["respiratory", "ANATOMY", 240, 251], ["Alveolar epithelium", "ANATOMY", 331, 350], ["alveolar macrophages", "ANATOMY", 355, 375], ["immune system", "ANATOMY", 407, 420], ["respiratory tract", "ANATOMY", 428, 445], ["respiratory infections", "DISEASE", 128, 150], ["respiratory infections", "DISEASE", 240, 262], ["Alveolar epithelium", "TISSUE", 331, 350], ["alveolar macrophages", "CELL", 355, 375], ["immune system", "ANATOMICAL_SYSTEM", 407, 420], ["respiratory tract", "ORGANISM_SUBDIVISION", 428, 445], ["alveolar macrophages", "CELL_TYPE", 355, 375], ["the immune response", "PROBLEM", 85, 104], ["bacterial and viral respiratory infections", "PROBLEM", 108, 150], ["air pollutants", "PROBLEM", 221, 235], ["respiratory infections", "PROBLEM", 240, 262], ["Alveolar epithelium and alveolar macrophages", "PROBLEM", 331, 375], ["viral", "OBSERVATION_MODIFIER", 122, 127], ["respiratory infections", "OBSERVATION", 128, 150], ["air pollutants", "OBSERVATION", 221, 235], ["respiratory", "ANATOMY", 240, 251], ["infections", "OBSERVATION", 252, 262], ["rapidly", "OBSERVATION_MODIFIER", 279, 286], ["densely", "OBSERVATION_MODIFIER", 294, 301], ["Alveolar", "ANATOMY_MODIFIER", 331, 339], ["epithelium", "ANATOMY_MODIFIER", 340, 350], ["alveolar macrophages", "OBSERVATION", 355, 375], ["pillars", "OBSERVATION_MODIFIER", 385, 392], ["respiratory tract", "ANATOMY", 428, 445]]], ["Inhaled pathogens must evade the innate immune system to establish infections (Bhattacharya and Westphalen 2016) .", [["infections", "DISEASE", 67, 77], ["Inhaled pathogens", "PROBLEM", 0, 17], ["infections", "PROBLEM", 67, 77], ["infections", "OBSERVATION", 67, 77]]], ["In vitro co-culture of secondary epithelial cells (A549 cells) and THP1 monocytes, differentiated into macrophage-like cells have been used in immunological and toxicological studies on the respiratory health to better understand the effect of cell-cell interaction and to better mimic the first line of defense i.e., alveolar epithelium and macrophages (Dehai, et al. 2014; Holownia, et al. 2015 ).Introduction:Family of Toll-like receptors (TLRs) expressed by epithelial and dedicated immune cells are an important component in pathogen recognition and innate immune response (Medzhitov 2001) .", [["epithelial cells", "ANATOMY", 33, 49], ["A549 cells", "ANATOMY", 51, 61], ["THP1 monocytes", "ANATOMY", 67, 81], ["macrophage-like cells", "ANATOMY", 103, 124], ["respiratory", "ANATOMY", 190, 201], ["cell", "ANATOMY", 244, 248], ["cell", "ANATOMY", 249, 253], ["alveolar epithelium", "ANATOMY", 318, 337], ["macrophages", "ANATOMY", 342, 353], ["epithelial", "ANATOMY", 462, 472], ["immune cells", "ANATOMY", 487, 499], ["secondary epithelial cells", "CELL", 23, 49], ["A549 cells", "CELL", 51, 61], ["THP1 monocytes", "CELL", 67, 81], ["macrophage-like cells", "CELL", 103, 124], ["cell", "CELL", 244, 248], ["cell", "CELL", 249, 253], ["alveolar epithelium", "TISSUE", 318, 337], ["macrophages", "CELL", 342, 353], ["Toll-like receptors", "GENE_OR_GENE_PRODUCT", 422, 441], ["TLRs", "GENE_OR_GENE_PRODUCT", 443, 447], ["epithelial", "CELL", 462, 472], ["immune cells", "CELL", 487, 499], ["secondary epithelial cells", "CELL_TYPE", 23, 49], ["A549 cells", "CELL_LINE", 51, 61], ["THP1 monocytes", "CELL_LINE", 67, 81], ["macrophage-like cells", "CELL_TYPE", 103, 124], ["macrophages", "CELL_TYPE", 342, 353], ["Toll-like receptors", "PROTEIN", 422, 441], ["TLRs", "PROTEIN", 443, 447], ["epithelial and dedicated immune cells", "CELL_TYPE", 462, 499], ["secondary epithelial cells", "PROBLEM", 23, 49], ["A549 cells", "TEST", 51, 61], ["THP1 monocytes", "TEST", 67, 81], ["toxicological studies", "TEST", 161, 182], ["cell-cell interaction", "TREATMENT", 244, 265], ["alveolar epithelium and macrophages", "PROBLEM", 318, 353], ["secondary epithelial cells", "OBSERVATION", 23, 49], ["A549 cells", "OBSERVATION", 51, 61], ["THP1 monocytes", "OBSERVATION", 67, 81], ["macrophage", "OBSERVATION_MODIFIER", 103, 113], ["alveolar epithelium", "ANATOMY", 318, 337], ["macrophages", "ANATOMY", 342, 353], ["epithelial", "ANATOMY", 462, 472], ["immune cells", "OBSERVATION", 487, 499]]], ["Activation of TLRs on airway epithelial cells has been shown to induce the production of several cytokines, chemokines, and antimicrobial peptides (Guillot, et al. 2005; Hertz, et al. 2003; Sha, et al. 2004 ).", [["airway epithelial cells", "ANATOMY", 22, 45], ["TLRs", "GENE_OR_GENE_PRODUCT", 14, 18], ["airway epithelial cells", "CELL", 22, 45], ["TLRs", "PROTEIN", 14, 18], ["airway epithelial cells", "CELL_TYPE", 22, 45], ["cytokines", "PROTEIN", 97, 106], ["chemokines", "PROTEIN", 108, 118], ["airway epithelial cells", "PROBLEM", 22, 45], ["chemokines", "TREATMENT", 108, 118], ["antimicrobial peptides", "TREATMENT", 124, 146], ["airway", "ANATOMY", 22, 28], ["epithelial cells", "OBSERVATION", 29, 45]]], ["The importance of TLRs for the host defense in the lung has been demonstrated by the increased susceptibility of TLR knockout mice towards viral or bacterial infections (Takeuchi, et al. 2000; Wetzler 2003 ).", [["lung", "ANATOMY", 51, 55], ["viral or bacterial infections", "DISEASE", 139, 168], ["TLRs", "GENE_OR_GENE_PRODUCT", 18, 22], ["lung", "ORGAN", 51, 55], ["TLR", "GENE_OR_GENE_PRODUCT", 113, 116], ["mice", "ORGANISM", 126, 130], ["TLRs", "PROTEIN", 18, 22], ["TLR", "PROTEIN", 113, 116], ["mice", "SPECIES", 126, 130], ["mice", "SPECIES", 126, 130], ["viral or bacterial infections", "PROBLEM", 139, 168], ["lung", "ANATOMY", 51, 55], ["increased", "OBSERVATION_MODIFIER", 85, 94], ["bacterial", "OBSERVATION_MODIFIER", 148, 157], ["infections", "OBSERVATION", 158, 168]]], ["This is because each member of TLR family recognizes specific pathogen-associated molecular patterns (PAMPs), e.g., TLR3 is activated by virus-derived double-stranded RNA (Alexopoulou, et al. 2001 ) and TLR4 by bacterial lipopolysaccharides (Beutler 2002) , whereas TLR7 and TLR8 recognize single-stranded viral RNA (Diebold, et al. 2004; Heil, et al. 2004J o u r n a l P r e -p r o o fFor the co-culture experiments, A549 cells were seeded in 12-well plates at a seeding density of 120,000 cells per well in FBS supplemented media and allowed them to attach for 4 hours.", [["A549 cells", "ANATOMY", 418, 428], ["cells", "ANATOMY", 491, 496], ["TLR", "GENE_OR_GENE_PRODUCT", 31, 34], ["pathogen-associated molecular patterns", "GENE_OR_GENE_PRODUCT", 62, 100], ["PAMPs", "GENE_OR_GENE_PRODUCT", 102, 107], ["TLR3", "GENE_OR_GENE_PRODUCT", 116, 120], ["TLR4", "GENE_OR_GENE_PRODUCT", 203, 207], ["TLR7", "GENE_OR_GENE_PRODUCT", 266, 270], ["TLR8", "GENE_OR_GENE_PRODUCT", 275, 279], ["A549 cells", "CELL", 418, 428], ["cells", "CELL", 491, 496], ["FBS", "ORGANISM_SUBSTANCE", 509, 512], ["TLR family", "PROTEIN", 31, 41], ["pathogen-associated molecular patterns", "PROTEIN", 62, 100], ["PAMPs", "PROTEIN", 102, 107], ["TLR3", "PROTEIN", 116, 120], ["TLR4", "PROTEIN", 203, 207], ["TLR7", "PROTEIN", 266, 270], ["TLR8", "PROTEIN", 275, 279], ["A549 cells", "CELL_LINE", 418, 428], ["double-stranded RNA", "TREATMENT", 151, 170], ["TLR4 by bacterial lipopolysaccharides", "TREATMENT", 203, 240], ["the co-culture experiments", "TEST", 390, 416], ["A549 cells", "PROBLEM", 418, 428], ["FBS supplemented media", "TREATMENT", 509, 531], ["viral RNA", "OBSERVATION", 306, 315], ["A549 cells", "OBSERVATION", 418, 428], ["seeding density", "OBSERVATION_MODIFIER", 464, 479]]], ["Once the A549 cells were attached to the bottom of the well, media in the wells was aspirated and activated macrophage-like THP-1 cells were seeded at a seeding density of 24,000 cells per well on top of attached A549 cells.", [["A549 cells", "ANATOMY", 9, 19], ["macrophage-like THP-1 cells", "ANATOMY", 108, 135], ["cells", "ANATOMY", 179, 184], ["A549 cells", "ANATOMY", 213, 223], ["A549 cells", "CELL", 9, 19], ["macrophage", "CELL", 108, 118], ["THP-1 cells", "CELL", 124, 135], ["cells", "CELL", 179, 184], ["A549 cells", "CELL", 213, 223], ["A549 cells", "CELL_LINE", 9, 19], ["activated macrophage", "CELL_TYPE", 98, 118], ["THP-1 cells", "CELL_LINE", 124, 135], ["24,000 cells", "CELL_LINE", 172, 184], ["A549 cells", "CELL_LINE", 213, 223], ["the A549 cells", "TREATMENT", 5, 19], ["media in the wells", "TREATMENT", 61, 79], ["THP-1 cells", "TREATMENT", 124, 135], ["A549 cells", "OBSERVATION", 9, 19], ["seeding density", "OBSERVATION_MODIFIER", 153, 168], ["A549 cells", "OBSERVATION", 213, 223]]], ["The co-cultured cells were incubated at 37\u00b0C and 5% CO 2 for 40 hours before exposing the cells to the first exposure.", [["cells", "ANATOMY", 16, 21], ["cells", "ANATOMY", 90, 95], ["CO 2", "CHEMICAL", 52, 56], ["cells", "CELL", 16, 21], ["cells", "CELL", 90, 95], ["co-cultured cells", "CELL_LINE", 4, 21], ["The co-cultured cells", "TEST", 0, 21]]], ["The seeded co-culture yields approximately 400,000-600,000 cells per well after the end of the exposure.", [["cells", "ANATOMY", 59, 64], ["cells", "CELL", 59, 64]]], ["One hour before the exposure the co-culture medium was replaced with fresh medium supplemented with 5% FBS, 2mM L-Glut, and 100 U/ml (pen/strep).Cell exposureThe study was designed as a two-step submerged exposure.", [["FBS", "ANATOMY", 103, 106], ["Cell", "ANATOMY", 145, 149], ["FBS", "ORGANISM_SUBSTANCE", 103, 106], ["L-Glut", "SIMPLE_CHEMICAL", 112, 118], ["Cell", "CELL", 145, 149], ["the co-culture medium", "TREATMENT", 29, 50], ["FBS", "TEST", 103, 106], ["pen/strep", "TEST", 134, 143], ["Cell exposure", "PROBLEM", 145, 158], ["The study", "TEST", 158, 167], ["Glut", "ANATOMY", 114, 118]]], ["Co-cultured cells were exposed to three concentrations of PM 2.5-1 (25\u00b5g/ml, 50\u00b5g/ml, and 100\u00b5g/ml corresponding to 6.6, 13.2, and 26.3 \u00b5g/cm 2 ) in duplicate wells for 24 hours at 37\u00b0C and 5% CO 2 .Cell exposureThe PM 2.5-1 -exposed cells were then co-exposed for next 24 hours to fixed doses of three lysis buffer was added to each well.", [["cells", "ANATOMY", 12, 17], ["Cell", "ANATOMY", 199, 203], ["cells", "ANATOMY", 234, 239], ["PM 2.5-1", "CHEMICAL", 216, 224], ["CO 2", "CHEMICAL", 193, 197], ["cells", "CELL", 12, 17], ["Cell", "CELL", 199, 203], ["cells", "CELL", 234, 239], ["Co-cultured cells", "CELL_LINE", 0, 17], ["PM 2.5-1 -exposed cells", "CELL_LINE", 216, 239], ["Co-cultured cells", "TEST", 0, 17], ["Cell exposure", "PROBLEM", 199, 212], ["The PM", "TEST", 212, 218], ["exposed cells", "TREATMENT", 226, 239], ["three lysis buffer", "TREATMENT", 297, 315]]], ["Cells were then lysed for 2 hours at 37\u00b0C and 5% CO 2 followed by 30 minutes at room temperature on a plate shaker to release formazan from the cells.", [["Cells", "ANATOMY", 0, 5], ["cells", "ANATOMY", 144, 149], ["formazan", "CHEMICAL", 126, 134], ["CO 2", "CHEMICAL", 49, 53], ["formazan", "CHEMICAL", 126, 134], ["Cells", "CELL", 0, 5], ["formazan", "SIMPLE_CHEMICAL", 126, 134], ["cells", "CELL", 144, 149], ["a plate shaker", "TREATMENT", 100, 114]]], ["After incubation, absorbance was measured at 570 nm using a Synergy H1, Microplate reader (BioTek, USA).", [["absorbance", "TEST", 18, 28], ["a Synergy H1", "TREATMENT", 58, 70]]], ["The absorbance values of the exposed cells were then normalized against the untreated controls and the percentage of cellular metabolic activity was calculated by the following formula: ((absorbance exposed/absorbance control) *100 %).", [["cells", "ANATOMY", 37, 42], ["cellular", "ANATOMY", 117, 125], ["cells", "CELL", 37, 42], ["cellular", "CELL", 117, 125], ["exposed cells", "CELL_LINE", 29, 42], ["The absorbance values", "TEST", 0, 21], ["the exposed cells", "PROBLEM", 25, 42], ["(absorbance exposed/absorbance control", "TREATMENT", 187, 225], ["absorbance", "OBSERVATION_MODIFIER", 4, 14], ["cellular", "OBSERVATION", 117, 125], ["metabolic activity", "OBSERVATION", 126, 144]]], ["IL-6 pro-inflammatory cytokine production was assessed after two-step submerged exposure.", [["IL-6", "GENE_OR_GENE_PRODUCT", 0, 4], ["IL-6", "PROTEIN", 0, 4], ["pro-inflammatory cytokine", "PROTEIN", 5, 30], ["IL", "TREATMENT", 0, 2]]], ["Co-cultured cells were first exposed to three doses (25, 50, PM stimulation increased the production of IL-6 in a dose-dependent manner in the cocultured cells.", [["cells", "ANATOMY", 12, 17], ["cells", "ANATOMY", 154, 159], ["cells", "CELL", 12, 17], ["IL-6", "GENE_OR_GENE_PRODUCT", 104, 108], ["cells", "CELL", 154, 159], ["Co-cultured cells", "CELL_LINE", 0, 17], ["IL-6", "PROTEIN", 104, 108], ["cocultured cells", "CELL_LINE", 143, 159], ["Co-cultured cells", "TEST", 0, 17], ["PM stimulation", "TEST", 61, 75], ["IL", "TEST", 104, 106], ["cocultured cells", "OBSERVATION", 143, 159]]], ["Of the studied viral ligands, TLR7/8 induced the highest production of IL-6Cell exposurewhereas TLR3 induced a marginal increase in IL-6 production compared to unexposed control cells.", [["cells", "ANATOMY", 178, 183], ["TLR7", "GENE_OR_GENE_PRODUCT", 30, 34], ["8", "GENE_OR_GENE_PRODUCT", 35, 36], ["IL-6Cell", "GENE_OR_GENE_PRODUCT", 71, 79], ["TLR3", "GENE_OR_GENE_PRODUCT", 96, 100], ["IL-6", "GENE_OR_GENE_PRODUCT", 132, 136], ["cells", "CELL", 178, 183], ["TLR7/8", "PROTEIN", 30, 36], ["IL", "PROTEIN", 71, 73], ["TLR3", "PROTEIN", 96, 100], ["IL-6", "PROTEIN", 132, 136], ["unexposed control cells", "CELL_TYPE", 160, 183], ["the studied viral ligands", "TEST", 3, 28], ["TLR7", "TEST", 30, 34], ["IL", "TEST", 71, 73], ["a marginal increase in IL", "PROBLEM", 109, 134], ["viral ligands", "OBSERVATION", 15, 28], ["marginal", "OBSERVATION_MODIFIER", 111, 119], ["increase", "OBSERVATION_MODIFIER", 120, 128]]], ["TLR4 also significantly increased the IL-6 production relative to the unexposed control.", [["TLR4", "GENE_OR_GENE_PRODUCT", 0, 4], ["IL-6", "GENE_OR_GENE_PRODUCT", 38, 42], ["TLR4", "PROTEIN", 0, 4], ["IL-6", "PROTEIN", 38, 42], ["the IL", "TREATMENT", 34, 40], ["the unexposed control", "TREATMENT", 66, 87], ["significantly", "OBSERVATION_MODIFIER", 10, 23], ["increased", "OBSERVATION_MODIFIER", 24, 33]]], ["In co-exposure to PM and TLR7/8, the IL-6 release of the cells increased significantly at the lowest PM dose when compared to responses of the cells after PM exposure only.Cell exposureHowever, PM and TLR7/8 co-exposure resulted in much lower IL-6 concentrations than for TLR 7/8 ligand alone.", [["cells", "ANATOMY", 57, 62], ["cells", "ANATOMY", 143, 148], ["Cell", "ANATOMY", 172, 176], ["PM", "CELL", 18, 20], ["TLR7/8", "GENE_OR_GENE_PRODUCT", 25, 31], ["IL-6", "GENE_OR_GENE_PRODUCT", 37, 41], ["cells", "CELL", 57, 62], ["PM", "SIMPLE_CHEMICAL", 101, 103], ["cells", "CELL", 143, 148], ["PM", "SIMPLE_CHEMICAL", 155, 157], ["Cell", "CELL", 172, 176], ["TLR7/8", "GENE_OR_GENE_PRODUCT", 201, 207], ["IL-6", "GENE_OR_GENE_PRODUCT", 243, 247], ["TLR 7/8 ligand", "GENE_OR_GENE_PRODUCT", 272, 286], ["TLR7", "PROTEIN", 25, 29], ["IL-6", "PROTEIN", 37, 41], ["TLR7", "PROTEIN", 201, 205], ["IL-6", "PROTEIN", 243, 247], ["TLR 7/8 ligand", "PROTEIN", 272, 286], ["TLR7", "TEST", 25, 29], ["the IL", "TREATMENT", 33, 39], ["the cells", "PROBLEM", 53, 62], ["Cell exposureHowever", "TEST", 172, 192], ["TLR7", "TEST", 201, 205]]], ["With the highest PM dose, IL-6 levels were not only lower than after exposure to TLR-7/8 ligand alone but they were also decreased when compared to IL-6 release after the cells were exposed to same PM mass without the ligand.", [["cells", "ANATOMY", 171, 176], ["IL-6", "GENE_OR_GENE_PRODUCT", 26, 30], ["TLR-7/8 ligand", "GENE_OR_GENE_PRODUCT", 81, 95], ["IL-6", "GENE_OR_GENE_PRODUCT", 148, 152], ["cells", "CELL", 171, 176], ["IL", "PROTEIN", 26, 28], ["TLR", "PROTEIN", 81, 84], ["IL-6", "PROTEIN", 148, 152], ["IL-6 levels", "TEST", 26, 37], ["TLR", "TEST", 81, 84], ["IL", "TEST", 148, 150], ["the cells", "PROBLEM", 167, 176], ["decreased", "OBSERVATION_MODIFIER", 121, 130], ["mass", "OBSERVATION", 201, 205]]], ["Co-exposure to PM and TLR3 induced lower cytokine secretion than PM alone.", [["TLR3", "GENE_OR_GENE_PRODUCT", 22, 26], ["PM", "SIMPLE_CHEMICAL", 65, 67], ["TLR3", "PROTEIN", 22, 26], ["cytokine", "PROTEIN", 41, 49], ["TLR3 induced lower cytokine secretion", "PROBLEM", 22, 59], ["lower", "ANATOMY_MODIFIER", 35, 40], ["cytokine secretion", "OBSERVATION", 41, 59]]], ["In contrast, co-exposure to PM and TLR4 caused IL-6 production that was higher than that of cells exposed to either PM or TLR4 alone ( Figure 1 ).", [["cells", "ANATOMY", 92, 97], ["TLR4", "GENE_OR_GENE_PRODUCT", 35, 39], ["IL-6", "GENE_OR_GENE_PRODUCT", 47, 51], ["cells", "CELL", 92, 97], ["TLR4", "GENE_OR_GENE_PRODUCT", 122, 126], ["TLR4", "PROTEIN", 35, 39], ["TLR4", "PROTEIN", 122, 126], ["IL", "TEST", 47, 49]]], ["PM increased the production of TNF-\u03b1 dose-dependently.", [["PM", "SIMPLE_CHEMICAL", 0, 2], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 31, 36], ["TNF", "PROTEIN", 31, 34], ["TNF", "TREATMENT", 31, 34], ["increased", "OBSERVATION_MODIFIER", 3, 12], ["production", "OBSERVATION_MODIFIER", 17, 27]]], ["TLR7/8 induced the highest production of TNF-\u03b1, whereas TLR3 was not able to induce TNF-\u03b1 production in our cell model.", [["cell", "ANATOMY", 108, 112], ["TLR7", "GENE_OR_GENE_PRODUCT", 0, 4], ["8", "GENE_OR_GENE_PRODUCT", 5, 6], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 41, 46], ["TLR3", "GENE_OR_GENE_PRODUCT", 56, 60], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 84, 89], ["cell", "CELL", 108, 112], ["TLR7/8", "PROTEIN", 0, 6], ["TNF", "PROTEIN", 41, 44], ["TLR3", "PROTEIN", 56, 60], ["TNF", "PROTEIN", 84, 87], ["TNF", "TEST", 41, 44], ["TNF", "TEST", 84, 87]]], ["TLR4 induced slight but non-significant increase in TNF-\u03b1 production.", [["TLR4", "GENE_OR_GENE_PRODUCT", 0, 4], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 52, 57], ["TLR4", "PROTEIN", 0, 4], ["TNF", "PROTEIN", 52, 55], ["non-significant increase", "PROBLEM", 24, 48], ["TNF", "PROBLEM", 52, 55], ["slight", "OBSERVATION_MODIFIER", 13, 19], ["non-significant", "OBSERVATION_MODIFIER", 24, 39], ["increase", "OBSERVATION_MODIFIER", 40, 48], ["TNF", "OBSERVATION", 52, 55]]], ["\u0399n PM and TLR7/8 co-exposures, production of TNF-\u03b1 was approximately the same for all PM doses and comparable to the response after exposure to highest PM dose alone, but significantly lower than after exposure to TLR7/8 alone.", [["TLR7", "GENE_OR_GENE_PRODUCT", 10, 14], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 45, 50], ["PM", "SIMPLE_CHEMICAL", 152, 154], ["TLR7", "GENE_OR_GENE_PRODUCT", 214, 218], ["8", "GENE_OR_GENE_PRODUCT", 219, 220], ["TLR7", "PROTEIN", 10, 14], ["TNF", "PROTEIN", 45, 48], ["TLR7", "PROTEIN", 214, 218], ["TLR7", "TEST", 10, 14], ["TNF", "TEST", 45, 48], ["TLR7", "TREATMENT", 214, 218]]], ["Interestingly, when the cell model was coexposed to PM and TLR3, cytokine secretion was lower than in stimulation with PM alone, but the difference was not statistically significant.", [["cell", "ANATOMY", 24, 28], ["cell", "CELL", 24, 28], ["PM", "CELL", 52, 54], ["TLR3", "GENE_OR_GENE_PRODUCT", 59, 63], ["PM", "SIMPLE_CHEMICAL", 119, 121], ["TLR3", "PROTEIN", 59, 63], ["cytokine", "PROTEIN", 65, 73], ["the cell model", "TEST", 20, 34], ["TLR3", "TREATMENT", 59, 63], ["cytokine secretion", "TEST", 65, 83]]], ["In contrast to other two ligands, cells primed PM responded to TLR4 exposure by significantly enhanced TNF-\u03b1 production ( Figure 2 ).", [["cells", "ANATOMY", 34, 39], ["PM", "ANATOMY", 47, 49], ["cells", "CELL", 34, 39], ["PM", "CELL", 47, 49], ["TLR4", "GENE_OR_GENE_PRODUCT", 63, 67], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 103, 108], ["TLR4", "PROTEIN", 63, 67], ["TNF", "PROTEIN", 103, 106], ["TLR4 exposure", "TREATMENT", 63, 76]]], ["In co-exposure to PM and TLR7/8, the production of IL-8 increased slightly for the lowest two doses when compared to respective PM dose alone.", [["PM", "CELL", 18, 20], ["TLR7", "GENE_OR_GENE_PRODUCT", 25, 29], ["8", "GENE_OR_GENE_PRODUCT", 30, 31], ["IL-8", "GENE_OR_GENE_PRODUCT", 51, 55], ["PM", "SIMPLE_CHEMICAL", 128, 130], ["TLR7", "PROTEIN", 25, 29], ["IL-8", "PROTEIN", 51, 55], ["the production of IL", "TREATMENT", 33, 53]]], ["However, no significant indication of additive effects of PM and TLR7/8 was observed at any of the dose levels.", [["PM", "SIMPLE_CHEMICAL", 58, 60], ["TLR7", "GENE_OR_GENE_PRODUCT", 65, 69], ["8", "GENE_OR_GENE_PRODUCT", 70, 71], ["TLR7", "PROTEIN", 65, 69], ["PM and TLR7/8", "TREATMENT", 58, 71], ["no", "UNCERTAINTY", 9, 11], ["significant", "OBSERVATION_MODIFIER", 12, 23]]], ["Similar to TLR7/8, co-exposure to PM and TLR3 induced roughly the same level of cytokine secretion than PM.", [["TLR7", "GENE_OR_GENE_PRODUCT", 11, 15], ["8", "GENE_OR_GENE_PRODUCT", 16, 17], ["PM", "GENE_OR_GENE_PRODUCT", 34, 36], ["TLR3", "GENE_OR_GENE_PRODUCT", 41, 45], ["TLR7", "PROTEIN", 11, 15], ["TLR3", "PROTEIN", 41, 45], ["cytokine", "PROTEIN", 80, 88], ["cytokine secretion", "PROBLEM", 80, 98], ["cytokine secretion", "OBSERVATION", 80, 98]]], ["In contrast, co-exposure to PM and TLR4 caused IL-8 production that was higher than that of cells exposed to PM or TLR4 alone ( Figure 3 ).", [["cells", "ANATOMY", 92, 97], ["TLR4", "GENE_OR_GENE_PRODUCT", 35, 39], ["IL-8", "GENE_OR_GENE_PRODUCT", 47, 51], ["cells", "CELL", 92, 97], ["TLR4", "GENE_OR_GENE_PRODUCT", 115, 119], ["TLR4", "PROTEIN", 35, 39], ["TLR4", "PROTEIN", 115, 119], ["IL", "TEST", 47, 49]]], ["Cell cycle analysis was performed using PI staining after two-step submerged exposure described in Figure 1.", [["Cell", "ANATOMY", 0, 4], ["Cell", "CELL", 0, 4], ["Cell cycle analysis", "TEST", 0, 19], ["PI staining", "PROBLEM", 40, 51], ["two-step submerged exposure", "TREATMENT", 58, 85]]], ["We characterized the cytokine response of A549-THP1 co-culture to viral TLR ligands (TLR3, TLR7/8) and bacterial TLR ligand (TLR4).", [["A549-THP1", "ANATOMY", 42, 51], ["A549-THP1", "CELL", 42, 51], ["TLR ligands", "GENE_OR_GENE_PRODUCT", 72, 83], ["TLR3", "GENE_OR_GENE_PRODUCT", 85, 89], ["TLR7", "GENE_OR_GENE_PRODUCT", 91, 95], ["8", "GENE_OR_GENE_PRODUCT", 96, 97], ["bacterial TLR ligand", "GENE_OR_GENE_PRODUCT", 103, 123], ["TLR4", "GENE_OR_GENE_PRODUCT", 125, 129], ["cytokine", "PROTEIN", 21, 29], ["A549", "CELL_LINE", 42, 46], ["THP1 co-culture", "CELL_LINE", 47, 62], ["viral TLR ligands", "PROTEIN", 66, 83], ["TLR3", "PROTEIN", 85, 89], ["TLR7/8", "PROTEIN", 91, 97], ["bacterial TLR ligand", "PROTEIN", 103, 123], ["TLR4", "PROTEIN", 125, 129], ["the cytokine response", "TEST", 17, 38], ["A549", "TEST", 42, 46], ["THP1 co-culture", "TEST", 47, 62], ["viral TLR ligands", "TEST", 66, 83], ["TLR3", "TEST", 85, 89], ["TLR7", "TEST", 91, 95], ["bacterial TLR", "ANATOMY", 103, 116]]], ["Results showed that both viral ligands caused an increase in IL-6 and IL-8 levels compared to control.", [["IL-6", "GENE_OR_GENE_PRODUCT", 61, 65], ["IL-8", "GENE_OR_GENE_PRODUCT", 70, 74], ["both viral ligands", "PROBLEM", 20, 38], ["IL", "TEST", 61, 63], ["IL", "TEST", 70, 72], ["viral ligands", "OBSERVATION", 25, 38], ["increase", "OBSERVATION_MODIFIER", 49, 57]]], ["However, response to TLR7/8 ligand was very high compared TLR3 ligand response.", [["TLR7", "GENE_OR_GENE_PRODUCT", 21, 25], ["8", "GENE_OR_GENE_PRODUCT", 26, 27], ["TLR3", "GENE_OR_GENE_PRODUCT", 58, 62], ["TLR7/8 ligand", "PROTEIN", 21, 34], ["TLR3", "PROTEIN", 58, 62], ["TLR7/8 ligand", "TEST", 21, 34]]], ["Our results are partially consistent with the study on primary airway epithelial cells, showing that exposure to TLR3 ligand increased IL-6, IL-8, and TNF-\u03b1 production of the cells (Lever, et al. 2015) .", [["primary airway epithelial cells", "ANATOMY", 55, 86], ["cells", "ANATOMY", 175, 180], ["airway epithelial cells", "CELL", 63, 86], ["TLR3", "GENE_OR_GENE_PRODUCT", 113, 117], ["IL-6", "GENE_OR_GENE_PRODUCT", 135, 139], ["IL-8", "GENE_OR_GENE_PRODUCT", 141, 145], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 151, 156], ["cells", "CELL", 175, 180], ["primary airway epithelial cells", "CELL_TYPE", 55, 86], ["TLR3", "PROTEIN", 113, 117], ["TNF", "PROTEIN", 151, 154], ["the study", "TEST", 42, 51], ["primary airway epithelial cells", "TEST", 55, 86], ["TLR3 ligand", "TEST", 113, 124], ["IL", "TEST", 135, 137], ["IL", "TEST", 141, 143], ["TNF", "TEST", 151, 154], ["partially consistent with", "UNCERTAINTY", 16, 41], ["airway epithelial cells", "OBSERVATION", 63, 86]]], ["Interestingly, in our study TLR3 ligand did not induce TNF-\u03b1 production.", [["TLR3", "GENE_OR_GENE_PRODUCT", 28, 32], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 55, 60], ["TLR3", "PROTEIN", 28, 32], ["TNF", "PROTEIN", 55, 58], ["our study TLR3 ligand", "TEST", 18, 39], ["TNF", "PROBLEM", 55, 58]]], ["TNF-\u03b1 serves an important physiological role of activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u039a\u03b2) andCell exposureinflux of neutrophils to the site of inflammation (Sch\u00fctze, et al. 1995) .", [["B cells", "ANATOMY", 117, 124], ["Cell", "ANATOMY", 136, 140], ["neutrophils", "ANATOMY", 159, 170], ["site", "ANATOMY", 178, 182], ["inflammation", "DISEASE", 186, 198], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 0, 5], ["kappa-light-chain-enhancer of activated B cells", "GENE_OR_GENE_PRODUCT", 77, 124], ["NF-\u039a\u03b2", "GENE_OR_GENE_PRODUCT", 126, 131], ["Cell", "CELL", 136, 140], ["neutrophils", "CELL", 159, 170], ["TNF-\u03b1", "PROTEIN", 0, 5], ["nuclear factor kappa-light-chain-enhancer of activated B cells", "PROTEIN", 62, 124], ["NF-\u039a\u03b2", "PROTEIN", 126, 131], ["neutrophils", "CELL_TYPE", 159, 170], ["TNF", "TEST", 0, 3], ["nuclear factor kappa-light", "TEST", 62, 88], ["activated B cells", "PROBLEM", 107, 124], ["NF", "TEST", 126, 128], ["Cell exposureinflux of neutrophils", "PROBLEM", 136, 170], ["inflammation", "PROBLEM", 186, 198], ["inflammation", "OBSERVATION", 186, 198]]], ["A study on the A549-THP1 co-culture has concluded that TNF-\u03b1 was secreted by activated macrophages and A549-THP1 co-culture when exposed to PM but not by PM-exposed A549 cells (Kasurinen, et al. 2018 ).", [["A549-THP1", "ANATOMY", 15, 24], ["macrophages", "ANATOMY", 87, 98], ["A549-THP1", "ANATOMY", 103, 112], ["A549 cells", "ANATOMY", 165, 175], ["A549-THP1", "CELL", 15, 24], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 55, 60], ["macrophages", "CELL", 87, 98], ["A549-THP1", "CELL", 103, 112], ["PM", "SIMPLE_CHEMICAL", 154, 156], ["A549 cells", "CELL", 165, 175], ["A549", "CELL_LINE", 15, 19], ["THP1 co-culture", "CELL_LINE", 20, 35], ["TNF", "PROTEIN", 55, 58], ["\u03b1", "PROTEIN", 59, 60], ["activated macrophages", "CELL_TYPE", 77, 98], ["A549-THP1 co-culture", "CELL_LINE", 103, 123], ["A549 cells", "CELL_LINE", 165, 175], ["A study", "TEST", 0, 7], ["the A549", "TEST", 11, 19], ["THP1 co-culture", "TEST", 20, 35], ["TNF", "TEST", 55, 58], ["activated macrophages", "PROBLEM", 77, 98], ["A549", "TEST", 103, 107], ["THP1 co-culture", "TEST", 108, 123], ["A549 cells", "OBSERVATION", 165, 175]]], ["Furthermore, TNF-\u03b1 has been detected in neither control A549 cells nor the cells exposed to cigarette smoke (Holownia, et al. 2016 with the results of the study that has been conducted on human lung mucoepidermoid carcinoma (H292) and THP-1 cells.", [["A549 cells", "ANATOMY", 56, 66], ["cells", "ANATOMY", 75, 80], ["lung mucoepidermoid carcinoma", "ANATOMY", 194, 223], ["H292", "ANATOMY", 225, 229], ["THP-1 cells", "ANATOMY", 235, 246], ["lung mucoepidermoid carcinoma", "DISEASE", 194, 223], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 13, 18], ["A549 cells", "CELL", 56, 66], ["cells", "CELL", 75, 80], ["cigarette", "ORGANISM", 92, 101], ["human", "ORGANISM", 188, 193], ["lung mucoepidermoid carcinoma", "CANCER", 194, 223], ["H292", "CELL", 225, 229], ["THP-1 cells", "CELL", 235, 246], ["TNF", "PROTEIN", 13, 16], ["-\u03b1", "PROTEIN", 16, 18], ["A549 cells", "CELL_LINE", 56, 66], ["human lung mucoepidermoid carcinoma (H292) and THP-1 cells", "CELL_LINE", 188, 246], ["human", "SPECIES", 188, 193], ["human", "SPECIES", 188, 193], ["TNF", "TEST", 13, 16], ["the study", "TEST", 151, 160], ["human lung mucoepidermoid carcinoma", "PROBLEM", 188, 223], ["lung", "ANATOMY", 194, 198], ["mucoepidermoid carcinoma", "OBSERVATION", 199, 223]]], ["LPS stimulation induced significant pro-inflammatory cytokines in both cell lines (Liu, et al. 2018 ).Cell exposureCo-cultures primed with PM 2.5-1 on subsequent exposure with viral ligand TLR7/8 showed no additive effect on the response of pro-inflammatory cytokines as the response remained roughly the same as for PM 2.5-1 alone.", [["cell lines", "ANATOMY", 71, 81], ["Cell", "ANATOMY", 102, 106], ["LPS", "CHEMICAL", 0, 3], ["PM 2.5-1", "CHEMICAL", 139, 147], ["LPS", "SIMPLE_CHEMICAL", 0, 3], ["cell lines", "CELL", 71, 81], ["Cell", "CELL", 102, 106], ["TLR7", "GENE_OR_GENE_PRODUCT", 189, 193], ["8", "GENE_OR_GENE_PRODUCT", 194, 195], ["pro-inflammatory cytokines", "PROTEIN", 36, 62], ["cell lines", "CELL_LINE", 71, 81], ["viral ligand TLR7/8", "PROTEIN", 176, 195], ["pro-inflammatory cytokines", "PROTEIN", 241, 267], ["LPS stimulation", "TEST", 0, 15], ["significant pro-inflammatory cytokines", "PROBLEM", 24, 62], ["Cell exposureCo-cultures", "TEST", 102, 126], ["viral ligand TLR7", "TEST", 176, 193], ["additive effect", "PROBLEM", 206, 221], ["pro-inflammatory cytokines", "TEST", 241, 267], ["significant", "OBSERVATION_MODIFIER", 24, 35], ["pro-inflammatory cytokines", "OBSERVATION", 36, 62], ["both cell lines", "OBSERVATION", 66, 81], ["no", "UNCERTAINTY", 203, 205], ["pro-inflammatory cytokines", "OBSERVATION", 241, 267]]], ["This indicates that in PM 2.5-1 primed co-cultures the pro-inflammatory response was altered against TLR7/8 ligand.", [["co-cultures", "CELL", 39, 50], ["TLR7/8 ligand", "GENE_OR_GENE_PRODUCT", 101, 114], ["PM 2.5-1 primed co-cultures", "CELL_LINE", 23, 50], ["TLR7/8 ligand", "PROTEIN", 101, 114]]], ["Another viral ligand TLR3 behaved differently as it alone induced very low levels of IL-8 and IL-6 but not induce the production of TNF-\u03b1 in co-culture.", [["TLR3", "GENE_OR_GENE_PRODUCT", 21, 25], ["IL-8", "GENE_OR_GENE_PRODUCT", 85, 89], ["IL-6", "GENE_OR_GENE_PRODUCT", 94, 98], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 132, 137], ["TLR3", "PROTEIN", 21, 25], ["IL-8", "PROTEIN", 85, 89], ["IL-6", "PROTEIN", 94, 98], ["TNF", "PROTEIN", 132, 135], ["Another viral ligand TLR3", "PROBLEM", 0, 25], ["IL", "TEST", 85, 87], ["IL", "TEST", 94, 96], ["TNF", "PROBLEM", 132, 135], ["co-culture", "PROBLEM", 141, 151], ["viral", "OBSERVATION", 8, 13], ["ligand TLR3", "OBSERVATION", 14, 25]]], ["In addition, when PM primed co-cultures were exposed to TLR3 ligand, the production of IL-8 and IL-6 was not further increased.", [["co-cultures", "CELL", 28, 39], ["TLR3", "GENE_OR_GENE_PRODUCT", 56, 60], ["IL-8", "GENE_OR_GENE_PRODUCT", 87, 91], ["IL-6", "GENE_OR_GENE_PRODUCT", 96, 100], ["PM primed co-cultures", "CELL_LINE", 18, 39], ["TLR3", "PROTEIN", 56, 60], ["IL-8", "PROTEIN", 87, 91], ["IL-6", "PROTEIN", 96, 100], ["co-cultures", "TEST", 28, 39], ["the production of IL", "TREATMENT", 69, 89], ["increased", "OBSERVATION_MODIFIER", 117, 126]]], ["This indicates that in addition to low inflammatory potential of TLR3 ligand, it may also suppress responses induced by PM.Cell exposureSeveral studies have indicated that urban particulate matter decreases the ability of the macrophage to phagocytize and weakens the capacity of alveolar macrophages as well as alveolar epithelium to mount an effective immune response against viral stimuli (Migliaccio, et al. 2013; Xu, et al. 2008; Zhou and Kobzik 2007) .", [["Cell", "ANATOMY", 123, 127], ["macrophage", "ANATOMY", 226, 236], ["alveolar macrophages", "ANATOMY", 280, 300], ["alveolar epithelium", "ANATOMY", 312, 331], ["TLR3 ligand", "GENE_OR_GENE_PRODUCT", 65, 76], ["Cell", "CELL", 123, 127], ["macrophage", "CELL", 226, 236], ["alveolar macrophages", "CELL", 280, 300], ["alveolar epithelium", "TISSUE", 312, 331], ["TLR3 ligand", "PROTEIN", 65, 76], ["macrophage", "CELL_TYPE", 226, 236], ["alveolar macrophages", "CELL_TYPE", 280, 300], ["low inflammatory potential of TLR3 ligand", "PROBLEM", 35, 76], ["Cell exposureSeveral studies", "TEST", 123, 151], ["urban particulate matter", "PROBLEM", 172, 196], ["the macrophage to phagocytize", "TREATMENT", 222, 251], ["alveolar macrophages", "PROBLEM", 280, 300], ["alveolar epithelium", "PROBLEM", 312, 331], ["viral stimuli", "TEST", 378, 391], ["low", "OBSERVATION_MODIFIER", 35, 38], ["inflammatory", "OBSERVATION_MODIFIER", 39, 51], ["TLR3 ligand", "OBSERVATION", 65, 76], ["capacity", "OBSERVATION_MODIFIER", 268, 276], ["alveolar macrophages", "OBSERVATION", 280, 300], ["alveolar epithelium", "ANATOMY", 312, 331]]], ["Results from an in vivo study on mice also that ultrafine carbon particle exposure suppresses the early immune response in the lung.", [["lung", "ANATOMY", 127, 131], ["carbon particle", "CHEMICAL", 58, 73], ["carbon", "CHEMICAL", 58, 64], ["mice", "ORGANISM", 33, 37], ["ultrafine carbon particle", "SIMPLE_CHEMICAL", 48, 73], ["lung", "ORGAN", 127, 131], ["mice", "SPECIES", 33, 37], ["mice", "SPECIES", 33, 37], ["an in vivo study", "TEST", 13, 29], ["ultrafine carbon particle exposure", "TREATMENT", 48, 82], ["immune response", "OBSERVATION", 104, 119], ["lung", "ANATOMY", 127, 131]]], ["However, at day 7 inflammation and viral exacerbation increased drastically (Lambert, et al. 2003) .", [["inflammation", "DISEASE", 18, 30], ["inflammation", "PROBLEM", 18, 30], ["viral exacerbation", "PROBLEM", 35, 53], ["viral", "OBSERVATION_MODIFIER", 35, 40], ["exacerbation", "OBSERVATION_MODIFIER", 41, 53], ["increased", "OBSERVATION_MODIFIER", 54, 63], ["drastically", "OBSERVATION_MODIFIER", 64, 75]]], ["Therefore, in our study, it could be assumed that prior exposure to PM 2.", [["our study", "TEST", 14, 23]]], ["In this study, any of the stimulations did not induce significant changes to ROS stress.Cell exposureMoreover, no drastic changes in viability were seen.", [["Cell", "ANATOMY", 88, 92], ["ROS", "CHEMICAL", 77, 80], ["ROS", "SIMPLE_CHEMICAL", 77, 80], ["Cell", "CELL", 88, 92], ["this study", "TEST", 3, 13], ["ROS stress", "PROBLEM", 77, 87], ["Cell exposureMoreover", "TEST", 88, 109], ["drastic changes in viability", "PROBLEM", 114, 142], ["no", "UNCERTAINTY", 111, 113], ["drastic", "OBSERVATION_MODIFIER", 114, 121], ["viability", "OBSERVATION_MODIFIER", 133, 142]]], ["Activation of pro-inflammatory Lastly, we also studied the cell cycle phase distribution of exposed cells.", [["cell", "ANATOMY", 59, 63], ["cells", "ANATOMY", 100, 105], ["cell", "CELL", 59, 63], ["cells", "CELL", 100, 105], ["exposed cells", "CELL_TYPE", 92, 105], ["exposed cells", "PROBLEM", 92, 105], ["pro-inflammatory", "OBSERVATION_MODIFIER", 14, 30], ["exposed cells", "OBSERVATION", 92, 105]]], ["Therefore, we assumed that the increase in the number of cells in the G2-M phase is associated with viral ligand-induced cell cycle arrest to progeny viral production.", [["cells", "ANATOMY", 57, 62], ["cell", "ANATOMY", 121, 125], ["cells", "CELL", 57, 62], ["cell", "CELL", 121, 125], ["viral ligand", "PROTEIN", 100, 112], ["viral ligand", "PROBLEM", 100, 112], ["cell cycle arrest", "PROBLEM", 121, 138], ["increase", "OBSERVATION_MODIFIER", 31, 39], ["associated with", "UNCERTAINTY", 84, 99], ["viral ligand", "OBSERVATION", 100, 112], ["cell cycle arrest", "OBSERVATION", 121, 138], ["viral production", "OBSERVATION", 150, 166]]], ["However, viral ligands failed to induce modifications in the G2-M phase in PM 2.5-1 primed co-cultures.", [["PM 2.5-1", "CELL", 75, 83], ["co-cultures", "CELL", 91, 102], ["PM 2.5-1 primed co-cultures", "CELL_LINE", 75, 102], ["viral ligands", "PROBLEM", 9, 22], ["viral ligands", "OBSERVATION", 9, 22]]], ["From our results, it can be speculated that prior exposure to PM may alter the viral virulence.", [["PM", "CHEMICAL", 62, 64], ["the viral virulence", "PROBLEM", 75, 94], ["viral virulence", "OBSERVATION", 79, 94]]], ["On the other hand, bacterial ligand TLR4Cell exposureincreased the number of cells in the Sub-G1 phase, with no effect on G1-G0 and G2-M phases.", [["cells", "ANATOMY", 77, 82], ["TLR4Cell", "GENE_OR_GENE_PRODUCT", 36, 44], ["cells", "CELL", 77, 82], ["TLR4Cell", "PROTEIN", 36, 44], ["bacterial ligand TLR4Cell", "TEST", 19, 44], ["bacterial", "OBSERVATION", 19, 28], ["ligand TLR4Cell", "OBSERVATION", 29, 44], ["no", "UNCERTAINTY", 109, 111]]], ["In correlation to the results from thiol assay, which accounts for the early apoptotic cells; pretreatment of cells with PM 2.5-1 slightly increased the number of cells in the Sub-G1Cell exposurephase, especially at higher doses of PM 2.5-1.", [["cells", "ANATOMY", 87, 92], ["cells", "ANATOMY", 110, 115], ["cells", "ANATOMY", 163, 168], ["thiol", "CHEMICAL", 35, 40], ["PM 2.5-1", "CHEMICAL", 121, 129], ["thiol", "CHEMICAL", 35, 40], ["cells", "CELL", 87, 92], ["cells", "CELL", 110, 115], ["cells", "CELL", 163, 168], ["early apoptotic cells", "CELL_TYPE", 71, 92], ["thiol assay", "TEST", 35, 46], ["the early apoptotic cells", "PROBLEM", 67, 92], ["pretreatment of cells", "PROBLEM", 94, 115], ["PM", "TEST", 121, 123], ["early", "OBSERVATION_MODIFIER", 71, 76], ["apoptotic cells", "OBSERVATION", 77, 92], ["increased", "OBSERVATION_MODIFIER", 139, 148]]], ["The response was, however, not statistically significant when compared to PM 2.5-1 alone but it shows that co-exposure with TLR4 ligand has some effect on the number of cells in the Sub-G1 phase.", [["cells", "ANATOMY", 169, 174], ["TLR4", "GENE_OR_GENE_PRODUCT", 124, 128], ["cells", "CELL", 169, 174], ["TLR4", "PROTEIN", 124, 128], ["TLR4 ligand", "PROBLEM", 124, 135], ["co-exposure", "OBSERVATION", 107, 118], ["TLR4 ligand", "OBSERVATION", 124, 135], ["some", "OBSERVATION_MODIFIER", 140, 144], ["effect", "OBSERVATION_MODIFIER", 145, 151]]], ["Therefore, our results indicate that PM 2.5-1 priming modifies immune responses against bacterial and viral stimulation in the studied cell model.Conclusion:PM 2.5-1 exposure altered the pro-inflammatory cytokine response to both bacterial and viral stimuli in the alveolar lung cell model.", [["cell", "ANATOMY", 135, 139], ["alveolar lung cell", "ANATOMY", 265, 283], ["PM 2.5-1", "CHEMICAL", 157, 165], ["PM 2.5-1", "GENE_OR_GENE_PRODUCT", 37, 45], ["cell", "CELL", 135, 139], ["alveolar lung cell", "CELL", 265, 283], ["pro-inflammatory cytokine", "PROTEIN", 187, 212], ["immune responses", "TREATMENT", 63, 79], ["bacterial and viral stimulation", "PROBLEM", 88, 119], ["the pro-inflammatory cytokine response", "PROBLEM", 183, 221], ["viral stimuli", "TEST", 244, 257], ["viral stimulation", "OBSERVATION", 102, 119], ["pro-inflammatory cytokine", "OBSERVATION", 187, 212], ["both bacterial", "OBSERVATION_MODIFIER", 225, 239], ["viral stimuli", "OBSERVATION", 244, 257], ["alveolar", "ANATOMY_MODIFIER", 265, 273], ["lung", "ANATOMY", 274, 278], ["cell model", "OBSERVATION", 279, 289]]], ["PM 2.5-1 increased the sensitivity of the A549-THP1 coculture to produce pro-inflammatory cytokines, which potentially leads to hyperinflammatory response against bacterial infection.", [["A549-THP1", "ANATOMY", 42, 51], ["PM 2.5-1", "CHEMICAL", 0, 8], ["bacterial infection", "DISEASE", 163, 182], ["A549-THP1", "CELL", 42, 51], ["A549", "CELL_LINE", 42, 46], ["THP1 coculture", "CELL_LINE", 47, 61], ["pro-inflammatory cytokines", "PROTEIN", 73, 99], ["the A549", "TEST", 38, 46], ["THP1 coculture", "TEST", 47, 61], ["pro-inflammatory cytokines", "PROBLEM", 73, 99], ["hyperinflammatory response", "PROBLEM", 128, 154], ["bacterial infection", "PROBLEM", 163, 182], ["pro-inflammatory cytokines", "OBSERVATION", 73, 99], ["bacterial", "OBSERVATION_MODIFIER", 163, 172], ["infection", "OBSERVATION", 173, 182]]], ["Instead, virus-mediated proinflammatory effects were suppressed if the co-culture model of the alveolar barrier was primed with PM 2.5-1.", [["alveolar barrier", "ANATOMY", 95, 111], ["alveolar barrier", "MULTI-TISSUE_STRUCTURE", 95, 111], ["virus-mediated proinflammatory effects", "PROBLEM", 9, 47], ["the alveolar barrier", "TREATMENT", 91, 111], ["virus", "OBSERVATION", 9, 14], ["proinflammatory", "OBSERVATION_MODIFIER", 24, 39], ["alveolar", "ANATOMY", 95, 103]]], ["These findings provide insight into the underlying immunomodulatory effects of fine particulate matter, which potentially leads to susceptibility to respiratory infections.Funding:The work was supported by P\u00e4ivikki and Sakari Sohlberg Foundation, Juho Vainio Foundation, and the Academy of Finland grants (319245, 294081, 287982).", [["respiratory", "ANATOMY", 149, 160], ["respiratory infections", "DISEASE", 149, 171], ["fine particulate matter", "PROBLEM", 79, 102], ["respiratory infections", "PROBLEM", 149, 171], ["immunomodulatory effects", "OBSERVATION", 51, 75], ["fine", "OBSERVATION_MODIFIER", 79, 83], ["particulate matter", "OBSERVATION", 84, 102], ["respiratory", "ANATOMY", 149, 160], ["infections", "OBSERVATION", 161, 171]]]], "PMC7216866": [["To the Editor:As of 24 April 2020, over 2.8 million cases of Coronavirus disease 2019 (COVID-19) with ~200,000 deaths have been reported in 210 countries (https://www.worldometers.info/coronavirus/).", [["Coronavirus disease", "DISEASE", 61, 80], ["deaths", "DISEASE", 111, 117], ["Coronavirus disease", "PROBLEM", 61, 80], ["COVID", "TEST", 87, 92], ["Coronavirus disease", "OBSERVATION", 61, 80]]], ["Studies have shown that ~30% of the hospitalised patients with COVID-19\u2014usually those who were older (mean age of 60\u201370 years) and with multiple systemic co-morbidities\u2014require admission to intensive care units (ICUs) and ventilatory support [1\u20133].", [["systemic co-morbidities", "DISEASE", 145, 168], ["patients", "ORGANISM", 49, 57], ["patients", "SPECIES", 49, 57], ["Studies", "TEST", 0, 7], ["multiple systemic co-morbidities", "PROBLEM", 136, 168], ["ventilatory support", "TREATMENT", 222, 241], ["multiple", "OBSERVATION_MODIFIER", 136, 144], ["systemic", "OBSERVATION_MODIFIER", 145, 153], ["co-morbidities", "OBSERVATION", 154, 168]]], ["While provision of the critical care service is crucial, it is important not to forget about the eye care in these critically ill patients.To the Editor:Occurrence of ocular complications, particularly corneal infection (a potentially blinding condition), has been a recurrent theme for critically ill patients in ICUs [4].", [["eye", "ANATOMY", 97, 100], ["ocular", "ANATOMY", 167, 173], ["corneal", "ANATOMY", 202, 209], ["critically ill", "DISEASE", 115, 129], ["ocular complications", "DISEASE", 167, 187], ["corneal infection", "DISEASE", 202, 219], ["critically ill", "DISEASE", 287, 301], ["eye", "ORGAN", 97, 100], ["patients", "ORGANISM", 130, 138], ["ocular", "ORGAN", 167, 173], ["corneal", "TISSUE", 202, 209], ["patients", "ORGANISM", 302, 310], ["patients", "SPECIES", 130, 138], ["patients", "SPECIES", 302, 310], ["ocular complications", "PROBLEM", 167, 187], ["corneal infection", "PROBLEM", 202, 219], ["a potentially blinding condition", "PROBLEM", 221, 253], ["ocular", "ANATOMY", 167, 173], ["complications", "OBSERVATION", 174, 187], ["corneal", "ANATOMY", 202, 209], ["infection", "OBSERVATION", 210, 219]]], ["Main predisposing factors include the inability to close the eyes causing exposure keratopathy, impaired blinking reflex, drying of ocular surface causing breakdown of corneal epithelium, contamination from the infected respiratory secretions, and intermittent positive-pressure from the ventilation causing venous stasis and conjunctival oedema [4].", [["eyes", "ANATOMY", 61, 65], ["ocular surface", "ANATOMY", 132, 146], ["corneal epithelium", "ANATOMY", 168, 186], ["respiratory secretions", "ANATOMY", 220, 242], ["venous", "ANATOMY", 308, 314], ["conjunctival", "ANATOMY", 326, 338], ["keratopathy", "DISEASE", 83, 94], ["impaired blinking", "DISEASE", 96, 113], ["venous stasis", "DISEASE", 308, 321], ["conjunctival oedema", "DISEASE", 326, 345], ["eyes", "ORGAN", 61, 65], ["corneal epithelium", "TISSUE", 168, 186], ["venous", "MULTI-TISSUE_STRUCTURE", 308, 314], ["Main predisposing factors", "PROBLEM", 0, 25], ["exposure keratopathy", "PROBLEM", 74, 94], ["impaired blinking reflex", "PROBLEM", 96, 120], ["ocular surface", "PROBLEM", 132, 146], ["corneal epithelium", "PROBLEM", 168, 186], ["contamination", "PROBLEM", 188, 201], ["the infected respiratory secretions", "PROBLEM", 207, 242], ["intermittent positive-pressure", "PROBLEM", 248, 278], ["the ventilation", "TREATMENT", 284, 299], ["venous stasis", "PROBLEM", 308, 321], ["conjunctival oedema", "PROBLEM", 326, 345], ["eyes", "ANATOMY", 61, 65], ["keratopathy", "OBSERVATION", 83, 94], ["impaired", "OBSERVATION_MODIFIER", 96, 104], ["blinking reflex", "OBSERVATION", 105, 120], ["ocular", "ANATOMY", 132, 138], ["corneal epithelium", "ANATOMY", 168, 186], ["infected", "OBSERVATION_MODIFIER", 211, 219], ["respiratory secretions", "OBSERVATION", 220, 242], ["pressure", "OBSERVATION_MODIFIER", 270, 278], ["venous", "ANATOMY", 308, 314], ["stasis", "OBSERVATION", 315, 321], ["conjunctival oedema", "OBSERVATION", 326, 345]]], ["This issue recently came to light where a patient with COVID-19 in our ICU, ventilated for several days, developed an exposure keratopathy with corneal abrasion, which was reported as \u2018white cornea with presumed infection\u2019.", [["corneal", "ANATOMY", 144, 151], ["cornea", "ANATOMY", 191, 197], ["keratopathy", "DISEASE", 127, 138], ["corneal abrasion", "DISEASE", 144, 160], ["infection", "DISEASE", 212, 221], ["patient", "ORGANISM", 42, 49], ["corneal", "TISSUE", 144, 151], ["cornea", "ORGAN", 191, 197], ["patient", "SPECIES", 42, 49], ["COVID", "TEST", 55, 60], ["ventilated", "TREATMENT", 76, 86], ["an exposure keratopathy", "PROBLEM", 115, 138], ["corneal abrasion", "PROBLEM", 144, 160], ["white cornea", "PROBLEM", 185, 197], ["infection", "PROBLEM", 212, 221], ["keratopathy", "OBSERVATION", 127, 138], ["corneal abrasion", "OBSERVATION", 144, 160], ["cornea", "ANATOMY", 191, 197], ["presumed", "UNCERTAINTY", 203, 211], ["infection", "OBSERVATION", 212, 221]]], ["This was immediately reviewed by the ophthalmology team and prophylactic topical antibiotic medication was instituted.", [["prophylactic topical antibiotic medication", "TREATMENT", 60, 102]]], ["This underscores the importance of incorporating prevention, recognition, and management of eye problems as part of the care bundle of COVID-19.To the Editor:In addition, COVID-19 patients who require critical care are usually those that are elderly with multiple co-morbidities.", [["eye", "ANATOMY", 92, 95], ["eye", "ORGAN", 92, 95], ["patients", "ORGANISM", 180, 188], ["patients", "SPECIES", 180, 188], ["eye problems", "PROBLEM", 92, 104], ["COVID", "TEST", 135, 140], ["critical care", "TREATMENT", 201, 214], ["multiple co-morbidities", "PROBLEM", 255, 278]]], ["These factors have significant clinical ramifications for the eyes as elderly patients who develop corneal infection are associated with poorer visual outcome and higher rate of complications such as corneal perforation, need for emergency corneal transplant, and evisceration (removal of all the internal contents of an eye) [5].To the Editor:Prevention is therefore paramount.", [["eyes", "ANATOMY", 62, 66], ["corneal", "ANATOMY", 99, 106], ["corneal", "ANATOMY", 200, 207], ["corneal", "ANATOMY", 240, 247], ["eye", "ANATOMY", 321, 324], ["corneal infection", "DISEASE", 99, 116], ["corneal perforation", "DISEASE", 200, 219], ["eyes", "ORGAN", 62, 66], ["patients", "ORGANISM", 78, 86], ["corneal", "MULTI-TISSUE_STRUCTURE", 99, 106], ["corneal", "TISSUE", 200, 207], ["corneal", "TISSUE", 240, 247], ["eye", "ORGAN", 321, 324], ["patients", "SPECIES", 78, 86], ["corneal infection", "PROBLEM", 99, 116], ["poorer visual outcome", "PROBLEM", 137, 158], ["higher rate of complications", "PROBLEM", 163, 191], ["corneal perforation", "PROBLEM", 200, 219], ["emergency corneal transplant", "TREATMENT", 230, 258], ["evisceration", "PROBLEM", 264, 276], ["removal", "TREATMENT", 278, 285], ["corneal", "ANATOMY", 99, 106], ["infection", "OBSERVATION", 107, 116], ["corneal", "ANATOMY", 200, 207], ["perforation", "OBSERVATION", 208, 219], ["corneal", "ANATOMY", 240, 247], ["transplant", "OBSERVATION", 248, 258], ["evisceration", "OBSERVATION", 264, 276], ["internal", "ANATOMY_MODIFIER", 297, 305], ["eye", "ANATOMY", 321, 324]]], ["With this in mind, we provide some practical and important practice points with an aim to improve the eye care for critically ill patients (Fig. 1).", [["eye", "ANATOMY", 102, 105], ["critically ill", "DISEASE", 115, 129], ["eye", "ORGAN", 102, 105], ["patients", "ORGANISM", 130, 138], ["patients", "SPECIES", 130, 138]]], ["In the current pandemic, we hope that these strategies will help reduce the avoidable risk of sight-threatening complications (and potential medical litigation) and provide a more holistic care for the critically ill patients during the battle against COVID-19.", [["critically ill", "DISEASE", 202, 216], ["patients", "ORGANISM", 217, 225], ["patients", "SPECIES", 217, 225], ["these strategies", "TREATMENT", 38, 54], ["sight-threatening complications", "PROBLEM", 94, 125], ["COVID", "TEST", 252, 257]]], ["It would be an unimaginable tragedy for patients with COVID-19 to recover from the life-threatening respiratory illness but to wake up with visual impairment.", [["respiratory", "ANATOMY", 100, 111], ["respiratory illness", "DISEASE", 100, 119], ["visual impairment", "DISEASE", 140, 157], ["patients", "ORGANISM", 40, 48], ["patients", "SPECIES", 40, 48], ["COVID", "TEST", 54, 59], ["threatening respiratory illness", "PROBLEM", 88, 119], ["visual impairment", "PROBLEM", 140, 157], ["respiratory illness", "OBSERVATION", 100, 119]]]], "cf56dc5fb4fec54ad75f2402c22b411d56419366": [["The article is based on a review of 28 150,401 scientific articles and 29,690 patent families that make reference to the Antarctic 29 or Southern Ocean in the open access Lens database of scientific and patent literature.", [["patent", "OBSERVATION", 203, 209]]]], "81d3ee960a0c51e41ac8f9522862e238cdbf1977": [["IntroductionThere are scarce data about the impact of epidemics on children's growth and development.", [["children", "ORGANISM", 67, 75], ["children", "SPECIES", 67, 75]]], ["Preserving children's well-being during stressful times such as pandemics needs greater attention in the medical literature.", [["children", "ORGANISM", 11, 19], ["children", "SPECIES", 11, 19]]], ["Children's health is one of the most important issues in the Sustainable Development Goals (SDGs), and science has shown that genetic predispositions are modified by environmental influences, such as those experienced during a pandemic, and affect learning capacities, adaptive behaviors, lifelong physical and mental health, and adult productivity.IntroductionEpidemics or pandemics, such as COVID-19, produce potential risks to child development due to the risk of illness, protective confinement, social isolation, and the increased stress level of parents and caregivers.", [["pandemics", "DISEASE", 374, 383], ["illness", "DISEASE", 467, 474], ["Children", "ORGANISM", 0, 8], ["Children", "SPECIES", 0, 8], ["IntroductionEpidemics", "TREATMENT", 349, 370], ["pandemics", "TREATMENT", 374, 383], ["COVID", "TREATMENT", 393, 398], ["illness", "PROBLEM", 467, 474], ["social isolation", "TREATMENT", 500, 516]]], ["This situation becomes an adverse childhood experience (ACEs) and may generate toxic stress, with consequent potential losses for brain development, individual and collective health, and the long-term impairment of cognition, mental and physical health, and working capacity of future adults.IntroductionStudies to improve the understanding of the impact of epidemics and pandemics such as COVID-19 on children's mental health and development can help to guide strategies to prevent damage to children's growth and promote positive development.IntroductionThe COVID-19 pandemic has produced impacts on general health and child development through exposure to the virus and consequent infection, as well as through the social confinement recommended or mandated in an attempt to slow the progress of COVID-19, enable adequate medical care, and prevent the collapse of health care systems.IntroductionConsequently, the pandemic demands that millions of parents and caregivers demonstrate a high capacity for resilience to ensure protective health measures to prevent contagion.", [["brain", "ANATOMY", 130, 135], ["impairment of cognition", "DISEASE", 201, 224], ["COVID-19", "CHEMICAL", 390, 398], ["infection", "DISEASE", 684, 693], ["brain", "ORGAN", 130, 135], ["adults", "ORGANISM", 285, 291], ["children", "ORGANISM", 402, 410], ["children", "ORGANISM", 493, 501], ["children", "SPECIES", 402, 410], ["children", "SPECIES", 493, 501], ["toxic stress", "PROBLEM", 79, 91], ["brain development", "PROBLEM", 130, 147], ["the long-term impairment of cognition", "PROBLEM", 187, 224], ["IntroductionStudies", "TREATMENT", 292, 311], ["epidemics", "PROBLEM", 358, 367], ["pandemics", "PROBLEM", 372, 381], ["COVID", "TREATMENT", 390, 395], ["damage to children's growth", "PROBLEM", 483, 510], ["the virus", "PROBLEM", 659, 668], ["consequent infection", "PROBLEM", 673, 693], ["COVID", "TREATMENT", 799, 804], ["the collapse of health care systems", "PROBLEM", 851, 886], ["a high capacity", "PROBLEM", 986, 1001], ["protective health measures", "TREATMENT", 1027, 1053], ["long-term", "OBSERVATION_MODIFIER", 191, 200], ["infection", "OBSERVATION", 684, 693], ["collapse", "OBSERVATION", 855, 863]]], ["One of the pillars for overcoming adversity is interaction among people, which is compromised by isolation, leading to increased stress in both parents and children.", [["people", "ORGANISM", 65, 71], ["children", "ORGANISM", 156, 164], ["people", "SPECIES", 65, 71], ["children", "SPECIES", 156, 164], ["increased stress", "PROBLEM", 119, 135], ["pillars", "OBSERVATION_MODIFIER", 11, 18], ["increased", "OBSERVATION_MODIFIER", 119, 128], ["stress", "OBSERVATION", 129, 135]]], ["In addition to general care and strategies to minimize stress, preserving children's well-being is an important focus, increasingly highlighted in medical literature.IntroductionChildren's good health is one of the most important issues for the SDGs, and science demonstrates that genetic predispositions (biology) are modified by environmental J o u r n a l P r e -p r o o f influences (ecology) and affect learning capacities, adaptive behaviors, lifelong physical and mental health, and adult productivity.", [["children", "ORGANISM", 74, 82], ["Children", "ORGANISM", 178, 186], ["children", "SPECIES", 74, 82], ["Children", "SPECIES", 178, 186], ["general care", "TREATMENT", 15, 27], ["strategies", "TREATMENT", 32, 42], ["stress", "PROBLEM", 55, 61], ["learning capacities", "PROBLEM", 408, 427]]], ["[1] From this perspective, there are several factors that influence the physical and mental health of children and adolescents experiencing the stress inherent in a pandemic, such as isolation itself, school shutdown, reduced social life and physical activities, changes to routine, sleep difficulties, exposure to disharmony at home, excessive screen use, unhealthy diet, and others.", [["pandemic", "DISEASE", 165, 173], ["sleep difficulties", "DISEASE", 283, 301], ["disharmony", "DISEASE", 315, 325], ["children", "ORGANISM", 102, 110], ["children", "SPECIES", 102, 110], ["sleep difficulties", "PROBLEM", 283, 301]]], ["[2] Depending on levels and kinds of support, high and continuous stress may either be tolerable or become toxic to children and adolescents.", [["children", "ORGANISM", 116, 124], ["children", "SPECIES", 116, 124], ["adolescents", "SPECIES", 129, 140], ["support", "TREATMENT", 37, 44]]], ["ACEs are traumatic or stressful events that occur in childhood, such as abuse, neglect, domestic violence, and parents with substance dependence or mental illness.", [["ACEs", "DISEASE", 0, 4], ["traumatic", "DISEASE", 9, 18], ["neglect", "DISEASE", 79, 86], ["domestic violence", "DISEASE", 88, 105], ["substance dependence", "DISEASE", 124, 144], ["mental illness", "DISEASE", 148, 162], ["ACEs", "GENE_OR_GENE_PRODUCT", 0, 4], ["traumatic", "PROBLEM", 9, 18], ["stressful events", "PROBLEM", 22, 38], ["neglect", "PROBLEM", 79, 86], ["substance dependence", "PROBLEM", 124, 144], ["mental illness", "PROBLEM", 148, 162], ["traumatic", "OBSERVATION", 9, 18]]], ["The pandemic can be understood as another source of ACE.", [["ACE", "GENE_OR_GENE_PRODUCT", 52, 55], ["ACE", "TREATMENT", 52, 55]]], ["[3] This review of the scientific literature about the impacts of isolation, environmental restriction, social distancing, and the challenges of maintaining general child health and development within the context of previous epidemics and the COVID-19 pandemic was undertaken in light of the above.MethodsThe guidelines from the Preferred Reporting Items for Systematic Reviews [4] were used to conduct this review of the scientific literature about the impacts on the general health, development, and mental health of children and adolescents as a result of previous epidemics and/or the COVID-19 pandemic.MethodsObservational, cross-sectional, cohort, and ecological studies, case series, and systematic reviews, without language restrictions were included in the study.", [["children", "ORGANISM", 519, 527], ["children", "SPECIES", 519, 527], ["adolescents", "SPECIES", 532, 543], ["isolation", "TREATMENT", 66, 75], ["previous epidemics", "PROBLEM", 216, 234], ["the COVID", "TEST", 239, 248], ["previous epidemics", "PROBLEM", 559, 577], ["the COVID", "TEST", 585, 594], ["pandemic", "PROBLEM", 598, 606], ["ecological studies", "TEST", 658, 676], ["systematic reviews", "TEST", 695, 713], ["the study", "TEST", 762, 771]]], ["Studies of non-human subjects and experimental studies were excluded.", [["non-human", "ORGANISM", 11, 20], ["Studies of non-human subjects", "TEST", 0, 29], ["experimental studies", "TEST", 34, 54]]], ["All of the studies were assessed in relation to their characteristics, quality, and congruence with the theme.", [["the studies", "TEST", 7, 18]]], ["Each study's summary was initially analyzed and those that did not meet the inclusion criteria were excluded.", [["Each study's summary", "TEST", 0, 20]]], ["Two tools were used to measure the quality of the articles included in this review: CASP and AMSTAR 2 ( Fig. 1) .ResultsFrom the PubMed platform, 80 articles were selected, of which 14 were analyzed and eight were included in this review.", [["CASP and AMSTAR", "TREATMENT", 84, 99]]], ["A search for the descriptors resulted in only two studies from the WHO COVID-19 database, neither of which was selected, since they did not meet the criteria of the present review.", [["the WHO COVID", "TEST", 63, 76]]], ["No articles containing the descriptors were found on the Scielo platform.", [["articles", "OBSERVATION", 3, 11]]], ["In total, nine studies were included in this review.", [["nine studies", "TEST", 10, 22]]], ["The CASP checklist resulted in scores greater than 5 in six studies and one less than 5.", [["The CASP checklist", "TEST", 0, 18], ["scores", "TEST", 31, 37]]], ["Using the ASTAR 2 criteria, the quality of the systematic reviews included was classified as high high ( Table 1 ).ResultsThe study by Almond describes poor educational and physical performance and lower income and socioeconomic status as adults in children whose mothers were infected by the Spanish flu during the 1918 pandemic.", [["children", "ORGANISM", 249, 257], ["mothers", "ORGANISM", 264, 271], ["children", "SPECIES", 249, 257], ["the systematic reviews", "TEST", 43, 65], ["The study", "TEST", 122, 131]]], ["[5] The study by Wang et al. on the psychological consequences of the COVID-19 pandemic, investigated 1,210 individuals, the majority female (67.3%), from families of three to five people (80.7%), with children (67.4%), in 194 Chinese cities.", [["people", "ORGANISM", 181, 187], ["children", "ORGANISM", 202, 210], ["people", "SPECIES", 181, 187], ["children", "SPECIES", 202, 210], ["The study", "TEST", 4, 13]]], ["In total, 53.8% of respondents rated the psychological impact of the outbreak as moderate or severe, 16.5% reported moderate to severe depressive symptoms, 28.8% reported moderate to severe anxiety symptoms, and 8.1% reported moderate to severe levels of stress.", [["depressive symptoms", "DISEASE", 135, 154], ["anxiety", "DISEASE", 190, 197], ["moderate to severe depressive symptoms", "PROBLEM", 116, 154], ["moderate to severe anxiety symptoms", "PROBLEM", 171, 206], ["moderate to severe levels of stress", "PROBLEM", 226, 261], ["moderate", "OBSERVATION_MODIFIER", 81, 89], ["severe", "OBSERVATION_MODIFIER", 93, 99], ["severe", "OBSERVATION_MODIFIER", 128, 134], ["severe", "OBSERVATION_MODIFIER", 183, 189]]], ["The majority of respondents spent 20 to 24 hours a day at home (84.7%) and stated that they were concerned about family members contracting COVID-19.", [["COVID-19", "CHEMICAL", 140, 148]]], ["The \"parents\" group had higher levels of stress, anxiety, and depression when compared with the \"no J o u r n a l P r e -p r o o f children\" group, a statistically significant difference, and the majority of parents stated that they were \"very\" or \"somewhat worried\" about a child getting COVID-19.", [["anxiety", "DISEASE", 49, 56], ["depression", "DISEASE", 62, 72], ["children", "SPECIES", 131, 139], ["stress", "PROBLEM", 41, 47], ["anxiety", "PROBLEM", 49, 56], ["depression", "PROBLEM", 62, 72], ["significant", "OBSERVATION_MODIFIER", 164, 175], ["difference", "OBSERVATION", 176, 186]]], ["[6] In another study, data were obtained from 586 parents interviewed in 2009 in the United States, Mexico, and Canada about the H1N1 pandemic.", [["H1N1", "DISEASE", 129, 133], ["another study", "TEST", 7, 20]]], ["[7] The respondents were predominantly female (78%), with an average age of 37 years.", [["respondents", "ORGANISM", 8, 19]]], ["In the investigation of factors related to child stress, the most common diagnosis was acute stress disorder (16.7%), while 6.2% of children had post-traumatic stress disorder (PTSD).", [["acute stress disorder", "DISEASE", 87, 108], ["post-traumatic stress disorder", "DISEASE", 145, 175], ["PTSD", "DISEASE", 177, 181], ["children", "ORGANISM", 132, 140], ["children", "SPECIES", 132, 140], ["child stress", "PROBLEM", 43, 55], ["acute stress disorder", "PROBLEM", 87, 108], ["post-traumatic stress disorder", "PROBLEM", 145, 175], ["PTSD", "PROBLEM", 177, 181], ["post-traumatic stress disorder", "OBSERVATION", 145, 175]]], ["A total of 44.4% reported that their children did not receive professional mental health support, while 93.2% of the parents did not receive psychological assistance from professionals.ResultsOf the children who had access to mental health services during the pandemic, the most common diagnosis was anxiety disorder (20%), while only 1.4% had PTSD.ResultsAdditionally, the criteria for diagnosing PTSD were found in 30% of the confined children and in 25% of the parents (based on reports from 398 parents), which indicates the high traumatic potential of social isolation and living in conditions of constant fear due to the advance of the pandemic.", [["anxiety disorder", "DISEASE", 300, 316], ["PTSD", "DISEASE", 344, 348], ["PTSD", "DISEASE", 398, 402], ["children", "ORGANISM", 37, 45], ["children", "ORGANISM", 199, 207], ["children", "ORGANISM", 437, 445], ["children", "SPECIES", 37, 45], ["children", "SPECIES", 199, 207], ["children", "SPECIES", 437, 445], ["professional mental health support", "TREATMENT", 62, 96], ["psychological assistance", "TREATMENT", 141, 165], ["anxiety disorder", "PROBLEM", 300, 316], ["PTSD", "PROBLEM", 344, 348], ["PTSD", "PROBLEM", 398, 402], ["social isolation", "TREATMENT", 557, 573], ["the pandemic", "PROBLEM", 638, 650], ["social isolation", "OBSERVATION", 557, 573]]], ["J o u r n a l P r e -p r o o f A cross-sectional study assessed the psychological distress of 117 patients having an average age of 34 years who had survived or had contacts with the Ebola epidemic in Nigeria.", [["Ebola", "DISEASE", 183, 188], ["patients", "ORGANISM", 98, 106], ["Ebola", "ORGANISM", 183, 188], ["patients", "SPECIES", 98, 106], ["A cross-sectional study", "TEST", 31, 54]]], ["The death of a friend (OR = 6.0, 95% CI, 1.2-32.9) was significantly associated with feeling unhappy or depressed and with loss of ability to concentrate.", [["death", "DISEASE", 4, 9], ["depressed", "DISEASE", 104, 113], ["CI", "TEST", 37, 39], ["depressed", "PROBLEM", 104, 113], ["loss of ability", "PROBLEM", 123, 138]]], ["Additionally, the most reported psychological suffering was \"inability to focus on the task at hand\" (38.5%) and \"loss of sleep due to worry\" (33.3%). reported anxiety symptoms.", [["hand", "ANATOMY", 95, 99], ["loss of sleep", "DISEASE", 114, 127], ["anxiety", "DISEASE", 160, 167], ["hand", "ORGANISM_SUBDIVISION", 95, 99], ["loss of sleep", "PROBLEM", 114, 127], ["anxiety symptoms", "PROBLEM", 160, 176]]], ["They concluded that serious infectious diseases, such as COVID-19, may cause mental health problems in children and that more studies are needed on this issue.", [["infectious diseases", "DISEASE", 28, 47], ["COVID-19", "CHEMICAL", 57, 65], ["children", "ORGANISM", 103, 111], ["children", "SPECIES", 103, 111], ["serious infectious diseases", "PROBLEM", 20, 47], ["mental health problems", "PROBLEM", 77, 99], ["serious", "OBSERVATION_MODIFIER", 20, 27], ["infectious", "OBSERVATION", 28, 38]]], ["[12] Brooks et al. conducted a review of studies on the psychological impact of quarantine due to COVID-19.", [["COVID", "TEST", 98, 103]]], ["Most studies reported anxiety, stress, and depression.", [["anxiety", "DISEASE", 22, 29], ["depression", "DISEASE", 43, 53], ["Most studies", "TEST", 0, 12], ["anxiety", "PROBLEM", 22, 29], ["stress", "PROBLEM", 31, 37], ["depression", "PROBLEM", 43, 53]]], ["[13] From the surveys included in the review, data revealed that more than 20% (230 out of 1057 individuals) reported fear, 18% reported nervousness and 186 reported sadness.ResultsAdditionally, pre-quarantine predictors were shown to influence the level of psychological impactfor example, having a history of psychiatric illness was associated with feelings of anxiety and anger, while lower levels of formal education, J o u r n a l P r e -p r o o f lower age (16-24 years), female gender, and having one child as opposed to no children (although having three or more children appeared somewhat protective) were also associated with negative psychological impacts.", [["nervousness", "DISEASE", 137, 148], ["sadness", "DISEASE", 166, 173], ["psychiatric illness", "DISEASE", 311, 330], ["anxiety", "DISEASE", 363, 370], ["anger", "DISEASE", 375, 380], ["children", "ORGANISM", 531, 539], ["children", "ORGANISM", 571, 579], ["children", "SPECIES", 531, 539], ["children", "SPECIES", 571, 579], ["nervousness", "PROBLEM", 137, 148], ["sadness", "PROBLEM", 166, 173], ["pre-quarantine predictors", "TREATMENT", 195, 220], ["psychiatric illness", "PROBLEM", 311, 330], ["anxiety", "PROBLEM", 363, 370]]], ["The longer the quarantine, the greater the levels of post-traumatic stress.", [["post-traumatic stress", "DISEASE", 53, 74], ["post-traumatic stress", "PROBLEM", 53, 74], ["greater", "OBSERVATION_MODIFIER", 31, 38], ["post-traumatic stress", "OBSERVATION", 53, 74]]], ["Fear of infection, a lack of basic supplies, and unclear information from officials were associated with frustration and anger.", [["infection", "DISEASE", 8, 17], ["infection", "PROBLEM", 8, 17], ["infection", "OBSERVATION", 8, 17]]], ["Among the postquarantine stressors analyzed, financial loss was considered to be a risk factor for psychological disorders.", [["financial loss", "DISEASE", 45, 59], ["psychological disorders", "DISEASE", 99, 122], ["financial loss", "PROBLEM", 45, 59], ["psychological disorders", "PROBLEM", 99, 122]]], ["Another study compared post-traumatic stress symptoms in quarantined parents and children with those who were not quarantined, revealing higher mean post-traumatic stress scores in children who had been quarantined than those who had not.", [["post-traumatic stress symptoms", "DISEASE", 23, 53], ["children", "ORGANISM", 81, 89], ["children", "ORGANISM", 181, 189], ["children", "SPECIES", 81, 89], ["children", "SPECIES", 181, 189], ["Another study", "TEST", 0, 13], ["post-traumatic stress symptoms", "PROBLEM", 23, 53], ["traumatic stress scores", "PROBLEM", 154, 177]]], ["Conversely, one study found that, although very few participants were extremely concerned about becoming infected or transmitting the virus to others, those who were concerned tended to be pregnant women and those with young children.", [["women", "ORGANISM", 198, 203], ["children", "ORGANISM", 225, 233], ["participants", "SPECIES", 52, 64], ["women", "SPECIES", 198, 203], ["children", "SPECIES", 225, 233], ["one study", "TEST", 12, 21], ["infected", "OBSERVATION", 105, 113]]], ["Finally, the review proposed activities to mitigate the consequences of isolation, which included providing the population with as much clear information as possible, providing adequate supplies, seeking to reduce stress, and providing organizational support for health-care professionals.", [["isolation", "TREATMENT", 72, 81], ["organizational support", "TREATMENT", 236, 258]]], ["[13]DiscussionThe COVID-19 pandemic has imposed a number of changes on daily routines needed to preserve individual health.", [["daily routines", "TREATMENT", 71, 85]]], ["Meanwhile, it is important to note that children around the world continue to grow and develop.", [["children", "ORGANISM", 40, 48], ["children", "SPECIES", 40, 48]]], ["In this scenario, one priority challenge is identifying and discussing pandemic-related factors that can negatively affect children's growth and development and impair each child's full potential, in order to develop prevention strategies that enable a healthier and more productive population over both the short and long term.DiscussionThe scientific literature describes healthy pregnancy, balanced nutrition, immunity to diseases, restful sleep, a family environment rich in positive stimuli, and a high-quality educational system as the fundamentals for optimal child growth and development.", [["children", "ORGANISM", 123, 131], ["children", "SPECIES", 123, 131], ["prevention strategies", "TREATMENT", 217, 238]]], ["[14] All these fundamentals are relevant to the prevention of toxic stress and for the development of strong and lasting neural connections in the child's brain.", [["neural", "ANATOMY", 121, 127], ["brain", "ANATOMY", 155, 160], ["brain", "ORGAN", 155, 160], ["child", "SPECIES", 147, 152], ["toxic stress", "PROBLEM", 62, 74], ["strong and lasting neural connections in the child's brain", "PROBLEM", 102, 160], ["strong", "OBSERVATION_MODIFIER", 102, 108], ["neural connections", "OBSERVATION", 121, 139], ["brain", "ANATOMY", 155, 160]]], ["[15] The high level of stress that humanity is experiencing as a result of the COVID-19 pandemic may generate tolerable or toxic stress for children and adolescents, depending on if and how support is ensured.", [["children", "ORGANISM", 140, 148], ["children", "SPECIES", 140, 148], ["the COVID", "TEST", 75, 84]]], ["Under the appropriate care and support of adults who J o u r n a l P r e -p r o o f provide children with constant feelings of security and affection, the child's body reorganizes itself biochemically and quickly returns to levels of physiological functioning without further damage.", [["body", "ANATOMY", 163, 167], ["adults", "ORGANISM", 42, 48], ["children", "ORGANISM", 92, 100], ["body", "ORGANISM_SUBDIVISION", 163, 167], ["children", "SPECIES", 92, 100], ["further damage", "PROBLEM", 268, 282]]], ["[16] However, when this support is non-existent or inadequate, a failure of the body's functions to return to basal level primarily impacts the cardiovascular and neurological systems, with consequent irreversible loss of connections in the infant brain, due to toxic stress.", [["body", "ANATOMY", 80, 84], ["cardiovascular", "ANATOMY", 144, 158], ["neurological", "ANATOMY", 163, 175], ["brain", "ANATOMY", 248, 253], ["cardiovascular and neurological systems", "DISEASE", 144, 183], ["body", "ORGANISM_SUBDIVISION", 80, 84], ["cardiovascular", "ANATOMICAL_SYSTEM", 144, 158], ["brain", "ORGAN", 248, 253], ["infant", "SPECIES", 241, 247], ["a failure of the body's functions", "PROBLEM", 63, 96], ["the cardiovascular and neurological systems", "PROBLEM", 140, 183], ["consequent irreversible loss of connections in the infant brain", "PROBLEM", 190, 253], ["toxic stress", "PROBLEM", 262, 274], ["cardiovascular", "ANATOMY", 144, 158], ["neurological systems", "ANATOMY", 163, 183], ["irreversible", "OBSERVATION_MODIFIER", 201, 213], ["loss", "OBSERVATION", 214, 218], ["brain", "ANATOMY", 248, 253], ["toxic stress", "OBSERVATION", 262, 274]]], ["[17, 18] Several factors related to the pandemic are recognized as ACEs and negatively interfere in the construction and structuring of the child's brain architecture.", [["brain", "ANATOMY", 148, 153], ["brain architecture", "MULTI-TISSUE_STRUCTURE", 148, 166], ["the pandemic", "PROBLEM", 36, 48], ["brain", "ANATOMY", 148, 153]]], ["[19, 20] Restrictive social and economic reconfigurations, the fear of contagion, illness caused by COVID-19, isolated family life, school closures, the lack of support networks for other adults, the loss of loved ones, the difficulty of combining working from home with fulltime childcare, financial challenges, increased exposure to pre-existing vulnerabilities (such as domestic violence, drug use, and mental illness in family members) can result in toxic stress, which will increase according to the sum of ACEs.", [["Restrictive social and economic reconfigurations", "DISEASE", 9, 57], ["fear of contagion", "DISEASE", 63, 80], ["illness", "DISEASE", 82, 89], ["domestic violence", "DISEASE", 373, 390], ["illness", "DISEASE", 413, 420], ["ACEs", "GENE_OR_GENE_PRODUCT", 512, 516], ["toxic stress", "PROBLEM", 454, 466]]], ["[21] The literature demonstrates that, for both parents and children, sleep routines and the balance of daily activities are usually altered during social isolation.", [["children", "ORGANISM", 60, 68], ["children", "SPECIES", 60, 68], ["sleep routines", "TREATMENT", 70, 84]]], ["In this context, the quality and duration of sleep may be irregular, the level of physical and outdoor activities substantially decreases, and the use of electronic devices such as TVs, cell phones and tablets (screen time) increases.", [["cell", "ANATOMY", 186, 190], ["cell", "CELL", 186, 190], ["irregular", "PROBLEM", 58, 67], ["electronic devices", "TREATMENT", 154, 172], ["TVs", "TEST", 181, 184], ["irregular", "OBSERVATION_MODIFIER", 58, 67]]], ["[22] An increase in parental stress levels during a pandemic, a factor that directly interferes in children's quality of life, is therefore evident.", [["pandemic", "DISEASE", 52, 60], ["children", "ORGANISM", 99, 107], ["children", "SPECIES", 99, 107], ["An increase in parental stress levels", "PROBLEM", 5, 42], ["increase", "OBSERVATION_MODIFIER", 8, 16]]], ["[6] Anxiety, excessive concern with cleanliness, excessive fear of falling ill or losing a loved one, concern for the elderly, increased domestic accidents, mood disorders, anxiety disorder, panic, or obsessive-compulsive disorder, and post-traumatic stress are consequences that children and adolescents may experience, according to research into pandemic situations similar to the current one.", [["Anxiety", "DISEASE", 4, 11], ["falling ill", "DISEASE", 67, 78], ["domestic accidents", "DISEASE", 137, 155], ["mood disorders", "DISEASE", 157, 171], ["anxiety disorder", "DISEASE", 173, 189], ["panic", "DISEASE", 191, 196], ["obsessive-compulsive disorder", "DISEASE", 201, 230], ["post-traumatic stress", "DISEASE", 236, 257], ["children", "ORGANISM", 280, 288], ["children", "SPECIES", 280, 288], ["Anxiety", "PROBLEM", 4, 11], ["falling ill", "PROBLEM", 67, 78], ["mood disorders", "PROBLEM", 157, 171], ["anxiety disorder", "PROBLEM", 173, 189], ["panic", "PROBLEM", 191, 196], ["obsessive-compulsive disorder", "PROBLEM", 201, 230], ["post-traumatic stress", "PROBLEM", 236, 257], ["compulsive disorder", "OBSERVATION", 211, 230]]], ["[7, 23] In addressing the challenges for pregnant women during pandemics, fetal losses caused by possible maternal infection have been investigated; however, losses due to secondary causes, such as mood changes during pregnancy and in the postpartum period are also relevant.", [["fetal", "ANATOMY", 74, 79], ["fetal losses", "DISEASE", 74, 86], ["maternal infection", "DISEASE", 106, 124], ["women", "ORGANISM", 50, 55], ["fetal", "ANATOMICAL_SYSTEM", 74, 79], ["women", "SPECIES", 50, 55], ["pandemics", "PROBLEM", 63, 72], ["fetal losses", "PROBLEM", 74, 86], ["maternal infection", "PROBLEM", 106, 124], ["secondary causes", "PROBLEM", 172, 188], ["mood changes during pregnancy", "PROBLEM", 198, 227], ["infection", "OBSERVATION", 115, 124]]], ["[24, 25] J o u r n a l P r e -p r o o fDiscussionThe literature reveals that maternal anxiety and depression during pregnancy are related to impairments in children's neurodevelopment and predispose increased behavioral disorders.", [["anxiety", "DISEASE", 86, 93], ["depression", "DISEASE", 98, 108], ["behavioral disorders", "DISEASE", 209, 229], ["children", "ORGANISM", 156, 164], ["children", "SPECIES", 156, 164], ["The literature", "TEST", 49, 63], ["maternal anxiety", "PROBLEM", 77, 93], ["depression during pregnancy", "PROBLEM", 98, 125], ["impairments in children's neurodevelopment", "PROBLEM", 141, 183], ["increased behavioral disorders", "PROBLEM", 199, 229], ["depression", "OBSERVATION", 98, 108]]], ["[5] Although there are no consolidated studies on the possible impacts of COVID-19 on the health of pregnant women and their children, especially over the long term, the maternal stress caused during this period is a problem that needs to be more widely addressed.", [["COVID-19", "CHEMICAL", 74, 82], ["COVID-19", "CHEMICAL", 74, 82], ["women", "ORGANISM", 109, 114], ["children", "ORGANISM", 125, 133], ["women", "SPECIES", 109, 114], ["children", "SPECIES", 125, 133], ["consolidated studies", "PROBLEM", 26, 46], ["COVID", "TEST", 74, 79], ["no", "UNCERTAINTY", 23, 25], ["consolidated", "OBSERVATION", 26, 38]]], ["[26] Genetic developmental programming is strongly influenced by the environment.DiscussionIn an environment with social restrictionswhere play and leisure activities are only possible within the home environment; where people wear masks and the learning of facial expressions, communication, and language is restricted; and where demonstrating affection is discouraged by manythere is a tendency towards limitations in the formation of certain areas of the brain, including the social brain, with consequent impairment in the acquisition of cognitive, behavioral, social, and communication skills.", [["facial", "ANATOMY", 258, 264], ["brain", "ANATOMY", 458, 463], ["brain", "ANATOMY", 486, 491], ["impairment in the acquisition of cognitive, behavioral, social, and communication skills", "DISEASE", 509, 597], ["people", "ORGANISM", 220, 226], ["brain", "ORGAN", 458, 463], ["brain", "ORGAN", 486, 491], ["people", "SPECIES", 220, 226], ["consequent impairment", "PROBLEM", 498, 519], ["brain", "ANATOMY", 458, 463], ["social brain", "ANATOMY", 479, 491]]], ["[27] Social isolation taken as a prophylactic measure during pandemics is important, but may have several negative impactssuch as anxiety and stress in adults and also in childrensince free socialization and relationships are important for well-being, increasing social behaviors and stimulating synaptic connections, favoring the construction of the social brain.", [["synaptic", "ANATOMY", 296, 304], ["brain", "ANATOMY", 358, 363], ["anxiety", "DISEASE", 130, 137], ["brain", "ORGAN", 358, 363], ["Social isolation", "TREATMENT", 5, 21], ["a prophylactic measure", "TREATMENT", 31, 53], ["anxiety", "PROBLEM", 130, 137], ["social brain", "ANATOMY", 351, 363]]], ["[28, 29] Studies comparing the symptoms of post-traumatic stress in parents and children confined in pandemic situations with those of families in normal routines indicate that stress levels are four times higher for children who have been in quarantine.", [["post-traumatic stress", "DISEASE", 43, 64], ["children", "ORGANISM", 80, 88], ["children", "ORGANISM", 217, 225], ["children", "SPECIES", 80, 88], ["children", "SPECIES", 217, 225], ["the symptoms", "PROBLEM", 27, 39], ["post-traumatic stress in parents", "PROBLEM", 43, 75], ["stress levels", "PROBLEM", 177, 190], ["post-traumatic stress", "OBSERVATION", 43, 64]]], ["[7] During pandemics such as the current one, one common measure is suspending in-person school activities to aid in controlling the spread of the virus.", [["the virus", "PROBLEM", 143, 152]]], ["The possible ways and times to carry out such activities are heavily discussed in the scientific context and their impacts affect families in different ways.DiscussionThe effectiveness of school shutdown as a measure to combat the spread of epidemics such as COVID-19 has been discussed.", [["COVID-19", "CHEMICAL", 259, 267], ["COVID-19", "CHEMICAL", 259, 267], ["epidemics", "PROBLEM", 241, 250], ["possible", "UNCERTAINTY", 4, 12]]], ["[ Kim et al., in a 2020 study based on a mathematical model that evaluated populations in two groups, one aged 19 years or below and another aged over 19, using a susceptibility-exposure-infection-recovery model to analyze school closure in Korea, concluded that this approach was essential in mitigating the COVID-19 epidemic.", [["infection", "DISEASE", 187, 196], ["a 2020 study", "TEST", 17, 29], ["infection", "PROBLEM", 187, 196], ["the COVID", "TEST", 305, 314], ["infection", "OBSERVATION", 187, 196]]], ["[32] They added that maintaining the suspension of classes would save 255 children in the Korean population, factoring a 30-fold increase in infection rate among students returning to school.DiscussionIn families with more favorable socioeconomic conditions, children and caregivers need to adapt to a distance-learning model.", [["infection", "DISEASE", 141, 150], ["children", "ORGANISM", 74, 82], ["children", "ORGANISM", 259, 267], ["children", "SPECIES", 74, 82], ["children", "SPECIES", 259, 267], ["infection rate", "PROBLEM", 141, 155], ["infection", "OBSERVATION", 141, 150]]], ["This can generate increased demands for parents to provide guidance to their children about the excessive use of electronic devices (screen time).", [["children", "ORGANISM", 77, 85], ["children", "SPECIES", 77, 85], ["electronic devices", "TREATMENT", 113, 131]]], ["It is also important to note that, in many cases, closing schools in less developed countries causes a total shutdown of learning activities, since the socioeconomic reality of a large portion of the population prevents access to distance education projects using the internet.", [["large", "OBSERVATION_MODIFIER", 179, 184]]], ["[2] In these countries, children have access to a range of playful, evaluative, extracurricular and socialization activities at school, and school closure therefore involves a substantial loss in the teaching/learning and socialization processes.", [["children", "ORGANISM", 24, 32], ["children", "SPECIES", 24, 32]]], ["In addition, a number of public policies take place in schoolsmainly in public J o u r n a l P r e -p r o o f institutionssuch as balanced and free food programs, guidance about personal hygiene, sports projects, citizenship incentives, and others.DiscussionIn a context in which children spend the whole day at home, [33] there are increased lonely periods and moments for child self-care.", [["children", "ORGANISM", 280, 288], ["children", "SPECIES", 280, 288]]], ["Situations such as these are fragile, particularly for children under 13 years of age who care for younger siblings without assistance from adults, which can cause an increased risk of domestic accidents, serious behavioral impacts and developmental disorders, such as selective mutism, speech delay, social interaction deficits, and others.", [["accidents", "DISEASE", 194, 203], ["developmental disorders", "DISEASE", 236, 259], ["mutism", "DISEASE", 279, 285], ["speech delay", "DISEASE", 287, 299], ["social interaction deficits", "DISEASE", 301, 328], ["children", "ORGANISM", 55, 63], ["children", "SPECIES", 55, 63], ["serious behavioral impacts", "PROBLEM", 205, 231], ["developmental disorders", "PROBLEM", 236, 259], ["selective mutism, speech delay", "PROBLEM", 269, 299], ["social interaction deficits", "PROBLEM", 301, 328], ["fragile", "OBSERVATION", 29, 36], ["increased", "OBSERVATION_MODIFIER", 167, 176], ["domestic accidents", "OBSERVATION", 185, 203]]], ["Other possible consequences of school closures are the possibility that child abuse may remain unreported and that the longer the period of school closures the higher the possibility that the child will never return to school.DiscussionThere are also nutritional risks and other impacts on children's growth and development.", [["children", "ORGANISM", 290, 298], ["children", "SPECIES", 290, 298], ["school closures", "TREATMENT", 31, 46]]], ["The literature demonstrates that a lack of basic supplies such as food, water, and clothing causes frustration and has been consistently associated with anxiety, months after quarantine in previous epidemics.", [["anxiety", "DISEASE", 153, 160], ["frustration", "PROBLEM", 99, 110], ["anxiety", "PROBLEM", 153, 160]]], ["[13] The causal factors of social contexts already related to dietary errors, child malnutrition, or obesity worsens due to decreased public support for the vulnerable (closures or limited functioning of schools that provide food, NGOs, and popular restaurants) with consequent difficulties with healthy nutrition.DiscussionThe pandemic, by restricting the maintenance of outside activities and weight loss programs, encourages a sedentary lifestyle due to social distancing and a ban on attending gyms, parks, and leisure areas, alongside an increase in the consumption of canned food (high in sodium) and industrialized foods (with a longer shelf life) containing less essential nutrients for the developing brain, resulting in a negative impact on the growth of children and adolescents.DiscussionIt is therefore important to anticipate malnutrition and childhood obesity classically associated with a higher incidence of respiratory infections and precarious immune response.", [["brain", "ANATOMY", 710, 715], ["respiratory", "ANATOMY", 925, 936], ["dietary errors", "DISEASE", 62, 76], ["malnutrition", "DISEASE", 84, 96], ["obesity", "DISEASE", 101, 108], ["weight loss", "DISEASE", 395, 406], ["sodium", "CHEMICAL", 595, 601], ["malnutrition", "DISEASE", 840, 852], ["obesity", "DISEASE", 867, 874], ["respiratory infections", "DISEASE", 925, 947], ["sodium", "CHEMICAL", 595, 601], ["sodium", "SIMPLE_CHEMICAL", 595, 601], ["brain", "ORGAN", 710, 715], ["children", "ORGANISM", 765, 773], ["children", "SPECIES", 765, 773], ["adolescents", "SPECIES", 778, 789], ["dietary errors", "PROBLEM", 62, 76], ["child malnutrition", "PROBLEM", 78, 96], ["obesity", "PROBLEM", 101, 108], ["decreased public support", "TREATMENT", 124, 148], ["consequent difficulties with healthy nutrition", "PROBLEM", 267, 313], ["weight loss programs", "TREATMENT", 395, 415], ["a longer shelf life", "TREATMENT", 634, 653], ["the developing brain", "PROBLEM", 695, 715], ["malnutrition", "PROBLEM", 840, 852], ["childhood obesity", "PROBLEM", 857, 874], ["respiratory infections", "PROBLEM", 925, 947], ["precarious immune response", "PROBLEM", 952, 978], ["increase", "OBSERVATION_MODIFIER", 543, 551], ["brain", "ANATOMY", 710, 715], ["obesity", "OBSERVATION", 867, 874], ["respiratory", "ANATOMY", 925, 936], ["infections", "OBSERVATION", 937, 947], ["precarious immune response", "OBSERVATION", 952, 978]]], ["In addition, there is a clear tendency for such patients to get worse due to these factors, and this may continue for many months after the pandemic has ended, due to a growing economic crisis and accentuated social vulnerabilities.DiscussionIn turn, a cross-section of 1,319 American adultsincluding 284 fatherssuggested that 68% of fathers feel closer or much closer to their children since the pandemic.", [["patients", "ORGANISM", 48, 56], ["fathers", "ORGANISM", 334, 341], ["children", "ORGANISM", 378, 386], ["patients", "SPECIES", 48, 56], ["children", "SPECIES", 378, 386], ["a growing economic crisis", "PROBLEM", 167, 192], ["accentuated social vulnerabilities", "PROBLEM", 197, 231], ["clear", "OBSERVATION_MODIFIER", 24, 29], ["tendency", "OBSERVATION", 30, 38], ["growing", "OBSERVATION_MODIFIER", 169, 176], ["economic crisis", "OBSERVATION", 177, 192], ["accentuated", "OBSERVATION_MODIFIER", 197, 208], ["social vulnerabilities", "OBSERVATION", 209, 231]]], ["[35] Child toxic stress in previously unstructured homesDiscussionThe pandemic experience of COVID-19 aggravates the rates of substance abuse, domestic violence, and untreated and pre-existing mental health problems.", [["substance abuse", "DISEASE", 126, 141], ["domestic violence", "DISEASE", 143, 160], ["Child toxic stress", "PROBLEM", 5, 23], ["COVID", "TEST", 93, 98], ["pre-existing mental health problems", "PROBLEM", 180, 215]]], ["2 Many caregivers have experienced symptoms of post-traumatic stress, confusion, anxiety, and anger.", [["post-traumatic stress", "DISEASE", 47, 68], ["confusion", "DISEASE", 70, 79], ["anxiety", "DISEASE", 81, 88], ["anger", "DISEASE", 94, 99], ["symptoms", "PROBLEM", 35, 43], ["post-traumatic stress", "PROBLEM", 47, 68], ["confusion", "PROBLEM", 70, 79], ["anxiety", "PROBLEM", 81, 88], ["post-traumatic stress", "OBSERVATION", 47, 68]]], ["This leads to caregivers having a greater predisposition to mental health problems, compounded by the reduced availability of elective care, while users of illicit substances face increased levels of stress, and families with a history of domestic violence do not benefit from the supervision of guardianship services.", [["domestic violence", "DISEASE", 239, 256], ["mental health problems", "PROBLEM", 60, 82], ["elective care", "TREATMENT", 126, 139], ["guardianship services", "TREATMENT", 296, 317]]], ["[13, 36] Issues such as these become even more relevant when analyzing children previously exposed to vulnerable domestic environments and who, through social isolation, are confined full time.", [["children", "ORGANISM", 71, 79], ["children", "SPECIES", 71, 79]]], ["[37, 38] Added to this is the child's inability to access external support networks, such as school, tutoring services, friendly environments, and play activities.DiscussionIt is thus evident that social isolation should be evaluated as a contributing factor for environments inappropriate to children's mental health.", [["children", "ORGANISM", 293, 301], ["children", "SPECIES", 293, 301], ["external support networks", "TREATMENT", 58, 83], ["social isolation", "TREATMENT", 197, 213]]], ["It is also necessary to understand that, in many homes, social isolation amplifies the harmful experiences that the child has faced for a long time, without the possibility of minimizing psychological aggression and resulting in toxic stress.", [["aggression", "DISEASE", 201, 211], ["toxic stress", "PROBLEM", 229, 241]]], ["There is therefore an urgent need for psychosocial support, especially for families that had already displayed risk factors for healthy child development prior to the pandemic.DiscussionStrategies for preventing health problems and promoting child growth and development Around the world, millions of children live with ACEs and many adults live with their legacy.", [["ACEs", "DISEASE", 320, 324], ["children", "ORGANISM", 301, 309], ["children", "SPECIES", 301, 309], ["psychosocial support", "TREATMENT", 38, 58], ["the pandemic", "PROBLEM", 163, 175]]], ["Scientific findings suggest that a 10% reduction in ACE prevalence could equate to annual savings of three million disability-adjusted life years (DALYs) or $105 billion.", [["ACE", "GENE_OR_GENE_PRODUCT", 52, 55], ["a 10% reduction in ACE prevalence", "TREATMENT", 33, 66]]], ["Programs to prevent ACEs and moderate their effects are hugely important, in line with SDG priorities.", [["ACEs", "DISEASE", 20, 24], ["SDG", "SIMPLE_CHEMICAL", 87, 90], ["ACEs", "PROBLEM", 20, 24], ["moderate", "OBSERVATION_MODIFIER", 29, 37]]], ["Rebalancing expenditures towards ensuring safe and nurturing childhoods is economically beneficial and would relieve pressures on healthcare systems.", [["Rebalancing expenditures", "PROBLEM", 0, 24], ["pressures on healthcare systems", "PROBLEM", 117, 148]]], ["[3] J o u r n a l P r e -p r o o f Initiatives that have a great impact on the general and mental health of children and adolescents include: public health education and family support strategies; parental training in organizing play, physical activities, a balanced diet, appropriate screen time and content, mindfulness techniques, moments to share anguish, listening time for children, the transmission of a sense of security and resilience, affection, and reciprocity in relationships between parents and children; satisfactory school learning; and specialized treatment for children who suffer toxic stress and its consequences.", [["children", "ORGANISM", 108, 116], ["children", "ORGANISM", 509, 517], ["children", "ORGANISM", 579, 587], ["children", "SPECIES", 108, 116], ["adolescents", "SPECIES", 121, 132], ["children", "SPECIES", 379, 387], ["children", "SPECIES", 509, 517], ["children", "SPECIES", 579, 587], ["Initiatives", "TREATMENT", 35, 46], ["family support strategies", "TREATMENT", 170, 195], ["parental training", "TREATMENT", 197, 214], ["toxic stress", "PROBLEM", 599, 611]]], ["Firstly, due to the immediacy imposed by the COVID-19 pandemic, this study was conducted in mere months.", [["the COVID", "TEST", 41, 50], ["this study", "TEST", 64, 74]]], ["Secondly, the review revealed a scarcity of publications that address the topic of child development and health in epidemic contexts, which reflects the continued inadequate focus on child development and its determinants.ConclusionsThe COVID-19 pandemic has produced high morbidity and mortality rates within the global population, [39] as well as risk factors for healthy growth and development among children.", [["children", "ORGANISM", 403, 411], ["children", "SPECIES", 403, 411], ["the review", "TEST", 10, 20], ["a scarcity of publications", "PROBLEM", 30, 56], ["The COVID", "TEST", 233, 242], ["high morbidity", "PROBLEM", 268, 282], ["mortality rates", "PROBLEM", 287, 302], ["inadequate", "OBSERVATION_MODIFIER", 163, 173], ["focus", "OBSERVATION", 174, 179], ["high", "OBSERVATION_MODIFIER", 268, 272], ["morbidity", "OBSERVATION", 273, 282]]], ["The increase in parental stress, the suspension of classroom activities, social isolation measures, nutritional risks, children's exposure to toxic stress, especially in previously unstructured homes, and a lack of physical activities are some of the factors found in the literature.ConclusionsIn the face of this pandemic, the creation of activities to promote health and healthy development and prevent toxic stress becomes a priority in order to improve the individual health of children and adolescents and their families, the health of the community, and the intellectual and working capacity of these individuals over the long term, with positive economic and social results for each nation, in order to ensure that the SDGs are fulfilled.Conflicts of interestThe authors declare no conflicts of interest.", [["toxic stress", "DISEASE", 142, 154], ["children", "ORGANISM", 119, 127], ["children", "ORGANISM", 482, 490], ["children", "SPECIES", 119, 127], ["children", "SPECIES", 482, 490], ["adolescents", "SPECIES", 495, 506], ["parental stress", "PROBLEM", 16, 31], ["classroom activities", "TREATMENT", 51, 71], ["social isolation measures", "TREATMENT", 73, 98], ["toxic stress", "PROBLEM", 142, 154], ["this pandemic", "PROBLEM", 309, 322], ["toxic stress", "PROBLEM", 405, 417], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["parental stress", "OBSERVATION", 16, 31]]]], "PMC7228376": [["INTRODUCTIONCoronavirus disease 2019 (COVID\u201019), which was first reported in Wuhan, Hubei province, China, has caused over 80 422 human infections and more than 2984 deaths (as of 4 March 2020) in China.1,2The confirmed cases outside China are increasing, which raised major global concern.", [["INTRODUCTIONCoronavirus disease", "DISEASE", 0, 31], ["infections", "DISEASE", 136, 146], ["deaths", "DISEASE", 166, 172], ["1,2", "CHEMICAL", 203, 206], ["human", "ORGANISM", 130, 135], ["human", "SPECIES", 130, 135], ["human", "SPECIES", 130, 135], ["INTRODUCTIONCoronavirus disease", "PROBLEM", 0, 31], ["increasing", "OBSERVATION_MODIFIER", 244, 254]]], ["Severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) was identified to be the pathogen of COVID\u201019.", [["acute respiratory syndrome coronavirus", "DISEASE", 7, 45], ["SARS\u2010CoV\u20102", "ORGANISM", 49, 59], ["Severe acute respiratory syndrome coronavirus", "SPECIES", 0, 45], ["SARS\u2010CoV", "SPECIES", 49, 57], ["Severe acute respiratory syndrome coronavirus", "PROBLEM", 0, 45], ["SARS\u2010CoV\u2010", "TEST", 49, 58], ["acute", "OBSERVATION_MODIFIER", 7, 12], ["respiratory syndrome", "OBSERVATION", 13, 33]]], ["SARS\u2010CoV\u20102 has joined SARS\u2010CoV and Middle East respiratory syndrome\u2010related coronavirus (MERS\u2010CoV) as another coronavirus that causes severe respiratory disease and human death.3,4", [["respiratory", "ANATOMY", 141, 152], ["SARS", "DISEASE", 0, 4], ["CoV\u20102", "CHEMICAL", 5, 10], ["respiratory syndrome\u2010related coronavirus", "DISEASE", 47, 87], ["coronavirus", "DISEASE", 110, 121], ["respiratory disease", "DISEASE", 141, 160], ["death", "DISEASE", 171, 176], ["3,4", "CHEMICAL", 177, 180], ["SARS\u2010CoV", "ORGANISM", 22, 30], ["Middle East respiratory syndrome\u2010related coronavirus", "ORGANISM", 35, 87], ["MERS\u2010CoV", "ORGANISM", 89, 97], ["human", "ORGANISM", 165, 170], ["coronavirus", "SPECIES", 110, 121], ["human", "SPECIES", 165, 170], ["SARS\u2010CoV", "SPECIES", 22, 30], ["Middle East respiratory syndrome\u2010related coronavirus", "SPECIES", 35, 87], ["MERS\u2010CoV", "SPECIES", 89, 97], ["human", "SPECIES", 165, 170], ["joined SARS\u2010CoV", "PROBLEM", 15, 30], ["Middle East respiratory syndrome\u2010related coronavirus", "PROBLEM", 35, 87], ["another coronavirus", "PROBLEM", 102, 121], ["severe respiratory disease", "PROBLEM", 134, 160], ["human death", "PROBLEM", 165, 176], ["Middle", "ANATOMY_MODIFIER", 35, 41], ["severe", "OBSERVATION_MODIFIER", 134, 140], ["respiratory disease", "OBSERVATION", 141, 160]]]]}